Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42273,-0.261829477416158,0.0121398879999139,-0.285623657895989,-0.238035296936326,2.08973005418122e-101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,42120,0.0916515737410211,0.00438920326317085,0.0830487353452063,0.100254412136836,2.94628121590844e-95
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,42094,0.18293684337432,0.00918190995526733,0.164940299861996,0.200933386886644,5.13999961905452e-87
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41861,0.240766118409857,0.0127318079681768,0.215811774792231,0.265720462027484,1.12674503712604e-78
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,40102,-0.0429570627918603,0.00240169190414324,-0.047664378923981,-0.0382497466597395,1.53074800540067e-70
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39902,-0.31877889094816,0.0184111556698994,-0.354864756061163,-0.282693025835158,2.91169584792931e-66
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,40102,-0.0926944739023111,0.00538363484976837,-0.103246398207857,-0.082142549596765,1.4305683139321e-65
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39804,0.100930970319187,0.00590838040595579,0.0893505447235137,0.11251139591486,1.4524554192679e-64
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39706,0.165572719936103,0.0103766870884006,0.145234413242838,0.185911026629369,1.18985918939681e-56
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42197,-0.0597992797271429,0.0038063384960947,-0.0672597031794885,-0.0523388562747973,4.11648331596069e-55
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,40080,0.130293158411487,0.00839938198829325,0.113830369714433,0.146755947108542,1.07486148918723e-53
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40097,0.0629566702172467,0.0041794696332621,0.054764909736053,0.0711484306984404,9.1373006424062e-51
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42223,0.0535811578232106,0.00370508721065701,0.0463191868903228,0.0608431287560983,4.90449601432592e-47
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,42170,0.116072176576811,0.00828329986256848,0.0998369088461766,0.132307444307445,2.73649325662723e-44
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41931,-0.0748655950354656,0.00545776339544913,-0.0855628112905459,-0.0641683787803853,1.60425430373116e-42
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,42144,0.0818024446163121,0.00619160942149614,0.0696668901501797,0.0939379990824445,1.35226023065357e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,42158,0.0449559445175325,0.00343548155174912,0.0382224006761043,0.0516894883589608,7.00088586665237e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42274,-0.0828049159115156,0.0063418601142981,-0.0952349617355399,-0.0703748700874914,1.0135426538336e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,42110,0.137728537781112,0.0105627183462257,0.11702560982251,0.158431465739715,1.28472856665879e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42094,0.0476074995491461,0.00369669485748445,0.0403619776284765,0.0548530214698156,1.01689614946084e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42184,-0.0358445996754674,0.002807731835348,-0.0413477540727495,-0.0303414452781854,4.21999613630392e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,40021,0.0910167801325626,0.00735138165131349,0.0766080720959882,0.105425488169137,5.7153849420555e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,42122,-0.214910990483111,0.0175000267080078,-0.249211042830807,-0.180610938135416,1.79157849397894e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41876,0.101269462189832,0.00828073082460648,0.0850392297736034,0.117499694606061,3.36794758538178e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,42256,0.0357178743541499,0.0029720292533665,0.0298926970175515,0.0415430516907482,4.27104224170197e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,40102,-0.0588068855399794,0.00499648102557903,-0.0685999883501143,-0.0490137827298445,8.70810338647267e-32
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,40097,-0.0714213073405315,0.00612576804733253,-0.0834278127133033,-0.0594148019677597,3.1563499811021e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42120,0.0634532057654402,0.00546322388404813,0.0527452869527059,0.0741611245781745,4.95274848580871e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,40102,-0.0589315500989841,0.0051295532565579,-0.0689854744818375,-0.0488776257161306,2.24948999908319e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41841,0.0695202319119113,0.00612040484859771,0.0575242384086598,0.0815162254151628,9.34935314854031e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41876,0.0612733262004762,0.00550062064872602,0.0504921097289733,0.0720545426719792,1.09645036697999e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,42140,0.0389357654255685,0.00350315829524423,0.0320695751668898,0.0458019556842472,1.43646216656711e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39784,0.141209928425458,0.0128036157889653,0.116114841479086,0.16630501537183,3.94283381442955e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42186,-0.0372584047945367,0.00338071298835547,-0.0438846022517135,-0.03063220733736,4.0376968299075e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,42256,0.0559887288638162,0.0052004583296134,0.045795830537774,0.0661816271898585,6.4531685851002e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,42078,0.0458386992832402,0.0042945678676493,0.0374213462626475,0.0542560523038328,1.74445764965433e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41985,0.078921297875442,0.00747636045704522,0.0642676313796333,0.0935749643712506,6.08479730505091e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40113,-0.0285716497366438,0.002710359446508,-0.0338839542517995,-0.0232593452214881,7.38915063329914e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40113,-0.0272805366889635,0.00259647571005691,-0.032369629080675,-0.0221914442972519,1.06625695069029e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,42161,-0.0213392569755292,0.00203226383309108,-0.0253224940883877,-0.0173560198626707,1.09233000953568e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41772,0.0589861486614851,0.00563675855023543,0.0479381019030237,0.0700341954199465,1.59964695797362e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,42223,0.0674417069130324,0.0064946343782325,0.0547122235316967,0.0801711902943681,3.66734978683138e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,40080,0.0935379099724007,0.00910708430202899,0.0756880247404239,0.111387795204377,1.2346094911358e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,42217,0.0637175650986647,0.0062070255037203,0.051551795111373,0.0758833350859565,1.25242029244476e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40035,0.0890239764306213,0.00867290279943789,0.0720250869437231,0.10602286591752,1.31826732076367e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42186,0.0247168741062251,0.0024146207313128,0.019984217472852,0.0294495307395982,1.68845545004039e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42103,0.0556076559837915,0.0055074127764394,0.0448131269419702,0.0664021850256127,6.99465880233634e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41961,0.0393257840627759,0.00393161743560025,0.0316198138889994,0.0470317542365524,1.81395584252103e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,40113,-0.0701394290193901,0.00701442323137073,-0.0838876985528768,-0.0563911594859035,1.93533130356972e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40054,-0.0371357889079266,0.0037536050596082,-0.0444928548247587,-0.0297787229910946,5.56321142173137e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42094,0.0827048558749949,0.00836633017786925,0.0663068487263712,0.0991028630236187,5.80983118227574e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,42193,0.116897337215303,0.0119697009944906,0.0934367232661016,0.140357951164505,1.88003319716601e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,42194,0.0627205313792356,0.00642478115656174,0.0501279603123745,0.0753131024460966,1.9516758649702e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,42186,0.0324296426939396,0.00332418433211973,0.0259142414029849,0.0389450439848942,2.08241841813499e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,42120,0.040266447781831,0.00417248247553448,0.0320883821297834,0.0484445134338785,5.80242869655397e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,42103,0.0378720578927616,0.0039313471985683,0.0301666173835677,0.0455774984019555,6.84933878261388e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,42120,-0.0280894692344488,0.00293869618331163,-0.0338493137537396,-0.022329624715158,1.40822365213127e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39804,0.0568334032321564,0.00596933514202723,0.0451335063537831,0.0685333001105298,2.0903021902854e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39804,0.0551380465575185,0.00579182503056334,0.0437860694976143,0.0664900236174226,2.10863992295931e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39863,-0.0300327342925501,0.00317288101825528,-0.0362515810883304,-0.0238138874967697,3.5390439105033e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,42211,-0.0267815118401169,0.00283633457369649,-0.032340727604562,-0.0212222960756718,4.25997985240899e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41829,0.0499053126769731,0.00532971925642135,0.0394590629343872,0.0603515624195589,8.99789007878848e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40020,0.0524316015712604,0.00560737598518533,0.0414411446402972,0.0634220585022237,1.04424212473172e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42094,-0.0188136782195673,0.00201853263357325,-0.0227700021813709,-0.0148573542577637,1.34424337836254e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,42144,-0.0443141918921597,0.00475553874567085,-0.0536350478336746,-0.0349933359506449,1.36931222855566e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,41291,0.0402401565963314,0.00432527592789357,0.03176261577766,0.0487176974150028,1.59116877851665e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41830,0.046672110924702,0.00506740949200348,0.0367399883203752,0.0566042335290288,3.76157965863106e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42121,0.0772871189602311,0.00842214803761853,0.0607797088064988,0.0937945291139634,5.11419288244103e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42004,0.048740948609025,0.00532738688255154,0.038299270319224,0.059182626898826,6.59792091114856e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40097,0.0316863333976714,0.00348729673411153,0.0248512317988128,0.03852143499653,1.20248434111017e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,42120,0.0360861805721103,0.00398471041256787,0.0282761481634772,0.0438962129807433,1.54295326203436e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39863,0.047134704757814,0.00523424235057883,0.0368755897506795,0.0573938197649485,2.52192103747047e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42094,0.0365229456798272,0.0040616948356125,0.0285620238020267,0.0444838675576277,2.76161906028454e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42213,0.126979725102783,0.0141407585463113,0.099263838352013,0.154695611853553,3.08408580334206e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42193,0.0377310746592818,0.00420394302914554,0.0294913463221566,0.0459708029964071,3.2135962661107e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,42120,-0.0247399131994482,0.00277342997297974,-0.0301758359464885,-0.0193039904524079,5.26803657630934e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39706,0.0569254788773542,0.00645034883102517,0.0442827951685448,0.0695681625861635,1.26619347187909e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,42159,0.0290326133827271,0.00330754662868893,0.0225498219904968,0.0355154047749574,1.87573639406554e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42108,0.0177239429826552,0.00203508932144033,0.0137351679126322,0.0217127180526783,3.43013903605673e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,42173,0.0587509786350437,0.00676037903348367,0.0455006357294157,0.0720013215406717,4.03795557978604e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41861,0.0678696320308448,0.007812792193332,0.052556559331914,0.0831827047297755,4.17492666989127e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,42296,0.0445741052315094,0.00517734015628112,0.0344265185251984,0.0547216919378204,8.17152167418622e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39863,0.0246217681946904,0.00287668247692879,0.01898347053991,0.0302600658494708,1.29378029485911e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42103,-0.0307605448658141,0.00359902570163212,-0.037814635241013,-0.0237064544906151,1.40532584910464e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39863,0.0647277280358476,0.007580847076789,0.0498692677653412,0.0795861883063541,1.54679645152112e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42094,-0.0360127012670003,0.00421943632382378,-0.0442827964616949,-0.0277426060723057,1.55771133457087e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41739,0.0884151077245874,0.0103724189023981,0.0680851666758872,0.108745048773288,1.71571557678955e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41887,0.0481492659465631,0.00566316742082872,0.0370494578017388,0.0592490740913874,2.06735786561218e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,42094,0.0306508354511258,0.00360819643332186,0.023578770441815,0.0377229004604367,2.19891361413622e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39784,0.0385597278738837,0.00453939165842239,0.0296625202233758,0.0474569355243916,2.25476780859325e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,42223,0.0215846111093242,0.00254823148603579,0.016590077396694,0.0265791448219543,2.70515835580615e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,42296,-0.0209162339371846,0.00247430770652948,-0.0257658770419824,-0.0160665908323868,3.12715842946917e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,40054,0.0606522698229543,0.00720407040021264,0.0465322918385375,0.0747722478073711,4.26827859400555e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,42223,-0.0310239155880275,0.00368941989457003,-0.0382551785813848,-0.0237926525946703,4.56664995857689e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42296,-0.021418209231592,0.00254761140244548,-0.0264115275803851,-0.0164248908827988,4.63098178466341e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,42223,0.0397168294137338,0.00473450360340317,0.0304372023510636,0.048996456476404,5.41325163328962e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,0.0264306655557887,0.00315688556761964,0.0202431698432542,0.0326181612683232,6.22560762734058e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,40113,0.017021671294172,0.00203409534921305,0.0130348444097145,0.0210084981786296,6.56458705347707e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42094,0.0689963060000848,0.00826034055909025,0.0528060385042679,0.0851865734959016,7.34800583815816e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42296,-0.0247416755458749,0.00296515524081027,-0.030553379817863,-0.0189299712738868,7.88662749353915e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,42004,0.0352746489371744,0.00423012804311491,0.0269835979726692,0.0435656999016796,8.25938138042706e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,40080,0.0224396556028803,0.00270187520425537,0.0171439802025397,0.0277353310032208,1.11440461413889e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,42103,0.0279555807405723,0.00341124368870363,0.0212695431107132,0.0346416183704314,2.73797433847929e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,40080,0.0250286058349583,0.00305508676599317,0.0190406357736116,0.0310165758963049,2.84636628161712e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41861,0.0531917453612871,0.00650795149622822,0.0404361604286798,0.0659473302938945,3.28322690173372e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42186,-0.0334813805708222,0.00411402071632358,-0.0415448611748165,-0.025417899966828,4.36936664079988e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,42213,0.0196327119860441,0.00244459781199905,0.014841300274526,0.0244241236975623,1.04899676233096e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42120,-0.0194947482739893,0.0024324002123997,-0.0242622526902927,-0.0147272438576859,1.19924932046226e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,42223,-0.0386669224541965,0.00483258736363859,-0.0481387936869281,-0.0291950512214648,1.33488920697093e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41957,0.0237376139148025,0.00298326450882952,0.0178904154774967,0.0295848123521084,1.91192501441351e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42144,0.0285912521321406,0.00359752766931388,0.0215400979002854,0.0356424063639958,2.06041029495578e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42103,0.0222707512378846,0.00280623378249725,0.01677053302419,0.0277709694515792,2.25657395754961e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39858,0.0376239903825213,0.00474741670335059,0.0283190536439542,0.0469289271210885,2.50588695362509e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42162,-0.0361430939940821,0.00458742257733811,-0.0451344422456648,-0.0271517457424994,3.569706471504e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41984,0.0428371931825084,0.00544169593810519,0.0321714691438222,0.0535029172211946,3.76944618395431e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42184,-0.0166733834005704,0.00212814577768311,-0.0208445491248293,-0.0125022176763115,5.06377453478002e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,42256,0.0246386958275317,0.0031465772093564,0.0184714044971931,0.0308059871578702,5.24048121527199e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,42094,0.0646509679058072,0.00830535618952955,0.0483724697743293,0.0809294660372852,7.54585536218842e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39863,0.0392597897041626,0.00506333412699861,0.0293356548152453,0.0491839245930799,9.73494888122856e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42256,-0.0201612099426527,0.00261030572374315,-0.0252774091611893,-0.0150450107241161,1.21217504483987e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42239,0.0247572590237712,0.00320931466921774,0.0184670022721044,0.0310475157754379,1.30571915700861e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,40097,0.0580600028501007,0.00755843630169935,0.04324546769877,0.0728745380014314,1.70733481060265e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39862,-0.0241793020513226,0.00315269591779351,-0.0303585860501978,-0.0180000180524473,1.8784577909238e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42213,-0.0367443336278004,0.00482974945560158,-0.0462106425607795,-0.0272780246948214,2.97654806899919e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40076,-0.0116953366260494,0.00155324221768018,-0.0147396913727026,-0.00865098187939629,5.49121997789228e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,42162,0.0514238419040667,0.00684029379429213,0.0380168660672541,0.0648308177408793,5.93689405978977e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42197,-0.0451628199798884,0.00601939758194894,-0.0569608392405083,-0.0333648007192685,6.64831803954111e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39881,0.041641615239375,0.00555954729050672,0.0307449025499818,0.0525383279287681,7.42479604792139e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41861,0.0493732199538151,0.00659681769215725,0.0364434572771869,0.0623029826304434,7.66204174748445e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42094,0.0262758239071038,0.00351527586679425,0.019385883208187,0.0331657646060205,8.23339940661977e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,42223,0.0328496200547717,0.00442262753631288,0.0241812700835984,0.0415179700259449,1.17440783752805e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,42213,-0.0289738624559499,0.00390192230467661,-0.0366216301731161,-0.0213260947387837,1.19307705639608e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41861,0.0448443316893425,0.00603943539070379,0.0330070383235631,0.056681625055122,1.19762083604209e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42121,0.0739740149371395,0.00996835503228139,0.054436039073868,0.093511990800411,1.23607690884295e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,42144,-0.0285888799209606,0.0038593500297231,-0.0361532059792178,-0.0210245538627033,1.36471122348958e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,42144,0.0483102657122885,0.00652432712470016,0.0355225845478762,0.0610979468767008,1.3963849333153e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39768,0.0615235246851399,0.00835172703285505,0.045154139700744,0.0778929096695358,1.8813993347517e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39804,0.0468118524062185,0.00636399291423305,0.0343384262943217,0.0592852785181153,2.03904338953091e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42004,0.0539032567025298,0.0073433336475728,0.0395103227532871,0.0682961906517725,2.25747325405829e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42103,0.0297883057527998,0.00406394937941094,0.0218229649691543,0.0377536465364452,2.4404811343446e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42181,-0.0243318769912996,0.00333555540115832,-0.0308695655775699,-0.0177941884050293,3.16687686486648e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39863,0.0248628574156242,0.00341672005678338,0.0181660861043288,0.0315596287269196,3.65808328335616e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42094,0.0587813208460815,0.00811919118563811,0.0428677061222308,0.0746949355699322,4.74804831604669e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40020,0.0281454737634055,0.00388807995458509,0.0205248370524188,0.0357661104743923,4.82960044414685e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42094,0.0322226688044748,0.0044649622270106,0.0234713428395341,0.0409739947694156,5.62087689487541e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41989,0.0271045604877904,0.00378938336506625,0.0196773690922606,0.0345317518833203,8.96764270383941e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40021,0.0593896857414044,0.00830246395352592,0.0431168563924936,0.0756625150903152,9.02154664625853e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42103,0.0373941703744089,0.00523460178652301,0.0271343508728238,0.047653989875994,9.57594073296036e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42099,0.0367659826194506,0.00514694510049593,0.0266779702224786,0.0468539950164226,9.60309610601746e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,42184,0.0566040984253777,0.00793022162289813,0.0410608640444974,0.0721473328062581,9.98967867332058e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39804,0.0373645823818506,0.00530262750306912,0.0269714324758352,0.0477577322878661,1.94964015237993e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41887,0.0571012341957285,0.00815950279495678,0.0411086087176132,0.0730938596738438,2.72442285069042e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40054,0.0505022402587077,0.00721881401185102,0.0363533647954797,0.0646511157219357,2.79040036945344e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39863,0.0274055015324076,0.00392627102857533,0.0197100103163999,0.0351009927484152,3.12642854323897e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,40084,-0.0249120712574594,0.00357459093929153,-0.0319182694984708,-0.017905873016448,3.37153655860014e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39959,-0.0302093620233681,0.004335516337345,-0.0387069740445643,-0.0217117500021719,3.40557613807741e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42145,0.0464492624881287,0.00669483612216724,0.0333273836886809,0.0595711412875765,4.16385671190593e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,42094,-0.0547028472578282,0.0079274295998458,-0.070240609273526,-0.0391650852421304,5.42589864226898e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39784,0.0483153842340827,0.00702330560145481,0.0345497052552313,0.0620810632129342,6.3545951177371e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41861,0.0406778243159017,0.00592168070718448,0.0290713301298201,0.0522843185019832,6.75313252350007e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41829,0.0365023987803018,0.00532207306652247,0.0260711355699178,0.0469336619906858,7.27360568870755e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,42120,0.0461320633023346,0.00672861127845922,0.0329439851965546,0.0593201414081147,7.39784693614652e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,42082,0.0486635847210886,0.00710343340764887,0.0347408552420968,0.0625863142000804,7.68207181840216e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,42186,0.0368581381267694,0.00538367282650343,0.0263061393868227,0.0474101368667161,7.92004813418434e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41829,0.0431753415941108,0.00631183049248005,0.0308041538288499,0.0555465293593717,8.2620438769102e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,42076,0.0506445807377912,0.00740654695286429,0.0361277487101772,0.0651614127654052,8.40384417176202e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39911,0.0431591382817215,0.00638312088430678,0.0306482213484802,0.0556700552149628,1.43728550899354e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,42213,-0.0205276880939723,0.00304133990748683,-0.0264887143126464,-0.0145666618752981,1.54582764536677e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,42223,0.018569479517892,0.00275205776802814,0.0131754462925569,0.0239635127432272,1.56785424261444e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42186,-0.0196059133014058,0.00290780401464971,-0.0253052091701193,-0.0139066174326924,1.62248850075736e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,42144,-0.0324080440080298,0.0048194511745053,-0.0418541683100602,-0.0229619197059994,1.83683249125537e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,42144,0.0479653576034029,0.00713706503002243,0.0339767101445589,0.0619540050622468,1.88555308136768e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42144,0.029814729146057,0.00445433712937927,0.0210842283724736,0.0385452299196403,2.27002628885653e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,42178,0.0320310750755953,0.00478775269659826,0.0226470797902628,0.0414150703609279,2.31987883641282e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42099,0.0570321147709249,0.00853660586336496,0.0403003672787296,0.0737638622631202,2.47242973095192e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39940,0.0369116583580385,0.00552481558925581,0.0260830198030971,0.0477402969129799,2.48943045253863e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42223,-0.0399176397757578,0.00599523174447057,-0.0516682939949202,-0.0281669855565955,2.88253067931195e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41861,0.0400649043362862,0.00601893481541729,0.0282677920980683,0.0518620165745041,2.92026998197414e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42122,0.0774499705683985,0.0116737804353471,0.0545693609151182,0.100330580221679,3.38521948295053e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41936,0.0561965545438444,0.00847151797806851,0.0395923793068301,0.0728007297808587,3.40863377547128e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41876,0.0371958025607443,0.0056553890046555,0.0261112401116195,0.0482803650098691,4.98688089022457e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41770,-0.027162759441886,0.00414001642246962,-0.0352771916299265,-0.0190483272538456,5.55328945278165e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42094,0.0368607821117241,0.0056193910658617,0.0258467756226352,0.047874788600813,5.60228036944573e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39633,-0.0289110903840406,0.00442026937142417,-0.037574818352032,-0.0202473624160492,6.41517010791505e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,42094,0.0373852066175482,0.00572217208598098,0.0261697493290255,0.0486006639060709,6.67102797177468e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,42094,0.0471223172890761,0.00721635043276188,0.0329782704408628,0.0612663641372894,6.82630508233656e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39847,0.024828349970296,0.00381196667765764,0.0173568952820871,0.032299804658505,7.68491559746277e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41879,0.0400544060574494,0.00616315763982617,0.0279746170833901,0.0521341950315087,8.38764034275536e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41952,0.0239776137624993,0.00369111116737297,0.0167430358744483,0.0312121916505504,8.55218683661993e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39804,0.0245413576107724,0.00377903580581881,0.0171344474313675,0.0319482677901772,8.72798946712622e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42186,0.0149026876425668,0.00229594171161239,0.0104026418878065,0.0194027333973271,8.8435324676672e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42101,-0.0324267446222827,0.00501893681228445,-0.0422638607743602,-0.0225896284702052,1.07834033906674e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41967,-0.0182644925626548,0.00282825949836201,-0.0238078811794444,-0.0127211039458653,1.10043263834859e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42144,-0.0524916902221293,0.00813157832814401,-0.0684295837452916,-0.036553796698967,1.11864311351006e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42094,0.0390141318513283,0.00606211567709703,0.0271323851242181,0.0508958785784385,1.27229064614555e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41829,0.0335621995330814,0.00521940956327599,0.0233321567890605,0.0437922422771024,1.31965877913259e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39933,0.0173781684111753,0.00272175014522371,0.0120435381265368,0.0227127986958138,1.78564151672138e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,42120,0.0202703196828566,0.00318349397475112,0.0140306714923444,0.0265099678733688,1.98869981395165e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41829,0.0235426457268211,0.00371318711210566,0.016264798987094,0.0308204924665482,2.37156200340341e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42094,0.0558396028005613,0.00881422057153658,0.0385637304803496,0.073115475120773,2.44954589850132e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42004,0.0307938099465314,0.00486445137868159,0.0212594852443155,0.0403281346487474,2.52723277819588e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41987,0.0967237618197675,0.0153260267210022,0.0666847494466032,0.126762774192932,2.86243630505937e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,42213,0.0238253430801659,0.00377827943795781,0.0164199153817686,0.0312307707785632,2.95840068561563e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42256,-0.0180696223467145,0.00288249266704129,-0.0237193079741154,-0.0124199367193136,3.75414108784055e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,42144,-0.0199332189790919,0.00318569956046428,-0.0261771901176019,-0.0136892478405819,4.04578396763528e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,42144,-0.0225856509173795,0.00361343485725882,-0.0296679832376068,-0.0155033185971522,4.22071718095293e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42144,0.0402155651824988,0.0064770152061576,0.0275206153784299,0.0529105149865677,5.49644890219034e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,42103,0.0467865474558052,0.00759107966880498,0.0319080313049475,0.061665063606663,7.33387048675454e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,42213,0.0284586151166027,0.00464316417006362,0.019358013343278,0.0375592168899274,9.09057335304515e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42146,0.0161164959815987,0.0026482444410661,0.0109259368771092,0.0213070550860883,1.19236472785018e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,42186,-0.0195542683955089,0.00323551202239432,-0.0258958719594018,-0.0132126648316161,1.54801444988103e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41887,-0.0248072897849727,0.00412163439209252,-0.032885693193474,-0.0167288863764714,1.8056201947979e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,42296,0.0339591151458167,0.00564364383024037,0.0228975732385456,0.0450206570530879,1.82158646841636e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,42103,-0.0292330117193965,0.00487040885239107,-0.038779013070083,-0.01968701036871,1.99921930338472e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42197,-0.0273129689894276,0.00455303039023596,-0.0362369085542901,-0.0183890294245651,2.03992632000355e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40097,0.0239284044972703,0.0039883029823138,0.0161113306519353,0.0317454783426054,2.04030662654173e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41757,0.0121752148474413,0.0020343851525912,0.00818781994836253,0.01616260974652,2.22676746578892e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42223,0.0176518559491541,0.00296122116208765,0.0118478624714623,0.0234558494268459,2.57172783506182e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39768,0.0203053744820508,0.00340850474135753,0.01362470518899,0.0269860437751116,2.6466312542944e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40102,-0.0398593150103327,0.00669559650321755,-0.0529826841566391,-0.0267359458640263,2.71271110173869e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,40054,0.0883748139212635,0.0148777115533217,0.0592144992767531,0.117535128565774,2.93616089237651e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40076,-0.0298909426101496,0.00504017966045818,-0.0397696947446476,-0.0200121904756515,3.11137381151976e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42186,-0.0170984758565459,0.00288469050521809,-0.0227524692467733,-0.0114444824663184,3.15732613793866e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39863,-0.0262466319829579,0.00443149275727496,-0.0349323577872169,-0.017560906178699,3.26368652262288e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41815,-0.0343456110091886,0.00582033257037929,-0.045753462847132,-0.0229377591712452,3.70641926747379e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40097,0.0330477857531313,0.00561937349902404,0.0220338136950442,0.0440617578112185,4.19654696834957e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42120,-0.0209597702180571,0.00357225713160708,-0.0279613941960069,-0.0139581462401072,4.53593251214813e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,40054,0.0264120775782254,0.00450514983957597,0.0175819838926565,0.0352421712637943,4.6882504941673e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41861,0.0285575526062193,0.00487339088988643,0.0190057064620419,0.0381093987503967,4.74683085230498e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,42256,0.021972867193403,0.00376066492930673,0.0146019639319618,0.0293437704548442,5.25496203624641e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42032,-0.0344036263667458,0.00592179963085433,-0.0460103536432203,-0.0227968990902713,6.40857173657067e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42172,-0.017953083172388,0.00309483901915871,-0.0240189676499391,-0.0118871986948369,6.74682382066274e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42111,-0.0341664665181259,0.00589175875717745,-0.0457143136821937,-0.0226186193540581,6.82619566550576e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,40080,0.0217178983388113,0.00374875902364361,0.0143703306524698,0.0290654660251527,7.09054580463084e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,40097,-0.0227116188038382,0.00393297928867773,-0.0304202582096466,-0.0150029793980299,7.92152190582562e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,42094,0.0416585109841,0.00721494247581319,0.0275172237315061,0.0557997982366939,7.9231849199363e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42125,0.0260973341232311,0.00452637171688887,0.017225645558129,0.0349690226883333,8.32180555153878e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39706,0.0233135227134866,0.00404375607651817,0.015387760803511,0.0312392846234622,8.38019701506323e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40020,0.030518667779004,0.00529906865612565,0.0201324932129978,0.0409048423450103,8.6788414312683e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,40113,-0.0298763937328929,0.00518925412962036,-0.0400473318269488,-0.019705455638837,8.77440589057263e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42167,0.0384478228420032,0.00669298461318958,0.0253295730001516,0.0515660726838548,9.42652280476604e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,42094,-0.017440223582644,0.00303605361485081,-0.0233908886677516,-0.0114895584975364,9.43455382437478e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42004,0.0345764078199594,0.00602485916274991,0.0227676838609696,0.0463851317789492,9.741952497647e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42094,0.0319884535848692,0.00558527264004898,0.0210413192103732,0.0429355879593652,1.04327439310457e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40080,0.0389850977083964,0.00684368706859007,0.0255714710539598,0.0523987243628329,1.25459875145068e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,40113,-0.0138267486917655,0.00243147098053185,-0.018592431813608,-0.00906106556992309,1.32938725319599e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40080,0.0349408937518673,0.00614673465099484,0.0228932938359174,0.0469884936678172,1.34598435309812e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40097,0.0272118377244295,0.00479213430170436,0.017819254493089,0.0366044209557701,1.39406394057355e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,42197,-0.0280250877307387,0.00496583282995043,-0.0377581200774415,-0.0182920553840358,1.70027591923742e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40021,-0.0587618035641335,0.0104173022051187,-0.0791797158861661,-0.0383438912421009,1.73519733045115e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,40054,0.0356123139485649,0.0063307558910757,0.0232040324020565,0.0480205954950733,1.89783206806607e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39784,0.0209095815181011,0.00372374544245116,0.0136110404508968,0.0282081225853053,2.01281371762831e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41861,0.0326547092286417,0.00582285825519609,0.0212419070484574,0.044067511408826,2.08936840476538e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41876,0.0391946339932798,0.00699328126720528,0.0254878027095575,0.0529014652770022,2.13073710941607e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42004,0.0416462367332735,0.00745143310245318,0.0270414278524653,0.0562510456140817,2.330126045431e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42186,0.0175879180697277,0.00315390744410659,0.0114062594792788,0.0237695766601766,2.5023340692296e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,42004,-0.0197820869754563,0.00354893730536769,-0.026738004093977,-0.0128261698569357,2.53858826791842e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42126,-0.0196057411677574,0.0035198692564788,-0.0265046849104558,-0.0127067974250589,2.59793936969528e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,40021,0.0632387744954049,0.0113570881453313,0.0409788817305556,0.0854986672602543,2.63490494656177e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39863,0.0446263347822854,0.00802516547789165,0.0288970104456177,0.060355659118953,2.75007420000436e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40021,0.033675194104622,0.00605824591049997,0.021801032120042,0.0455493560892019,2.78433254042308e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41861,0.046180750536282,0.00833338273336538,0.0298473203788858,0.0625141806936781,3.05607460209651e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41876,0.0302557062066129,0.00546580882225765,0.0195427209149879,0.0409686914982379,3.16598449836121e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42103,0.0364329384689503,0.00660580171496416,0.0234855671076206,0.0493803098302801,3.54895130707533e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40054,0.0321711661787955,0.00585303648947851,0.0206992146594176,0.0436431176981733,3.96175119581259e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,42144,0.0265824616600633,0.00483950057541371,0.0170970405322524,0.0360678827878741,4.0305095651476e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,42045,0.0402951830057987,0.00735537336265371,0.0258786512149974,0.0547117147965999,4.37433011553339e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40021,-0.0491183812261569,0.0089682078636838,-0.0666960686389772,-0.0315406938133367,4.42403244531433e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41954,0.0270838574006063,0.00494741414038455,0.0173869256854525,0.03678078911576,4.47430741829654e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,40021,0.0571372656052662,0.0104433172322094,0.0366683638301358,0.0776061673803967,4.57000103133076e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41829,-0.0417095212382469,0.00763107188445822,-0.056666422131785,-0.0267526203447088,4.69703246548293e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,40113,-0.0153514913681224,0.00281194193074403,-0.0208628975523807,-0.00984008518386406,4.88224827543559e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,40113,-0.017280672016919,0.0031681571489587,-0.023490260028878,-0.0110710840049599,5.01854318235135e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39863,-0.0304228024847764,0.00558162634343037,-0.0413627901179,-0.0194828148516529,5.13387586864232e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,42099,-0.016989098972988,0.00312380350650357,-0.023111753845735,-0.010866444100241,5.46809228145081e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40054,-0.0507831488886004,0.00935327037366905,-0.0691155588209917,-0.032450738956209,5.77440828680236e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42103,0.0504758579075372,0.00929958126621147,0.0322486786257628,0.0687030371893117,5.80981201033272e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,42103,0.0279372576022324,0.00514990167616754,0.0178434503169441,0.0380310648875208,5.9061035944748e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,42267,-0.0307731870315768,0.00567916588918593,-0.0419043521743813,-0.0196420218887724,6.1128600801221e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,40021,-0.0629830827330482,0.0116272092942594,-0.0857724129497966,-0.0401937525162998,6.19496392223029e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41718,0.0475320678233006,0.00879377342958225,0.0302962719013194,0.0647678637452818,6.59241099448005e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,42186,0.0219516277426908,0.00406146618165363,0.0139911540266497,0.0299121014587319,6.6006913469731e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41861,0.0353633842456018,0.00654606034282317,0.0225331059736684,0.0481936625175352,6.70040445945282e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,42223,0.0357393390091193,0.00661830613169196,0.022767458991003,0.0487112190272355,6.77825123972183e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41829,-0.019133672515883,0.0035475448363207,-0.0260868603950716,-0.0121804846366945,7.03441265581473e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,42214,0.0301643602588845,0.00560033967443182,0.0191876944969981,0.0411410260207709,7.32276127856643e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42094,0.0328455053117561,0.00609877104288165,0.020891914067708,0.0447990965558041,7.34721709930284e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42156,0.0320609055444394,0.00596409341457002,0.0203712824518822,0.0437505286369966,7.76272931405264e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40080,0.0154463747051155,0.00287685385446301,0.00980774115036794,0.021085008259863,8.07176090162114e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42126,0.0411741094941502,0.0076699013892738,0.0261411027711735,0.0562071162171268,8.08684382752509e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42213,-0.0257020785586177,0.00479095876033783,-0.0350923577288798,-0.0163117993883556,8.24695932482759e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42296,-0.0148435301640026,0.00277007776553126,-0.0202728825844439,-0.00941417774356136,8.5324798315592e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42256,0.0180964460136115,0.00337966307561644,0.0114723063854033,0.0247205856418197,8.72403456739735e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42223,0.0188806134978303,0.00353497781113862,0.0119520569879986,0.025809170007662,9.39456063497679e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42248,0.0288290798933481,0.00539955325188379,0.0182459555196559,0.0394122042670403,9.494262948188e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39784,-0.0179560082820734,0.00336492039894706,-0.0245512522640097,-0.0113607643001372,9.68548895734124e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39863,0.0219352466557957,0.00412119232964582,0.0138577096896899,0.0300127836219015,1.04398870088786e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,42094,0.023250929635616,0.00437113059077808,0.0146835136776909,0.031818345593541,1.05964564986534e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41829,0.015619937943794,0.00293960817194106,0.0098583059267895,0.0213815699607985,1.09299522102957e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41829,0.0346890356661961,0.00652979078232922,0.0218906457328309,0.0474874255995614,1.100115297062e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41887,0.0376202562443858,0.00709325411694926,0.0237174781751653,0.0515230343136063,1.15405295490126e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39804,0.0302007879632693,0.00569932937631848,0.019030102385685,0.0413714735408535,1.18768128446019e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,42003,-0.0151079466920917,0.00285396901738319,-0.0207017259661628,-0.00951416741802069,1.21871310866345e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39772,0.0145838325989253,0.00275521162065529,0.00918361782244094,0.0199840473754097,1.22613900988042e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,42094,0.0290130342671083,0.00548521824407247,0.0182620065087262,0.0397640620254903,1.24783913553472e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,42256,0.0265904588098454,0.00504380380113883,0.0167046033596133,0.0364763142600775,1.371660504429e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,42223,0.0185791019867776,0.00352836677776119,0.0116635031023657,0.0254947008711895,1.41925173043465e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,42120,0.0239058717941812,0.00456192053503725,0.0149645075455082,0.0328472360428542,1.62830328331186e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,42057,0.030033260347309,0.00573785658786655,0.0187870614350906,0.0412794592595275,1.68281740626938e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42103,-0.0177497999534774,0.00339252858445337,-0.024399155979006,-0.0111004439279488,1.70286656488311e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,40080,0.0143003789203051,0.0027395887127174,0.00893078504337898,0.0196699727972312,1.82317613994298e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40102,-0.0144096276614277,0.00276121258463545,-0.0198216043273132,-0.00899765099554224,1.83604680056436e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41635,0.020077872669874,0.00385294291817667,0.0125261045502477,0.0276296407895003,1.90780258575548e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42103,0.0388372572232507,0.00747195425754293,0.0241922268784666,0.0534822875680348,2.04807309162878e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,40054,0.0352622609074402,0.00678482902367888,0.0219639960210296,0.0485605257938508,2.05961567338684e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,40058,-0.0103754896766156,0.0019966392191845,-0.0142889025462172,-0.006462076807014,2.06784638151826e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39768,0.0240390341058532,0.00463181929170359,0.0149606682941142,0.0331173999175923,2.14221575215471e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41829,0.0303272321451936,0.00584460406987767,0.0188718081682334,0.0417826561221539,2.14784301517623e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42091,-0.0181049065503598,0.00349300150408931,-0.0249511894983748,-0.0112586236023447,2.21412986185379e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,42103,-0.0235584193273135,0.00454887543968043,-0.0324742151890871,-0.0146426234655399,2.2649043766212e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39863,-0.0189994359741222,0.00367122357039584,-0.026195034172098,-0.0118038377761463,2.31765366533532e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,42144,0.0350709784607931,0.00678435998707296,0.0217736328861301,0.0483683240354561,2.38361488027437e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42296,-0.0155300270509322,0.00300433370790176,-0.0214185211184196,-0.00964153298344474,2.38547317699055e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,42186,-0.0148928995982379,0.00288873764826238,-0.0205548253888321,-0.00923097380764362,2.56664824959343e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42162,-0.0261034076202657,0.00506434712570784,-0.0360295279866531,-0.0161772872538783,2.58257259655523e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42168,-0.0279255307914723,0.00543525479779501,-0.0385786301951505,-0.0172724313877941,2.81931390453496e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42167,0.0173477642435132,0.00337885834884298,0.010725201879781,0.0239703266072455,2.87435029225066e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40054,-0.0164510454941073,0.00320643330478527,-0.0227356547714865,-0.0101664362167282,2.93748959378039e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42103,0.0303855111995742,0.00592473253135826,0.018773035438112,0.0419979869610364,2.96152679583229e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,40102,0.0380043824025259,0.00744379008363763,0.0234145538385962,0.0525942109664557,3.35458081837721e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39804,0.0123305429729112,0.00241524641330632,0.00759666000283077,0.0170644259429916,3.36007101440207e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,42296,0.032708605062503,0.00640833851645232,0.0201482615702565,0.0452689485547496,3.3708298026791e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39706,0.0291454583032402,0.00571228326569338,0.0179493831024812,0.0403415335039992,3.41511632488209e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39706,-0.0294811863548546,0.00578236070950414,-0.0408146133454827,-0.0181477593642265,3.48373151965835e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39863,0.03705896344631,0.00727395324343434,0.0228020150891787,0.0513159118034413,3.55176846007428e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39881,0.0234982935080337,0.00461309818669121,0.0144566210621189,0.0325399659539485,3.5690678164069e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,42144,0.0185958759572932,0.00365141564771906,0.0114391012877639,0.0257526506268226,3.57799547827288e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41999,0.0269761925897625,0.0053052687125813,0.0165778659131031,0.0373745192664218,3.73226317778179e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39706,0.0353464054043726,0.00696062048757872,0.0217035892487183,0.0489892215600269,3.87856713552433e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39804,-0.0394950579569081,0.0077783264550447,-0.0547405778087957,-0.0242495381050205,3.88766029122069e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,40055,-0.0248238632873312,0.00489690202990302,-0.0344217912659412,-0.0152259353087213,4.05860602798573e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42024,-0.0216831752390586,0.00427792824047481,-0.0300679145903892,-0.013298435887728,4.06298973661053e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41813,0.037320422785495,0.00736888525915418,0.0228774076775528,0.0517634378934372,4.15045685339513e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39784,0.0259297918321705,0.00512982082358076,0.0158753430179522,0.0359842406463887,4.38232818671853e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41984,0.0241109439382094,0.00478462780442953,0.0147330734415276,0.0334888144348913,4.7373832775679e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,42120,-0.0381132524006338,0.00757599849489554,-0.052962209450629,-0.0232642953506385,4.95022335585236e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42111,-0.0155352496984382,0.00309009652299036,-0.0215918388834993,-0.00947866051337713,5.0375295622407e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39863,0.011100456747458,0.00220805268567884,0.00677267348352747,0.0154282400113885,5.05615136831044e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40080,0.0151395071868789,0.00301189250176027,0.00923619788342879,0.0210428164903291,5.07255808513477e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39804,-0.0467984868125044,0.00931651859696654,-0.0650588632625588,-0.0285381103624499,5.16520266825084e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,42213,-0.0153401372642827,0.003057343880044,-0.0213325312691689,-0.00934774325939648,5.30465287595144e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41927,-0.0215228982660447,0.00429542541763838,-0.0299419320846159,-0.0131038644474735,5.49727898796858e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42087,0.042608380213707,0.00850526015302007,0.0259380703137877,0.0592786901136264,5.52510384446669e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39958,0.0136718012532508,0.00273134931643037,0.00831835659304726,0.0190252459134543,5.65955458570755e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39863,0.0118760625438043,0.00237593825369765,0.00721922356655693,0.0165329015210517,5.87038938023491e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41841,-0.0251203423155951,0.00502913691190282,-0.0349774506629246,-0.0152632339682655,5.9633160607954e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42186,-0.0192097124458745,0.00387190596906894,-0.0267986481452496,-0.0116207767464994,7.09067146772152e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41966,-0.0223918834034281,0.00453005476536361,-0.0312707907435408,-0.0135129760633154,7.79214366975836e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,42004,0.0269364283352727,0.00546168376024052,0.0162315281652013,0.0376413285053441,8.24589305617413e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42004,0.0118737695626794,0.00242820440970791,0.00711448891965189,0.0166330502057069,1.02091709112669e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42186,0.0133400584516751,0.00273129852354281,0.00798671334553117,0.018693403557819,1.05115719901356e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,40113,-0.0114421670890716,0.00234482316425971,-0.0160380204910206,-0.00684631368712258,1.07717987652176e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,42126,0.0283798176095613,0.00581880370701493,0.0169749623438121,0.0397846728753106,1.08849812773741e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42240,-0.0213647232397041,0.00438210235923929,-0.0299536438638131,-0.0127758026155951,1.09839131160412e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41887,0.022523481797271,0.00463925654144074,0.0134305389760472,0.0316164246184949,1.21835264231795e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42223,-0.0169267177510046,0.00348892495191475,-0.0237650106567576,-0.0100884248452517,1.23913655073006e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39804,0.0295246938564411,0.00609735435829658,0.0175738793141798,0.0414755083987024,1.30213446972093e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41861,0.0357672775544019,0.00739268838391091,0.0212776083219365,0.0502569467868673,1.3256594092023e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42103,0.0477198123693493,0.00987676813936202,0.0283613468161998,0.0670782779224989,1.37051450306128e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41774,0.0510808966541014,0.0105810591420859,0.030342020735613,0.0718197725725898,1.39828268934393e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,40097,-0.0260023357948894,0.00539721503352302,-0.0365808772605945,-0.0154237943291843,1.47155239987628e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,40097,0.0203738091858514,0.00423329218709708,0.0120765564991411,0.0286710618725617,1.5085919523173e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39719,0.0403109717408667,0.00838983346825292,0.023866898143091,0.0567550453386424,1.57092776891243e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42256,0.0375557920770263,0.0078230814028172,0.0222225525275046,0.052889031626548,1.59912595654476e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39706,0.0379706023357899,0.00793307932096099,0.0224217668667064,0.0535194378048734,1.72144458131093e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42094,0.0341222341470461,0.00713968038162303,0.020128460599065,0.0481160076950273,1.7790127135916e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40083,-0.036348187525117,0.00763695830826663,-0.0513166258093196,-0.0213797492409144,1.96559986147562e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42177,-0.0149359467025573,0.00314004321060308,-0.0210904313953393,-0.00878146200977529,1.98993716749751e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40097,0.0142921266060649,0.003005806820742,0.00840074523741058,0.0201835079747192,2.01147901708268e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,42004,-0.0125178180761191,0.00263931594144406,-0.0176908773213495,-0.00734475883088879,2.13029405380162e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40020,0.0326493607185969,0.00688475970040607,0.019155231705801,0.0461434897313928,2.14038716502118e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39804,0.0108836250475308,0.00230071173733222,0.0063742300423597,0.015393020052702,2.26804578884889e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40054,0.0298242790967316,0.00633015555134916,0.0174171742160872,0.0422313839773759,2.48999290000824e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,40054,-0.0231965266294692,0.00492659578486684,-0.0328526543678082,-0.0135403988911302,2.52723049331551e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,40021,0.0412031009311409,0.0087704879594437,0.0240129445306312,0.0583932573316505,2.66051919853312e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39466,0.0593135314253434,0.0126634206133673,0.0344932270231434,0.0841338358275434,2.85150957124851e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,42296,0.0249478328693926,0.00533656301056442,0.0144881693686863,0.0354074963700989,2.97047473312834e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,42162,-0.0235276005550083,0.00503543954611422,-0.0333970620653922,-0.0136581390446245,3.00690140161313e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,42122,0.0176639908758052,0.00378815805689901,0.0102392010842832,0.0250887806673273,3.1482835092649e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42120,-0.0183282288271259,0.00393172365072384,-0.0260344071825446,-0.0106220504717072,3.16856228384844e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39784,0.0253946553739817,0.00545963333568473,0.0146937740360396,0.0360955367119238,3.33765922815236e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41829,0.0214863373631589,0.00462169779039691,0.012427809693981,0.0305448650323369,3.36902145348615e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,42197,0.0266887342749704,0.00574311253462432,0.0154322337071067,0.0379452348428341,3.39963894025054e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39863,0.0255331734974263,0.00550483618991205,0.0147436945651986,0.0363226524296539,3.5543530869382e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,40097,0.0541362583109571,0.0116731593493694,0.031256865986193,0.0770156506357212,3.56456710045083e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42122,0.0225184199811722,0.00488502745594218,0.0129437661675255,0.0320930737948188,4.07147973588753e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42075,-0.0183675749078556,0.00398718067850971,-0.0261824490377346,-0.0105527007779765,4.13115937070912e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41829,-0.0212797704743713,0.00462595027918527,-0.0303466330215744,-0.0122129079271682,4.2642059931425e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,40054,0.0262126130826434,0.00570494450409664,0.015030921854614,0.0373943043106728,4.38215325990279e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,42144,-0.0333947037369434,0.00726926527204776,-0.047642463670157,-0.0191469438037297,4.39018501482373e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41876,0.0271878693256232,0.00592258757090532,0.0155795976866487,0.0387961409645976,4.46349686375289e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42103,0.0325635207864156,0.0070940448218897,0.0186591929355118,0.0464678486373194,4.46867562634619e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42223,0.0587170963725919,0.012793834921658,0.0336411799261422,0.0837930128190417,4.48494419702155e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39804,0.0243951638729876,0.00533022382173397,0.013947925182389,0.0348424025635862,4.77592662080666e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39784,0.0266840919470361,0.00583738892307116,0.0152428096578166,0.0381253742362556,4.90343939191138e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42122,0.0381220883594009,0.00834488422010049,0.0217661152880039,0.0544780614307978,4.96199726502808e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40054,-0.0176072991237009,0.00385512698777548,-0.0251633480197408,-0.010051250227661,4.99622080096211e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39804,-0.0322632722221053,0.00706778794059461,-0.0461161365856707,-0.0184104078585399,5.05513014931322e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41829,0.0163155796627209,0.00357609044066019,0.00930644239902692,0.0233247169264148,5.10467279158928e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42149,0.0230559506748788,0.00505941058614955,0.0131395059260256,0.0329723954237319,5.23531173200874e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41861,0.0254734378785664,0.00559834485924394,0.0145006819544483,0.0364461938026846,5.41001150525046e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42296,-0.0153335192064829,0.0033789693707649,-0.0219562991731821,-0.00871073923978371,5.73149555013326e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40054,0.0199547940036042,0.00439799778301226,0.0113347183489001,0.0285748696583082,5.76054752322531e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39863,0.0292880942025691,0.00647862669705877,0.0165899858763339,0.0419862025288043,6.22918719528327e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42053,0.0208329543750972,0.00461065222535047,0.0117960760134103,0.0298698327367841,6.28523070842067e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39804,0.0247842011637611,0.00549828330913172,0.0140075658778629,0.0355608364496593,6.62594675541613e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42223,-0.0283768423761867,0.0062985099326414,-0.0407219218441639,-0.0160317629082096,6.68475702650185e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40054,0.0149231074832755,0.00331488043392686,0.00842594183277882,0.0214202731337721,6.80647453506725e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,42256,0.0183752775787041,0.0040843091460953,0.0103700316523573,0.0263805235050509,6.88654423962267e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42162,0.0473230611355594,0.0105281730164717,0.0266878420232748,0.0679582802478439,7.02063826425003e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42146,-0.0164755665293451,0.00366856918773,-0.0236659621372959,-0.00928517092139434,7.15003673268855e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,42186,-0.0335167748988024,0.00746707210658283,-0.0481522362277047,-0.0188813135699001,7.2305980871634e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42094,0.0444915506084725,0.00992326543504703,0.0250419503557803,0.0639411508611646,7.40412873163589e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42103,0.0485518856739798,0.0108304437499597,0.0273242159240587,0.0697795554239009,7.42668819102528e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41716,0.0183989760231767,0.00410762870676812,0.0103480237579111,0.0264499282884422,7.557926152316e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42213,0.0296801837269852,0.00663831976147657,0.0166690769944911,0.0426912904594793,7.84987795351844e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41876,0.017465173748338,0.00390707980304322,0.00980729733437325,0.0251230501623027,7.88482860346335e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42296,-0.0155912808483227,0.00349678982044683,-0.0224449888963985,-0.00873757280024695,8.31277095919275e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42094,0.0461553894839008,0.0103558816204696,0.0258578615077805,0.0664529174600212,8.38445191169883e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,42273,0.027185318326951,0.00610991864407934,0.0152098777845555,0.0391607588693465,8.68319944526678e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42128,-0.0424248697308491,0.00953541651686129,-0.0611142861038972,-0.023735453357801,8.69150712860796e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",42223,-0.0333016193577262,0.00749796225756733,-0.0479976253825582,-0.0186056133328942,9.01020556993449e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42146,-0.0109658948112473,0.00247040833142723,-0.0158078951408447,-0.00612389448164995,9.11674092776235e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42122,-0.0148067853504922,0.00333916543629235,-0.0213515496056252,-0.00826202109535918,9.31437367515663e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,40054,0.0170091183079661,0.0038358563195632,0.00949083992162225,0.02452739669431,9.33042780997696e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42103,0.0277394252914663,0.0062746073594356,0.0154411948669725,0.0400376557159601,9.90923120558684e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40080,0.0378426017755506,0.00856377170796593,0.0210576092279373,0.0546275943231638,1.00155922310437e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,42103,-0.0141636469471599,0.0032079711235668,-0.0204512703493508,-0.00787602354496897,1.0176407384666e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39784,0.0155834308753243,0.00352938033825398,0.00866584541234652,0.0225010163383021,1.01848872396731e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40102,0.0295269249481746,0.00668914500989004,0.0164162007287902,0.0426376491675591,1.02379962048366e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41829,0.0246655591552172,0.00558859194702601,0.0137119189390463,0.0356191993713882,1.0252982262851e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,42256,0.0200532689484819,0.00455463457472193,0.0111261851820269,0.0289803527149369,1.07698131115087e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42186,0.0166828842356753,0.00379211453415639,0.0092503397487288,0.0241154287226218,1.09434210818488e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40113,0.0137268354520576,0.00313269678273619,0.00758674975789468,0.0198669211462206,1.18804403829143e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41861,0.0295377173983451,0.00674557642420969,0.0163163876068941,0.0427590471897961,1.20276698201197e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,42103,0.0249102565161625,0.00568939316188299,0.0137590459188719,0.0360614671134532,1.20512295140238e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39604,0.0144471598315254,0.00330443400735442,0.00797046917711075,0.0209238504859401,1.2427906698907e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39863,-0.0104084005722153,0.00238131851696547,-0.0150757848654676,-0.00574101627896297,1.24931695975677e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40097,0.0229023041817907,0.00524922041000424,0.0126138321781823,0.033190776185399,1.29475879708993e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,42004,-0.0151737726137097,0.00347827583992366,-0.0219911932599601,-0.00835635196745937,1.29625203258423e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42120,-0.0264434254503878,0.00607303957987509,-0.038346583026943,-0.0145402678738326,1.34561451230514e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,42120,-0.0172305639648878,0.00395945651332314,-0.0249910987310011,-0.00947002919877442,1.36092229029591e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41876,0.0258255531513914,0.0059360215671342,0.0141909508798084,0.0374601554229745,1.3679564128999e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40113,-0.00821869077621273,0.00188909520550614,-0.0119213173790048,-0.00451606417342069,1.37001096245529e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42146,-0.015222631791653,0.00350888002335073,-0.0221000366374204,-0.00834522694588554,1.44665504138852e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41887,0.0264557112254063,0.00610328617790802,0.0144932703167066,0.038418152134106,1.47105487995676e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,42094,-0.0124016931317366,0.00286181985356449,-0.018010860044723,-0.00679252621875023,1.47869018668619e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,40020,0.0159291627084021,0.00368067676285707,0.00871503625320223,0.0231432891636019,1.51971709300494e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41985,0.010356959418573,0.00239790608072227,0.0056570635003574,0.0150568553367887,1.5779917907464e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39706,0.0159632666610321,0.00369690052539681,0.00871734163125431,0.0232091916908098,1.5888337580769e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,42073,-0.0288337094648947,0.00668424795106117,-0.0419348354489746,-0.0157325834808148,1.61755296326249e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,42296,0.0268507868262587,0.00622907722529579,0.014641795464679,0.0390597781878385,1.64033828100347e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42213,-0.0352427586852476,0.00818618413807029,-0.0512876795958654,-0.0191978377746299,1.68092540403438e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39784,0.0196977406652763,0.00458228289777679,0.0107164661856338,0.0286790151449188,1.73360168839899e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42197,-0.0147807553934057,0.00345100887669011,-0.0215447327917183,-0.00801677799509311,1.85693885164525e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39863,0.0165379391050434,0.0038625998679332,0.00896724336389436,0.0241086348461925,1.87213811047191e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,42296,-0.013263060681738,0.00309954161458759,-0.0193381622463297,-0.00718795911714635,1.89034586548441e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,40113,-0.00921351134135287,0.00215405273493796,-0.0134354547018313,-0.00499156798087446,1.90791427079238e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,40113,0.031568822207357,0.00738099634964438,0.017102069362054,0.04603557505266,1.91005966351795e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42004,0.0233290952713658,0.00546245668202649,0.0126226801745939,0.0340355103681377,1.96171746190291e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42126,0.0166623218932371,0.00390415269024858,0.00901018262034985,0.0243144611661243,1.9877556216936e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,40113,0.0156224821692104,0.00366132811919469,0.00844627905558884,0.022798685282832,1.99889022910988e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,40080,0.0234381390161568,0.0054988495102749,0.012660393976018,0.0342158840562956,2.03972989672327e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40021,-0.0491621324336672,0.0115597844477035,-0.071819309951166,-0.0265049549161683,2.12831232241695e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,42176,-0.0169003906375451,0.00397778018167814,-0.0246968397936342,-0.0091039414814559,2.16515351608659e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,42094,-0.020213320471307,0.0047589626271888,-0.029540887220597,-0.0108857537220169,2.17761030165763e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39784,-0.0191946191763517,0.00452859544423085,-0.0280706662470442,-0.0103185721056593,2.26888448878136e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42127,-0.0134618012576063,0.00317767863805355,-0.0196900513881912,-0.00723355112702133,2.28742066635886e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,40097,-0.0110988377454237,0.00262140681408925,-0.0162367951010387,-0.00596088038980882,2.31531342823841e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,42144,0.0512491855955674,0.0121222199970058,0.0274896344014361,0.0750087367896987,2.37705578667731e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42103,0.0224516662401871,0.00531072988759567,0.0120426356604996,0.0328606968198746,2.37817974203613e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,42091,-0.0125899093445558,0.0029786148162663,-0.0184279943844377,-0.00675182430467383,2.38705415379359e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42178,0.0257325519916967,0.00609119864218071,0.0137938026530225,0.0376713013303709,2.41056189687959e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,42223,-0.0129045679263237,0.00305929124111902,-0.0189007787589169,-0.00690835709373037,2.47973625011023e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,42121,-0.0284387557580913,0.00676096134743093,-0.0416902399990559,-0.0151872715171267,2.61314496338093e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41887,0.0258055939681439,0.00614332441487278,0.0137646781149932,0.0378465098212945,2.68037520802691e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41829,0.0286064231695194,0.00681130117585344,0.0152562728648467,0.0419565734741922,2.68927007920036e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39768,0.0291067788163253,0.00693467339171504,0.0155148189685638,0.0426987386640867,2.72347185593317e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40054,0.035150026688457,0.00839092078675619,0.0187038219464149,0.0515962314304991,2.82332828201706e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39863,0.0177151280916496,0.00422982774760859,0.00942466570633679,0.0260055904769625,2.83505902951927e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,42223,0.0139817539360562,0.00334274388847772,0.00742997591463983,0.0205335319574725,2.89930848705547e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39849,0.0251126163406749,0.00600381565141464,0.0133451376639022,0.0368800950174476,2.90277798402385e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39719,0.0171528324411,0.00410732009108453,0.00910248506257438,0.0252031798196257,2.98859043172909e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42296,-0.00971346197511247,0.00233704248935585,-0.0142940652542499,-0.00513285869597501,3.25491121066659e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42162,-0.0376222741042128,0.00905760944129262,-0.0553751886091464,-0.0198693595992793,3.29288107658469e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,42103,-0.0185307863311214,0.00446252367717874,-0.0272773327383918,-0.00978423992385108,3.30925924444037e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,42161,0.0194801359045308,0.00470587869022617,0.0102566136716875,0.0287036581373741,3.50215533771894e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42116,-0.00950194023743965,0.00229568808092268,-0.0140014888760481,-0.0050023915988312,3.5097723002135e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,42112,-0.018347871294173,0.00443902434296534,-0.0270483590063851,-0.00964738358196094,3.59829961256011e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,40080,-0.0407751492373816,0.00986797270866677,-0.0601163757463684,-0.0214339227283947,3.62202183574794e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,42144,-0.021799524779289,0.00528606449690481,-0.0321602111932225,-0.0114388383653556,3.7473610090543e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41861,-0.0200854838183087,0.00487228408806039,-0.029635160630907,-0.0105358070057103,3.77341333838276e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40054,0.0130672967280571,0.00317161251462339,0.00685093619939527,0.019283657256719,3.81551148116717e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,42094,0.0586009811450272,0.0142322932495006,0.0307056863760061,0.0864962759140484,3.85447117060428e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42120,-0.0159332410856455,0.00387974368336568,-0.0235375387050422,-0.00832894346624876,4.03688028599601e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42093,-0.0139050701976574,0.00338653578395501,-0.0205426803342092,-0.00726746006110556,4.05074162532082e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40093,-0.00836008938425003,0.00203594835394655,-0.0123505481579853,-0.0043696306105148,4.05089515207304e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,42223,-0.0267593411827035,0.00652788067349232,-0.0395539873027485,-0.0139646950626586,4.17024627366166e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39804,0.0167838634823003,0.00409559126552172,0.00875650460187774,0.0248112223627229,4.19778451259775e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40102,-0.0122537149391458,0.00299024052524876,-0.0181145863686333,-0.00639284350965823,4.19927221722315e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42059,-0.0172125421099201,0.00421082396048824,-0.025465757072477,-0.00895932714736314,4.38337110585304e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39872,0.0184045102855636,0.00450461482127208,0.00957546523587032,0.0272335553352569,4.42650921518826e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42004,0.01527531111638,0.00374036761702974,0.0079441905870017,0.0226064316457583,4.45541285657298e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,42095,-0.0329364883701679,0.00806820871374472,-0.0487501774491075,-0.0171227992912282,4.4869585858144e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41861,0.0213048950275024,0.00522229233127819,0.0110692020581972,0.0315405879968077,4.53883707076494e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42256,0.014524572803391,0.00356406659280458,0.00753900228149406,0.021510143325288,4.62306487687484e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,42094,0.0390940279540412,0.0095996886072461,0.0202786382838388,0.0579094176242435,4.68037539615532e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42197,0.0178570034868896,0.00439111545252665,0.00925041719993741,0.0264635897738419,4.79807946907183e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,42116,-0.0244917200415828,0.0060233796518184,-0.0362975441591468,-0.0126858959240187,4.80878993689184e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,42223,0.0157396236735534,0.00387414041250869,0.00814630846503639,0.0233329388820705,4.87843620317336e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41662,-0.0135147613475686,0.00332766064192164,-0.020036976205735,-0.00699254648940216,4.90902989979013e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41876,-0.00892920190463896,0.00220054571636948,-0.0132422715087231,-0.00461613230055476,4.98507665809495e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39706,0.0202712381832981,0.0049954784247845,0.0104801004707205,0.0300623758958757,4.98705081010137e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42071,0.0282345641656159,0.00696954770968817,0.0145742506546271,0.0418948776766047,5.126922145268e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42103,-0.0164064550721041,0.00405540660928289,-0.0243550520262986,-0.00845785811790966,5.24984741380781e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39804,0.0345914215985203,0.0085553683952845,0.0178228995437627,0.0513599436532779,5.30899400646245e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39902,0.0235552091141073,0.00582674862495272,0.0121347818092,0.0349756364190147,5.32320112597572e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42208,0.0274943406535027,0.00680427366739293,0.0141579642654126,0.0408307170415929,5.35877136037763e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39881,0.0233172971137237,0.00577446110425945,0.0119993533493752,0.0346352408780722,5.4284432957912e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40020,0.0233461383118326,0.00579103792405673,0.0119957039806814,0.0346965726429838,5.58194112730009e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42004,0.0179602519803696,0.00445534291211199,0.00922777987263005,0.0266927240881091,5.58206667449041e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42211,-0.00836509752922206,0.00207805359713742,-0.0124380825796114,-0.00429211247883271,5.71889488169776e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41742,0.0315757062083116,0.00784577502979106,0.0161979871499212,0.0469534252667021,5.74197615066053e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42120,-0.0152122232186027,0.00378114724553996,-0.022623271819861,-0.00780117461734435,5.77452190972648e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39906,-0.00335407027624143,0.000834552886947422,-0.00498979393465838,-0.00171834661782448,5.88450134176196e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42004,-0.0164634434937801,0.00409949343798879,-0.0244984506322381,-0.00842843635532207,5.95394544282281e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40020,0.0239950300907605,0.00598401746335622,0.0122663558625823,0.0357237043189387,6.1164462249951e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41861,0.0278002343705109,0.00694321144559159,0.0141915399371513,0.0414089288038704,6.26502608118308e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41861,0.0116151571120825,0.00290180556182607,0.00592761821090337,0.0173026960132616,6.29712972199986e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,42172,-0.00940658389123095,0.00235017371194434,-0.0140129243666419,-0.00480024341582005,6.3023559869665e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41861,0.0202598371583467,0.00507324681390636,0.0103162734030902,0.0302034009136032,6.54822257951461e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41861,0.0213728995543745,0.00537047806690214,0.0108467625432464,0.0318990365655027,6.93864660652494e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39863,0.0109608396220583,0.00275613303298452,0.00555881887740868,0.016362860366708,7.02832577613518e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40021,0.0199202122899492,0.0050196375763369,0.0100817226403289,0.0297587019395696,7.28065830477878e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41887,0.0218173393799298,0.00549831771080495,0.0110406366667521,0.0325940420931075,7.28761994882129e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41876,0.0375342041959688,0.00946236748255972,0.0189879639301518,0.0560804444617859,7.32808169559816e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39784,-0.0234878663445921,0.00592151758851146,-0.0350940408180745,-0.0118816918711096,7.34074805140037e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42167,0.0208425917913601,0.00525553255624578,0.0105417479811184,0.0311434356016019,7.35312662032686e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42095,0.0219756557664066,0.00556089049025869,0.0110763104054996,0.0328750011273136,7.79713353940963e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,40086,0.0143706494440617,0.00363954799349652,0.00723713537680853,0.0215041635113149,7.9146960739781e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40021,0.0308503185843139,0.00781718224092612,0.0155286413920987,0.0461719957765291,7.98111955761636e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42120,-0.0110018031053438,0.00278879941999921,-0.0164678499685422,-0.00553575624214533,8.02228886873037e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39804,0.012207233179743,0.00309536034670939,0.00614032690019257,0.0182741394592934,8.07434685339682e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42081,0.0122722689701809,0.00311616981880831,0.0061645761253166,0.0183799618150452,8.25087773781525e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41998,-0.0413511745613696,0.0105431377963636,-0.0620157246422423,-0.0206866244804969,8.82408641829736e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41861,0.0241175356887319,0.00615484438110057,0.0120540407017748,0.036181030675689,8.9583439957666e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,42284,-0.0182863330691959,0.00467776151607691,-0.0274547456407067,-0.00911792049768518,9.30667435359077e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39851,-0.0162782358866398,0.00416453557545579,-0.0244407256145331,-0.00811574615874641,9.33393137624882e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42202,0.037092422176529,0.00952663831341546,0.0184202110822347,0.0557646332708233,9.92822320493574e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42094,0.00848584834934147,0.00217984289868889,0.00421335626791125,0.0127583404307717,9.95633517980997e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,42246,0.00964558514667002,0.00248051444920849,0.00478377682622138,0.0145073934671187,0.000101347811004311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40080,0.0221993531808224,0.00571067972635035,0.0110064209171758,0.0333922854444691,0.000101950365859599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,42120,0.0230446454164696,0.00593906510942555,0.0114040778019956,0.0346852130309437,0.000104896908005415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42094,0.0414210791659966,0.0106905022112387,0.0204676948319688,0.0623744635000244,0.000107342203286013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42120,-0.0152827673895157,0.00394949022122144,-0.0230237682231098,-0.00754176655592172,0.000109569950172768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42262,0.0199451473254911,0.00515730883689361,0.00983682200517958,0.0300534726458025,0.000110555261333804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41876,0.0132692407504946,0.00343806817100909,0.00653062713531679,0.0200078543656724,0.000114180218712699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42256,-0.0100763435324289,0.00261101136840986,-0.0151939258145122,-0.0049587612503456,0.000114318931324627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40054,-0.0946442754471262,0.0245249168051722,-0.142713112385264,-0.0465754385089886,0.000114460864575003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,40020,0.0083033825320167,0.00215754539624719,0.00407459355537222,0.0125321715086612,0.000119510611903565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39804,-0.0157363683582271,0.00408993697783324,-0.0237526448347803,-0.00772009188167397,0.000119988127912064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41963,-0.00979260225045905,0.00254769976626328,-0.0147860937923351,-0.00479911070858302,0.000121778949050036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,42059,-0.00916105426901963,0.00238409727708585,-0.0138338849321079,-0.00448822360593136,0.000122339151619073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,40080,-0.0250285421421073,0.00651645024870477,-0.0378007846295687,-0.012256299654646,0.000123317196939719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40102,-0.0205342397992536,0.00536560112803708,-0.0310508180102063,-0.010017661588301,0.000130430480628088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42103,-0.0235690202006463,0.00616597789245112,-0.0356543368698505,-0.0114837035314421,0.000132763356168903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41887,-0.0279522777909664,0.00731847110556372,-0.0422964811578712,-0.0136080744240615,0.000134405497379214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,42256,0.0161567009996626,0.00423543133579794,0.00785525558149867,0.0244581464178266,0.000137002389891324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42094,-0.0328971478372928,0.00865032274438856,-0.0498517804162944,-0.0159425152582912,0.000143615250289542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,42256,0.018690886763482,0.00492152864278607,0.00904469062362127,0.0283370829033426,0.000146658518241977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41971,-0.0238698297420878,0.00628824272383523,-0.0361947854808048,-0.0115448740033707,0.000147761219257846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39804,0.0182364027605554,0.00480679392275244,0.00881508667196058,0.0276577188491502,0.000149134879604835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40021,-0.0453113697065501,0.0119660049267109,-0.0687647393629035,-0.0218580000501966,0.000153501902330501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41861,0.0367217189660944,0.00972038442875089,0.0176697654857427,0.0557736724464462,0.000158940860879474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42103,0.040036334848649,0.0106019973451162,0.0192564200522213,0.0608162496450767,0.000159888465973272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42103,0.0093600399813352,0.00247981322531363,0.00449960605972049,0.0142204739029499,0.000161050653080115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,42013,-0.0187114410572454,0.00495767835584204,-0.0284284906346958,-0.00899439147979502,0.000161223145856858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,40113,-0.0117175734463848,0.00310701874272962,-0.0178073301821348,-0.00562781671063473,0.000163240907701719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40021,0.0199283833645149,0.00529325018902958,0.00955361299401692,0.0303031537350129,0.000167518980082507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,40054,0.0209981240172442,0.0055862374843016,0.0100490985480131,0.0319471494864754,0.000171554522182374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42296,0.0106256207691525,0.00282718907914193,0.00508433017403434,0.0161669113642707,0.000171766648690636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41813,-0.034125986412528,0.00909975300642771,-0.0519615023051263,-0.0162904705199297,0.000177476237063962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40021,-0.0362753908144773,0.00968067231512289,-0.0552495085521181,-0.0173012730768364,0.000179750403213742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41829,0.0160932255605009,0.00429657760937063,0.0076719334461345,0.0245145176748673,0.000180768834595151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39864,-0.00826874134071121,0.00220757368061101,-0.0125955857547088,-0.00394189692671364,0.000180893031866225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,42296,0.0172005540287608,0.00460152663574254,0.00818156182270543,0.0262195462348162,0.000186271140391783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,42186,-0.0169649467811448,0.00455392908429853,-0.0258906477863699,-0.00803924577591971,0.000195875903532027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41861,0.0216878292630177,0.00582591530872305,0.0102690352579205,0.0331066232681149,0.000197998535326077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42120,-0.013527896988141,0.00363695037325349,-0.0206563197197179,-0.0063994742565642,0.000200405428700678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,42182,-0.0164975016836602,0.00444255453622694,-0.025204908574665,-0.00779009479265539,0.000205254209480811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39650,0.0201764184177755,0.00543646718721733,0.00952094273082953,0.0308318941047215,0.000207258791099989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40054,0.0238923204319074,0.00643822083086696,0.0112734076034081,0.0365112332604066,0.000207462525439589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42004,0.0116059997580766,0.00312967923830665,0.00547182845099557,0.0177401710651576,0.000209480617391998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40080,0.0107801316031535,0.00290763368522946,0.00508116958010379,0.0164790936262033,0.000210331800071256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39804,0.0274281836306633,0.0073979757902481,0.0129281510817771,0.0419282161795496,0.000210360492729835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,40113,-0.00571057438659064,0.00154161443657294,-0.00873213868227361,-0.00268901009090766,0.00021303623728958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39863,0.0212716926225777,0.00576383285033011,0.00997458023593071,0.0325688050092247,0.000224887008845401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40054,0.022859886884376,0.00619582350321184,0.0107160728180808,0.0350037009506712,0.000225736438935123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,42213,-0.0115515245068682,0.00313189944251699,-0.0176900474142015,-0.00541300159953492,0.000226636424285575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42223,0.0227451254525276,0.00616755030512483,0.0106567268544829,0.0348335240505722,0.000227058081262927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39804,0.0116301700352797,0.00316160081031009,0.00543343244707189,0.0178269076234875,0.000235705309009514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41869,-0.0208190356701821,0.00565988302441939,-0.0319124063980441,-0.0097256649423201,0.000235718274122417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39921,0.00906873224057809,0.00246801290916511,0.00423142693861447,0.0139060375425417,0.000239469467200048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,40080,0.0171350065959925,0.00466497217951258,0.00799166112414787,0.0262783520678372,0.000240754639534548
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39784,0.0138259707766493,0.00376806678585677,0.00644055987637007,0.0212113816769286,0.000244459182438488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40097,-0.00794498426565243,0.00216617850607099,-0.0121906941375516,-0.0036992743937533,0.000245866456761179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40080,0.0276679991503464,0.00755345841935642,0.0128632206484078,0.042472777652285,0.000250502396435997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,42120,0.00867756526209754,0.00237172984043212,0.00402897477485059,0.0133261557493445,0.000254456925881205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,42128,-0.0121092241036404,0.0033097372152003,-0.018596309045433,-0.00562213916184779,0.000254538751609574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42094,-0.00887678155438851,0.00242691360053368,-0.0136335322114345,-0.0041200308973425,0.000255559277271077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39665,0.0155967145667785,0.00427718285391595,0.00721343617310322,0.0239799929604537,0.00026713357633386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.0141172377161137,0.00387211494155006,-0.0217065830015518,-0.00652789243067559,0.000267530091534241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39804,0.0217405153927451,0.00597576058754899,0.0100280246411491,0.0334530061443412,0.000275941869615241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42120,-0.0123551076867949,0.00339879059601668,-0.0190167372549876,-0.00569347811860223,0.000278899198491623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42103,-0.0196697779818018,0.00541173320815137,-0.0302767750697785,-0.00906278089382514,0.00027943521773231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,40080,0.0119941857737082,0.00330030250903852,0.0055255928559927,0.0184627786914237,0.000280054300438705
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,42094,-0.0265823446500137,0.00732770032305707,-0.0409446372832056,-0.0122200520168219,0.000287114535754386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42197,-0.0134278640001156,0.00371116137296222,-0.0207017402911215,-0.00615398770910962,0.000297740566554433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41861,0.0170617541078103,0.00472039290878205,0.00780978400659751,0.0263137242090232,0.000302120767756287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40054,-0.0218461517732768,0.00605036557462937,-0.0337048682995503,-0.0099874352470032,0.000306728691931145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,42186,0.0209859193454312,0.00582028740974609,0.00957815602232889,0.0323936826685336,0.000312538834093126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42144,0.0278534460499651,0.00774094606032062,0.0126811917717367,0.0430257003281935,0.000321626125410044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40092,-0.00674257610577346,0.00187436103533083,-0.0104163237350219,-0.00306882847652504,0.000323002794824292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39575,-0.0172743941324901,0.00481148266800188,-0.0267049001617738,-0.00784388810320641,0.00033189372633585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41887,0.0114966290238816,0.00320497364548287,0.00521488067873523,0.0177783773690281,0.000335606254437538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,42296,-0.00926896724274788,0.00258681445954366,-0.0143391235834534,-0.00419881090204232,0.000340695557041413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42227,0.0309080836883598,0.00863472514287512,0.0139840224083246,0.0478321449683951,0.00034549002940694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39863,-0.019482213053391,0.00544367148828854,-0.0301518091704366,-0.00881261693634548,0.000346609088118625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42296,0.0100503207118895,0.00281014674238752,0.00454243309680996,0.015558208326969,0.00034956026962902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42144,0.0106874361708168,0.00298976426579269,0.00482749820986317,0.0165473741317705,0.000351938735932021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,42099,0.0335910014623313,0.00940020331173671,0.0151666029713273,0.0520153999533352,0.000353615413308556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39784,-0.00961075467170663,0.00268940035553713,-0.0148819793685594,-0.00433952997485385,0.000353715246661635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,42004,0.0319980172496313,0.00896104772192664,0.0144343637146551,0.0495616707846075,0.000357210241276416
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,42296,-0.00596501915872324,0.00167481356481614,-0.00924765374576288,-0.00268238457168361,0.000369906431206946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42144,0.0230649274450682,0.00647704905801609,0.0103699112913567,0.0357599435987797,0.00037073614283324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,42144,-0.00957833411319593,0.00269269288016343,-0.0148560121583163,-0.00430065606807561,0.000376227731292154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42223,-0.0222012538326089,0.00626260459191567,-0.0344759588327636,-0.00992654883245418,0.000393912804605853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42178,0.0260329591428671,0.00734752564526678,0.0116318088781442,0.0404341094075899,0.00039685290662332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42103,0.0309974581699794,0.0087529188830473,0.0138417371592067,0.0481531791807521,0.000399434650494577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39944,-0.0238309647233232,0.00672911665956951,-0.0370200333760795,-0.010641896070567,0.000399588596354431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,42103,0.014852521106007,0.00419498428698254,0.00663035190352122,0.0230746903084928,0.000400710971368599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42296,-0.00840536655090393,0.00237451395759665,-0.0130594139077934,-0.00375131919401449,0.000401778702385813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42004,0.0105132382571993,0.00297161094257659,0.00468888080974921,0.0163375957046494,0.000404762334040276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,42223,0.0166818241030898,0.00471998933367453,0.00743064500908773,0.0259330031970919,0.000410284939605271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.0357599957095252,0.0101304461770423,0.0159043212025223,0.0556156702165281,0.000417078714278164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41861,0.0218198972790086,0.0061835083634102,0.00970022088672461,0.0339395736712926,0.000419047449966951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,42223,0.0175911268907589,0.0049874692599427,0.00781568714127124,0.0273665666402466,0.00042163918407695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39863,0.0164005479957198,0.00465278332743918,0.00728109267393901,0.0255200033175006,0.000425434875888021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40020,0.0172471398257071,0.00489960238592598,0.00764391914929215,0.026850360502122,0.00043314045212605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42144,0.00995988875946244,0.0028364245024638,0.00440049673463338,0.0155192807842915,0.000447229951031322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,40020,-0.0141156317235591,0.00402387019951069,-0.0220024173146001,-0.00622884613251817,0.00045336513845397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41861,0.0352684485734645,0.0100572276431295,0.0155562823929307,0.0549806147539983,0.000455140459440594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42256,-0.0259593329257777,0.00741111804487548,-0.0404851242937336,-0.0114335415578217,0.000462011673404863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42083,-0.0224540827190251,0.00641393064037305,-0.0350253867741562,-0.00988277866389389,0.000465379242278889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39863,0.0245740692673759,0.00704061271004327,0.0107744683556911,0.0383736701790607,0.000484371440820473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41852,0.014141964833639,0.00407702362178825,0.00615099853493402,0.022132931132344,0.000524726066260177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,40080,0.0136941303510064,0.00395686621025056,0.00593867257891531,0.0214495881230975,0.000540533253011939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42184,-0.0117710438236805,0.00340215920748842,-0.0184392758703577,-0.00510281177700316,0.00054216233026162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40097,0.00826034703446969,0.00238846256377482,0.00357896040947104,0.0129417336594683,0.00054539501277878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41887,0.0166355621580921,0.00481760426753354,0.00719305779372633,0.0260780665224578,0.000556036994451905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42256,0.0141874719689451,0.00411339221107188,0.00612522323524418,0.022249720702646,0.000564248239803904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42103,0.019881514752395,0.00577228650551394,0.00856783320158772,0.0311951963032023,0.000574348516215194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,42144,0.00959812649987208,0.00278973663857122,0.00413024268827249,0.0150660103114717,0.000582442693111272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39863,-0.00977364761266062,0.00284158534533791,-0.0153431548895229,-0.00420414033579831,0.000585007556773784
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,40041,0.0114457512710223,0.00332842222034253,0.00492204371915096,0.0179694588228937,0.000586512744245076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,40021,0.0196850834630366,0.00573290168094619,0.00844859616838212,0.0309215707576912,0.000597625423572616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,42120,0.0194794976347419,0.00569246816628906,0.0083222600288153,0.0306367352406684,0.000623599916961111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39706,0.0236790228976707,0.00692743774412964,0.0101012449191766,0.0372568008761648,0.000632874358566929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42004,0.0200108209475372,0.00586355381497521,0.00851825547018575,0.0315033864248886,0.000645107631906573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41861,0.0177439231582511,0.00520120193998204,0.00754956735588635,0.0279382789606159,0.000648073135708535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42161,0.0124680109016229,0.00365503564883716,0.00530414102990203,0.0196318807733437,0.000648779976467888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,40020,0.0140989668356405,0.00414124082555987,0.00598213481754319,0.0222157988537379,0.000665192012936086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42004,-0.0200635105256015,0.00589351924870034,-0.0316148082530541,-0.0085122127981488,0.000665288029760024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,42179,0.0108291629276146,0.00318176427227557,0.00459290495395445,0.0170654209012747,0.000667272449906672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42193,0.0103611349224996,0.00304863644447497,0.00438580749132862,0.0163364623536705,0.000679318330668773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42144,-0.0171953329668404,0.00505956920767429,-0.027112088613882,-0.00727857731979881,0.00067941619373437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41861,0.013798072613038,0.00406262932995515,0.00583531912632588,0.0217608260997501,0.000685032044493897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,40092,-0.00511241993349342,0.0015052260573168,-0.00806266300583434,-0.0021621768611525,0.00068510774993569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41985,0.021910566459925,0.00645352143071817,0.00926166445571741,0.0345594684641326,0.000688036271229029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40021,0.0342551873371616,0.010106384975145,0.0144466727858774,0.0540637018884458,0.000702803542422824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41829,0.0132523974913484,0.00391297739509986,0.00558296179695271,0.0209218331857442,0.000709334074202446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42213,0.023068139797376,0.00681211934520947,0.00971638588076547,0.0364198937139866,0.000710415021739157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40002,-0.0299106560857916,0.00883834186421453,-0.0472338061396521,-0.0125875060319311,0.000716415043696153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,42186,-0.0120470232476999,0.00356254178993648,-0.0190296051559754,-0.00506444133942442,0.000722824649116459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42186,0.0285041813802484,0.00843613873331388,0.0119693494629532,0.0450390132975436,0.000730120106009034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41965,-0.0142490846476965,0.00422375985017856,-0.0225276539540464,-0.00597051534134647,0.00074424896607698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,42003,-0.0123072744341269,0.00364817374627065,-0.0194576949768174,-0.00515685389143648,0.00074427132078342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41985,0.0217956274495966,0.00646218116102573,0.00912975237398619,0.0344615025252071,0.000746293533555557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,40080,-0.0179156753430979,0.00531834443237689,-0.0283396304305566,-0.00749172025563918,0.000757975509039644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39706,0.0126645844518223,0.00376134895660836,0.00529234049686996,0.0200368284067747,0.00076254200496863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40102,-0.00935869642099952,0.00279089093603262,-0.0148288426556235,-0.00388855018637559,0.00080125719823581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42197,0.0145180895200922,0.00433043812991907,0.00603043078545082,0.0230057482547336,0.000802938854902537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40021,0.0104249512159753,0.00311143624986191,0.00432653616624591,0.0165233662657046,0.000809336938955476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40102,-0.024713527555461,0.00738444154200364,-0.0391870329777881,-0.0102400221331338,0.000820553143026046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40093,-0.0087239735381271,0.00260790654228592,-0.0138354703610075,-0.0036124767152467,0.000825003358732688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41861,0.0181999011152691,0.00544904564230375,0.00751977165635377,0.0288800305741845,0.000840154078172099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41876,-0.0169466843589503,0.00507511099511067,-0.0268939019093672,-0.00699946680853336,0.000842697218919166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,42103,-0.018951392225046,0.0056808255702576,-0.0300858103427509,-0.00781697410734108,0.000852244088317007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40054,0.0230251626865872,0.00690178799733941,0.00949765821180199,0.0365526671613725,0.000852427987078369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,42103,0.0275349654294598,0.00825951709508344,0.0113463119230963,0.0437236189358234,0.000859322089267327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41880,0.0136165026341177,0.00408760739795225,0.00560479213413127,0.0216282131341041,0.000867296545655636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39965,0.010730918588009,0.00322172348235464,0.00441634056259393,0.0170454966134241,0.000868877469170601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39665,0.0192066622675954,0.00576704599691826,0.00790325211363565,0.0305100724215552,0.000870161042139447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42296,-0.0102371828300506,0.00307464820870746,-0.0162634933191173,-0.00421087234098403,0.000872277242329191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42076,0.0260385613673745,0.00782214209693153,0.0107071628573887,0.0413699598773603,0.000874570033505525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,42144,0.0200668098977844,0.00603579080222406,0.00823665992542528,0.0318969598701436,0.000887797464342174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40010,-0.00931345182405907,0.00280236130227162,-0.0148060799765114,-0.0038208236716067,0.000892129806065208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41829,0.0195413024085738,0.00588041351223802,0.00801569192458731,0.0310669128925603,0.000892704719863071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,42146,-0.0173912377785343,0.00523437206790299,-0.0276506070316241,-0.00713186852544441,0.000894595315307777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,42103,0.0309671546901378,0.00932129105192903,0.0126974242283569,0.0492368851519187,0.000895600824022345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39804,-0.0204955430997153,0.00617851770627418,-0.0326054378040127,-0.00838564839541795,0.000912215023134694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,42137,-0.0631604960613914,0.0190684884440119,-0.100534733411655,-0.025786258711128,0.000927868326020055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,42256,-0.016716368741216,0.00505360843733794,-0.0266214412783984,-0.00681129620403365,0.000942831283165193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42184,-0.0230339207777321,0.00696999521182691,-0.0366951113929128,-0.00937273016255131,0.000953268450577115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42094,-0.0232789022329613,0.00704680896393549,-0.0370906478022749,-0.00946715666364775,0.000957571143798339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39665,0.0177520303986051,0.00538109620367364,0.00720508183940478,0.0282989789578054,0.000973670261338505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40080,-0.00924473782490109,0.00280324092227171,-0.0147390900325536,-0.00375038561724855,0.000977318845201567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41861,0.0176475436990129,0.00535989586897552,0.00714214779582086,0.0281529396022049,0.000995671180807702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41854,-0.0198917496047343,0.00604488978054105,-0.0317397335745948,-0.00804376563487383,0.0010022166988934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42094,0.0381213079388675,0.0116007228021052,0.0153838912467414,0.0608587246309936,0.0010185075756358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,40113,-0.0069882473349806,0.00212826145732877,-0.011159639791345,-0.00281685487861621,0.00102831845806147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39899,-0.00453320223751673,0.0013807438243402,-0.00723946013322352,-0.00182694434180994,0.00102979754707455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39768,0.0217859228819539,0.00663977728889113,0.00877195939572724,0.0347998863681805,0.00103729738415882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39863,0.0182116242727265,0.0055561456408974,0.00732157881656762,0.0291016697288854,0.00104974824238985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,42099,-0.0291171367215844,0.00888486313512306,-0.0465314684664256,-0.0117028049767432,0.00105133168320533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41984,0.029766652821399,0.00908672405762555,0.011956673668453,0.0475766319743451,0.00105628680230117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39706,-0.0130400857786051,0.00398680628277329,-0.0208542260928407,-0.00522594546436944,0.00107585322966166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42088,0.00818579597199603,0.00251382456354325,0.00325869982745127,0.0131128921165408,0.00113161304150019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40021,0.0158196690181692,0.00486975480605665,0.00627494959829814,0.0253643884380402,0.00116346204458661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42197,-0.0081021783323059,0.00249426308322705,-0.0129909339754309,-0.00321342268918088,0.00116380979226843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42103,0.026225200097392,0.00807536983792473,0.0103974752150595,0.0420529249797244,0.00116698823739947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42213,-0.00725676357792588,0.00223587267732817,-0.0116390740254891,-0.00287445313036266,0.00117496718286482
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,42006,0.0232027301612748,0.00716542654988931,0.00915849412349173,0.0372469661990578,0.00120613568669124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41971,-0.0194066948357976,0.00599748973603812,-0.0311617747184323,-0.00765161495316289,0.00121609925617103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,40080,0.0223706276988442,0.00691877744425984,0.0088098239080949,0.0359314314895935,0.00122724680858231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,40054,-0.0109819426497834,0.00339774351885563,-0.0176415199467405,-0.0043223653528264,0.0012323846732409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,40054,0.0125888969118515,0.00389753498554543,0.00494972834018249,0.0202280654835206,0.00124174316921462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42296,0.0104671842194195,0.0032411923563424,0.00411444720098837,0.0168199212378506,0.00124345589519677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42184,-0.0389181467276271,0.0120562557914015,-0.062548408078774,-0.0152878853764801,0.0012494834772394
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40054,0.0246698349076021,0.00766123991380431,0.00965380467654562,0.0396858651386585,0.00128530177692682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40021,-0.0168798866670954,0.00524299926612796,-0.0271561652287062,-0.00660360810548458,0.00128788773730638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,42072,-0.0118780566943957,0.00369088840069484,-0.0191121979597576,-0.00464391542903385,0.00129312342210905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,40054,-0.0139083417897429,0.0043254805900751,-0.0223862837462901,-0.00543039983319572,0.00130623964440991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42076,0.00841052141880641,0.00261615080416956,0.00328286584263408,0.0135381769949787,0.00130836371330755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39991,-0.023723822681046,0.00739988872016564,-0.0382276045725706,-0.00922004078952133,0.00134999898989154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,40021,0.0101446880464893,0.00317352550039188,0.00392457806572119,0.0163647980272574,0.00139427191385675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41829,0.0167247095725142,0.00523376357051139,0.00646653297431189,0.0269828861707165,0.00139911730816504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40054,-0.0322983019700588,0.0101206826267962,-0.0521348399185794,-0.0124617640215383,0.00142029158173231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42213,-0.0416585636006187,0.013076005469646,-0.0672875343211248,-0.0160295928801126,0.00144655709783662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39804,0.0120319515455135,0.00377791224589465,0.00462724354355996,0.019436659547467,0.00145265449195462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,42274,-0.0154771849227378,0.00486342041697436,-0.0250094889400075,-0.005944880905468,0.0014641860870149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42213,0.0211256968410585,0.00665450475109425,0.0080828675289138,0.0341685261532032,0.00150368761039349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,40020,0.0198677171913537,0.00627160233855293,0.00757537660778993,0.0321600577749174,0.0015397877454312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41664,-0.00818034856689786,0.00258266141162765,-0.013242364933688,-0.00311833220010766,0.00154173926718199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40054,-0.0247074831826178,0.00780626905431849,-0.040007770529082,-0.00940719583615353,0.00155467246337953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39863,-0.0202133063878657,0.00640238140614661,-0.032761973943913,-0.00766463883181832,0.0015976066086458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42094,0.0171904365837151,0.00545218891670545,0.0065041463069724,0.0278767268604578,0.0016200420595363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42120,-0.0118105866859082,0.00374894422074723,-0.0191585173585727,-0.00446265601324361,0.00163431849822492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42094,-0.0134656822511743,0.00427490287194596,-0.0218444918801884,-0.00508687262216019,0.00163677614123664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42103,-0.026331425126604,0.00836596022584353,-0.0427287071692573,-0.00993414308395071,0.00165077136218833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40020,0.0147691845720283,0.00469959831706599,0.00555797187057897,0.0239803972734776,0.00167878659657582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39881,0.0169639429637736,0.00540045086114499,0.00637905927592941,0.0275488266516178,0.00168711252647354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,42256,-0.0248911817101819,0.00794153863548203,-0.0404565974357267,-0.00932576598463714,0.0017264482429383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39577,0.0156883039825806,0.00502221243131428,0.00584476761720464,0.0255318403479566,0.00179033151258441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,42122,0.00999747774725145,0.00320496204302745,0.00371575214291765,0.0162792033515852,0.001816337106662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40054,0.0274550531731582,0.00880755879685607,0.0101922379313203,0.0447178684149961,0.00183045091226788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,42120,0.00825591886692241,0.00264918779353876,0.00306351079158645,0.0134483269422584,0.001834772268218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39863,0.0120260996107658,0.0038627265717697,0.00445515553009718,0.0195970436914344,0.00185452867592258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39863,0.0248782005905426,0.00799211723550869,0.00921365080894557,0.0405427503721396,0.0018578488303323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,40054,0.0142916341483962,0.00459844924933171,0.00527867361970608,0.0233045946770864,0.00188892553091541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42094,0.0392200431055007,0.0126232634857267,0.0144784466734763,0.0639616395375251,0.00189428900194106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,42004,-0.0109749280605921,0.003534503918043,-0.0179025557399564,-0.00404730038122784,0.00190640622071693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42256,-0.0194263991948234,0.00626069837618385,-0.0316973680121437,-0.00715543037750303,0.00192035218874883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,40113,-0.00821532618916604,0.00265105156995927,-0.0134113872662862,-0.00301926511204587,0.001947384729125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39768,0.0216859295351016,0.00699900178995436,0.00796788602679104,0.0354039730434121,0.00195057960362818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40054,-0.0114225730382557,0.00369109601272037,-0.0186571212231876,-0.00418802485332374,0.00197560075699495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42161,-0.0294941673868991,0.00954771901116133,-0.0482076966487753,-0.0107806381250229,0.0020116653702787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,42256,0.0110076709659678,0.00356383524338396,0.00402255388893527,0.0179927880430004,0.00201446078329883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40054,0.0136014864581284,0.00440716232126786,0.00496344830844336,0.0222395246078134,0.00203226781291686
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42094,-0.0122631241749738,0.00397896396224552,-0.020061893540975,-0.00446435480897253,0.00206055671427891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42197,-0.00958254466486821,0.00311180533358916,-0.015681683118703,-0.00348340621103347,0.00207838887532651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40054,0.0148074503362182,0.0048219009654969,0.00535652444384426,0.0242583762285921,0.00213960600111149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39706,0.0118717197275102,0.003866670879548,0.00429304480359611,0.0194503946514243,0.00214411643829586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39768,0.015183252685138,0.00495251716590102,0.00547631903997196,0.024890186330304,0.00217661717198203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,42213,0.00737433880049939,0.00240749494182223,0.00265564871452782,0.012093028886471,0.00219522106075143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40054,-0.0142837288411739,0.004665231249754,-0.0234275820906917,-0.00513987559165603,0.00220591780600285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39955,0.018616888438116,0.00608617050702417,0.00668799424434867,0.0305457826318834,0.00222709441414998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42101,-0.0138123746299859,0.00451643868121972,-0.0226645944451765,-0.00496015481479524,0.00223093612573418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42213,-0.0224229042210731,0.00734002034165574,-0.0368093440907184,-0.00803646435142787,0.00225603496196142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,40097,0.00871184003290777,0.00285177534298173,0.00312236036066358,0.014301319705152,0.00225691989959112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41829,-0.022605953428666,0.00741171156778396,-0.0371329081015225,-0.00807899875580942,0.00229291368619837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40028,-0.0180193464441274,0.00591465011775503,-0.0296120606749273,-0.00642663221332756,0.00232031883290202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39804,0.0159514203288357,0.00523966501716202,0.00568167689519817,0.0262211637624733,0.00233748194324077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42144,0.0211762470134101,0.00698106029759193,0.00749336883012988,0.0348591251966902,0.00242305503040397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,42044,-0.0217383965810581,0.00717022783757828,-0.0357920431427115,-0.00768475001940471,0.00243618355463512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,42021,-0.0164269501272343,0.00541998635664901,-0.0270501233862664,-0.00580377686820228,0.00244384743081147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,40097,-0.0126361374262145,0.00417354696472806,-0.0208162894770815,-0.00445598537534749,0.00247020130342181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42094,0.00860800692183683,0.00284573125218525,0.00303037366755374,0.0141856401761199,0.00249218072848361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39719,-0.0148480382263882,0.00490903267244421,-0.0244697422643788,-0.00522633418839752,0.00249532731188817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42094,-0.0109456015991916,0.00361990161479181,-0.0180406087641836,-0.00385059443419966,0.00250170712891214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42103,-0.01793228644917,0.00593394492393559,-0.0295628185000838,-0.0063017543982563,0.00251616051336418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41887,-0.0187830864679435,0.00621691166743806,-0.0309682333361221,-0.00659793959976492,0.00252202362246091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42004,0.0105547869411467,0.0034971075716666,0.00370045610068011,0.0174091177816132,0.00254824981306659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,42164,-0.0166322273373337,0.00551321083150645,-0.0274381205670864,-0.00582633410758105,0.00255957673118559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,42144,-0.0233798920344111,0.00775002025618038,-0.0385699317365247,-0.00818985233229757,0.00255994474018644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,42103,0.0291999733198759,0.00969584304157583,0.0101961209583873,0.0482038256813645,0.00260380218654647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40054,-0.012027925810327,0.00399471903599715,-0.0198575751208814,-0.00419827649977254,0.00261024787804642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42189,-0.00840430946947849,0.00279997706598472,-0.0138922645188086,-0.00291635442014843,0.00269107023354401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40021,0.0332715975539366,0.0110897761232638,0.0115356363523396,0.0550075587555335,0.00270412404787159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,42184,-0.0130009215257731,0.00433381427543571,-0.0214951975056271,-0.00450664554591915,0.00270598390183035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42296,-0.0128758206470009,0.00429862409845425,-0.0213011238799713,-0.0044505174140306,0.0027465582371623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,42144,-0.0262407916674254,0.00876362307236736,-0.0434174928892654,-0.00906409044558535,0.0027560786983928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39804,-0.0288333324312189,0.00962961774125099,-0.0477073832040708,-0.00995928165836694,0.00275768950978925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42096,0.0198024982303523,0.00662122433104318,0.00682489854150763,0.0327800979191969,0.00278808795467805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41887,-0.013235703543939,0.00443275991139956,-0.0219239129702822,-0.00454749411759591,0.00283300023044537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,42162,0.0178430579294431,0.00597627253239068,0.00612956376595735,0.0295565520929288,0.00283504592054121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39922,0.00849937983642965,0.00284817646842428,0.00291695395831806,0.0140818057145412,0.0028500985748251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41861,-0.0169385970959315,0.00567710592555306,-0.0280657247100155,-0.0058114694818475,0.00285358995985813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39706,0.0139830487639683,0.00469421922087717,0.00478237909104908,0.0231837184368876,0.00290058949006196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39881,0.0161245155955843,0.00541971985225548,0.00550186468516357,0.026747166506005,0.00293493901189323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40054,0.0192440162891636,0.00647554524642433,0.00655194760617189,0.0319360849721553,0.00296709740705992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0178014324392744,0.00600551630797367,0.00603062047564598,0.0295722444029028,0.00304043762366596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42062,0.0184046055831871,0.00621156027199632,0.00622994745007432,0.0305792637162999,0.00305253499838061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42004,-0.0362764583653078,0.0122472146929601,-0.0602809991635096,-0.012271917567106,0.00306191972829317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40054,0.0267187448258402,0.00902070051869715,0.00903817180919375,0.0443993178424866,0.00306372522511064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41986,0.0140535536126463,0.00474869726658068,0.00474610697014812,0.0233610002551444,0.00308748966301222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,42004,0.0208961472813838,0.00706190822240664,0.00705480716546682,0.0347374873973008,0.00309209165915556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,42103,-0.0154387380816717,0.0052233422719203,-0.0256764889346355,-0.00520098722870792,0.00312503854152628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,40020,0.0297203365262013,0.0100565536703435,0.010009491332328,0.0494311817200746,0.0031301764245529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41897,0.0139868127283789,0.0047355737895317,0.00470508810089673,0.023268537355861,0.003147046045936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42120,-0.0164152600713942,0.00556524568162379,-0.0273231416073768,-0.00550737853541156,0.00318753565597175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,40097,-0.0150202693944186,0.00509879773603252,-0.0250139129570423,-0.00502662583179486,0.00322754452396708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,40054,0.0077582295944281,0.00263761404850568,0.00258850605935697,0.0129279531294992,0.00327441498827481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42223,0.009830008901531,0.00334494390809524,0.00327391884166433,0.0163860989613977,0.00330099231705367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,40054,-0.00945950277443538,0.00322912503829001,-0.0157885878494838,-0.00313041769938695,0.0034028829576589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40021,-0.02112800985585,0.00721647785648905,-0.0352723064545685,-0.00698371325713145,0.00342140399154768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,42237,0.0207229371556017,0.0070805204704057,0.00684511703360651,0.0346007572775969,0.00343111598414904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41876,0.0170541682548324,0.00584460514866932,0.00559874216344057,0.0285095943462243,0.00352978356485436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42094,0.0117965557377652,0.00405338006908404,0.00385193080236049,0.0197411806731699,0.00361698304528089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,42129,-0.0133852525501613,0.00460430307379073,-0.0224096865747912,-0.00436081852553151,0.00365395060198256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,42120,-0.0358089205756964,0.0123217667912931,-0.0599595834866308,-0.011658257664762,0.00366525428840091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,42103,-0.0178033287235859,0.00612776747728767,-0.0298137529790698,-0.00579290446810209,0.00367461836936689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40020,0.0205973372995578,0.00709128840010402,0.00669841203535397,0.0344962625637617,0.00368469798840261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41876,-0.0104768076547934,0.00360916056132033,-0.0175507623549813,-0.00340285295460557,0.00370435315611963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42172,-0.00834462166549446,0.00287714195417098,-0.0139838198956696,-0.00270542343531934,0.00373411997853304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42240,-0.0103468975728673,0.00356948711458407,-0.0173430923174521,-0.00335070282828254,0.003753291639215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42094,-0.00994141671772042,0.00343290202605485,-0.0166699046887879,-0.00321292874665292,0.00378681143940568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42094,0.0130683457769075,0.00451469847061852,0.00421953677449517,0.0219171547793198,0.00380251754812555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40054,0.0140726676731673,0.00486596835006753,0.00453536970703497,0.0236099656392997,0.00383485867067558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42296,-0.0047325559836086,0.00163694823168927,-0.00794097451771957,-0.00152413744949762,0.00384545574790939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42080,0.054412695966184,0.018825036413963,0.0175156245948166,0.0913097673375515,0.00385341518635867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,40020,-0.0341285719632464,0.0118197759321635,-0.0572953327902869,-0.0109618111362059,0.00389193355433916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40054,-0.0121111533037785,0.00419794570708851,-0.020339126889672,-0.00388317971788506,0.00392160172879891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42248,0.011258106311776,0.00390259588723388,0.00360901837279759,0.0189071942507544,0.00392335993191758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42223,-0.0122451838695124,0.00424486607278415,-0.0205651213721693,-0.00392524636685542,0.0039242363173114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42144,-0.0253705627843807,0.00880430626717466,-0.042627003068043,-0.00811412250071836,0.00396301201024507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40054,0.00668108529756804,0.00231887083857217,0.00213609845396659,0.0112260721411695,0.00396964631534921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40054,0.0121372385104616,0.00421271865088627,0.00388030995472448,0.0203941670661987,0.00397073406636423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42094,-0.0273706380495324,0.0095063460545193,-0.0460030763163903,-0.0087381997826746,0.00399345475006736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,42223,0.013127801214387,0.00456519979085947,0.00418000962430247,0.0220755928044716,0.00403882407614695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,40054,-0.0200557499376226,0.00698618107554449,-0.0337486648456898,-0.00636283502955535,0.00410259033086638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,42274,-0.00906693669359317,0.00316150594745185,-0.0152634883505988,-0.00287038503658754,0.00413844512954106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40080,0.0214337454171745,0.00751446608198247,0.00670539189648881,0.0361620989378601,0.00434816185472863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39784,0.0138631724009072,0.00486756676855889,0.00432274153453177,0.0234036032672826,0.00440699166647926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39706,0.0214255217640528,0.0075236213429028,0.00667922393196334,0.0361718195961423,0.00441125118680115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40020,-0.0141927809498057,0.00498578872893953,-0.0239649268585272,-0.00442063504108427,0.00442653977019471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,42158,-0.0320862397374687,0.0112748987046169,-0.0541850411985178,-0.00998743827641947,0.00443678531504173
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41968,-0.0195205468039684,0.00686195786451288,-0.0329699842184136,-0.00607110938952313,0.00445171106159128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40020,0.032903459038068,0.0115755219329113,0.0102154360495619,0.0555914820265742,0.00448445002129637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39706,-0.0117515587886114,0.0041380524739081,-0.0198621416374713,-0.00364097593975152,0.00452176291480999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39922,-0.00938739368722668,0.00330644689850191,-0.0158680296082904,-0.00290675776616294,0.00453234196696196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42120,0.00678392067476928,0.00239171540339171,0.00209615848412154,0.011471682865417,0.00456926516600654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,40054,0.0203535647498166,0.00717796377215681,0.00628475575638922,0.0344223737432439,0.00458296175953215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40021,0.0128385634825639,0.00453623563816182,0.00394754163176671,0.021729585333361,0.00466010600063108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,40063,0.0135563969583711,0.00479325869544503,0.00416160991529884,0.0229511840014434,0.00468930547660923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,42120,-0.00915533616665939,0.00323927343605313,-0.0155043121013235,-0.00280636023199525,0.00471533287664161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,42146,0.00857162909174125,0.00303291009625378,0.00262712530308385,0.0145161328803987,0.00471750691207646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40002,0.0119242232065335,0.00421915126714738,0.00365468672292468,0.0201937596901424,0.00471882649608222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,40054,0.00883854909072313,0.00313254319733564,0.00269876442394527,0.014978333757501,0.00478826755015935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41876,-0.0266405322188384,0.00945293327237984,-0.0451682814327029,-0.00811278300497395,0.00483640814019141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,42120,-0.0128652926197072,0.0045681119031341,-0.02181879194985,-0.00391179328956436,0.00486499328089198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,40021,0.0323697889576252,0.0115132142577012,0.0098038890125308,0.0549356889027196,0.0049394578751324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,40102,-0.016712398611167,0.00594644344678747,-0.0283674277668704,-0.00505736945546358,0.00495548256477757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,42098,-0.0161548589808972,0.00575170881632378,-0.0274282082608918,-0.00488150970090256,0.00498158028582724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39706,-0.00941277332380981,0.00335123233319213,-0.0159811886968664,-0.00284435795075323,0.00498260362837012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39957,-0.0313226284000897,0.0111678287245053,-0.0532115727001201,-0.00943368410005934,0.00504506457274259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40053,0.0113912120957359,0.00406333123159235,0.00342708288181487,0.0193553413096569,0.00506539295623937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,42162,-0.0160144534503173,0.00573273006588467,-0.0272506043794512,-0.0047783025211833,0.00522154615769907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,42085,0.0097450757371264,0.00348963925545117,0.00290538279644211,0.0165847686778107,0.00523675555897179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,42094,0.0157087052328152,0.00562753198215586,0.00467874254778976,0.0267386679178407,0.00525573656372526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41876,0.0154580849611869,0.00555510091785294,0.00457008716219512,0.0263460827601786,0.00539911655772288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42004,-0.0172510869730658,0.00619999245742988,-0.0294030721896284,-0.00509910175650324,0.00540313310278656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,42172,-0.00806981667303984,0.00290305794423476,-0.01375981024374,-0.0023798231023397,0.00544766789088521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39830,0.0186282657728096,0.00670174212920021,0.00549285119957714,0.031763680346042,0.00545188870331743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41876,-0.0101345147792486,0.0036492897777692,-0.0172871227436762,-0.00298190681482096,0.0054923476159809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41977,0.0101993859903804,0.00367511572003897,0.00299615917910398,0.0174026128016567,0.00552384543350116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42120,-0.0117389376244571,0.00423773038893207,-0.0200448891867639,-0.00343298606215021,0.00561190369184847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41861,0.0124743489602394,0.0045039147713726,0.00364667600834907,0.0213020219121297,0.00561951223000071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39784,0.01270161955492,0.00459162845949557,0.00370202777430865,0.0217012113355313,0.00568023044408388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41888,0.0135896949115011,0.00491877880782559,0.0039488884481629,0.0232305013748392,0.00573870522878405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40021,-0.0273272014624901,0.00991873459608485,-0.0467679212708164,-0.00788648165416382,0.0058770511583991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42094,-0.0110766774401509,0.00402545744012681,-0.0189665740227994,-0.00318678085750234,0.00593774027499227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39706,-0.0168784136832111,0.00613717685907491,-0.0289072803269979,-0.0048495470394243,0.00596622389453864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39784,0.00983148987475229,0.00357711026511148,0.00282035375513379,0.0168426259943708,0.00599801402441161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,40054,-0.0213808185344268,0.00779490945333597,-0.0366588410629653,-0.00610279600588835,0.00609952319224715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40054,0.00950161314872975,0.00346730995015584,0.00270568564642431,0.0162975406510352,0.00614756780715328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41887,-0.0104370642441228,0.00381136864948804,-0.0179073467971194,-0.00296678169112623,0.00618244166311803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39706,-0.0172165217963998,0.00629548054277254,-0.029555663660234,-0.00487737993256567,0.00625336019594065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,40113,0.0057224486539609,0.00209307258321784,0.00162002639085394,0.00982487091706786,0.00626719621822023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39804,-0.0147075552125607,0.00538665045987425,-0.0252653901139142,-0.00414972031120714,0.00633674850266566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,42144,-0.0222986381442679,0.00818069100953158,-0.0383327925229498,-0.00626448376558603,0.00642389650879914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40020,0.0198525772233243,0.00729320877243797,0.0055578880293459,0.0341472664173028,0.00649794960005101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,42184,-0.0116837958681978,0.0042950515488191,-0.0201020969038833,-0.00326549483251241,0.00653110006598948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39768,0.0134667077973099,0.00495204583683112,0.0037606979571209,0.0231727176374989,0.00655026715491452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,42120,-0.0149514556242166,0.00549947658686794,-0.0257304297344778,-0.00417248151395543,0.00656254329931608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,42256,0.00744580191251633,0.00273902157242876,0.00207731963055595,0.0128142841944767,0.00656817509249378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42004,-0.0126704851294072,0.00466324527919897,-0.0218104458766372,-0.00353052438217719,0.00659459786542908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39706,-0.0111211600761516,0.00409332838640747,-0.0191440837135102,-0.00309823643879292,0.00660045629343167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42094,0.0105208547819516,0.00388306641180626,0.00291004461481129,0.0181316649490918,0.00674901262964631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39719,-0.0165202700870655,0.00611070631219544,-0.0284972544589686,-0.00454328571516242,0.00687244724305139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39881,0.010236074858814,0.00378768296619204,0.00281221624507757,0.0176599334725504,0.00689364633728673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41887,-0.0182602325932218,0.00675905379348718,-0.0315079780284566,-0.0050124871579869,0.00690992221293332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,42193,-0.00854209240350968,0.00316640045017299,-0.0147482372858487,-0.00233594752117061,0.0069904197965967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40054,-0.0199764728878282,0.00740507334341936,-0.0344904166409302,-0.00546252913472627,0.00699336568239298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39768,-0.00872438788005052,0.00323579447364679,-0.0150665450483982,-0.00238223071170281,0.00702440524934387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40054,-0.0311186353329194,0.0115528982571409,-0.0537623159169156,-0.00847495474892331,0.00707981407861883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40080,-0.00917676811669568,0.00341272772460517,-0.0158657144569218,-0.00248782177646956,0.00717791496149363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42178,-0.00964729542560804,0.00359278330012437,-0.0166891506938518,-0.00260544015736427,0.00725813071288043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,-0.0193677903319829,0.00722152394798918,-0.0335219772700417,-0.00521360339392408,0.00732893453854656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,40020,0.0110516607993094,0.00413381594596059,0.00294938154522668,0.0191539400533922,0.0075182096772853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39706,0.0118431299788857,0.00443040264752822,0.00315954078973038,0.020526719168041,0.00752587291636939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41861,0.0171604902037795,0.00643581500454595,0.00454629279486943,0.0297746876126895,0.00767646045417043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39804,-0.00694788779986248,0.00260622392548713,-0.0120560866938173,-0.00183968890590771,0.00769027808623617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40097,-0.00764457003338622,0.00287070914048966,-0.0132711599487459,-0.00201798011802649,0.00775714709956852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42120,0.00818803836412446,0.00307518207733897,0.00216068149254008,0.0142153952357088,0.00776311430802025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39665,-0.0140821766260263,0.00529263902616605,-0.0244557491173118,-0.00370860413474087,0.00780950167060434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,40020,-0.0092763612363632,0.00348807002780366,-0.0161129784908584,-0.00243974398186802,0.00783826785775201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42120,-0.00783657920482813,0.00296381579257133,-0.0136456581582679,-0.00202750025138832,0.00820111436937437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42075,-0.00822692625327546,0.00311439203141064,-0.0143311346348403,-0.0021227178717106,0.00826191584924476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42103,0.0212123406676717,0.00803649667707848,0.00546080718059789,0.0369638741547455,0.00831279719877012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42056,-0.00762290720182746,0.00289099934386818,-0.0132892659158091,-0.00195654848784582,0.00837995601377033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,42192,-0.0122336715388366,0.00463973402376972,-0.0213275502254252,-0.00313979285224792,0.008381186179074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41887,0.0115902011680753,0.00441838433019598,0.00293016788089119,0.0202502344552594,0.00872183195125596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41861,0.0109131442517367,0.00416078487757754,0.00275800589168471,0.0190682826117887,0.00873002413641278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39784,-0.0133869409709647,0.00510528330484781,-0.0233932962484664,-0.00338058569346304,0.00874958490821079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39706,0.0144929943795776,0.00555765510783409,0.00359999036822273,0.0253859983909324,0.00912673990640688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42103,0.0186600206667209,0.00715791328599178,0.00463051062617697,0.0326895307072647,0.0091468973937266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42186,-0.00879722989946944,0.00337538570618142,-0.015412985883585,-0.00218147391535386,0.00916337271356338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42186,-0.00739393497145276,0.00283814676366697,-0.01295670262824,-0.0018311673146655,0.00919257624281407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41861,0.0225227745596299,0.00864789031469536,0.00557290954282697,0.0394726395764328,0.00921362454931376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42144,-0.00913760857687254,0.00351026103249382,-0.0160177202005604,-0.00225749695318465,0.00924866385443434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40054,-0.0279130250801228,0.0107468259925875,-0.0489768040255943,-0.00684924613465131,0.00940790695299865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,42094,-0.0196241839114929,0.0075685148219489,-0.0344584729625127,-0.00478989486047301,0.00952858342033271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40054,0.0182475564953127,0.00705092934347846,0.00442773498209487,0.0320673780085304,0.00966734292375101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,40102,0.00754630027406262,0.00292047762224111,0.00182216413447005,0.0132704364136552,0.00978113262616455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39719,-0.0163525073346367,0.00633199712159205,-0.0287632216929571,-0.0039417929763163,0.00982155258023835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42103,-0.0315925170048598,0.012237568152984,-0.0555781505847083,-0.00760688342501116,0.00984524460700781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42120,-0.00818946829273606,0.0031763658106157,-0.0144151452815428,-0.00196379130392928,0.00994114619821168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41876,0.00941300327381641,0.00365319908535094,0.00225273306652857,0.0165732734811042,0.00998758711733107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41861,0.0171752613068772,0.00667756885215444,0.00408722635665446,0.0302632962570999,0.0101201564407624
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41813,-0.0148619039822546,0.00578064594048584,-0.0261919700256069,-0.00353183793890237,0.0101525781959384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39816,-0.00916524174534127,0.00356754906801626,-0.0161576379186531,-0.00217284557202939,0.0102110551764554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39784,0.0115655679425018,0.00450443881362097,0.00273686786780471,0.0203942680171989,0.0102543135705616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39863,-0.0116359682744428,0.00453609967319184,-0.0205267236338988,-0.00274521291498684,0.0103254072143191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39995,-0.00889217560748624,0.00347017569305133,-0.0156937199658668,-0.00209063124910563,0.010406883928551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42103,-0.03121336305344,0.012220446606424,-0.055165438402031,-0.00726128770484908,0.0106548442662669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40054,0.0143282918383345,0.0056185914395276,0.00331585261686036,0.0253407310598086,0.0107810416091722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41810,0.0173125824061637,0.00679159647630589,0.00400105331260417,0.0306241114997233,0.0108112998168525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,42161,-0.0100269694690356,0.00393443221762018,-0.0177384566155711,-0.00231548232250002,0.0108296093231901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39863,-0.00782199373250561,0.00307154543820093,-0.0138422227913794,-0.00180176467363178,0.010891768310413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40054,0.00837806994562528,0.00329677017900071,0.0019164003947839,0.0148397394964667,0.0110580141560866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,40113,-0.00499447491335786,0.00196689833474618,-0.00884959564946037,-0.00113935417725536,0.0111223370555812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39784,-0.0113356525782897,0.00446899528094222,-0.0200948833289364,-0.00257642182764294,0.0112105826549531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42256,-0.0171139853436699,0.00674776599618298,-0.0303396066961885,-0.00388836399115124,0.0112163900668405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40097,-0.0102865635466251,0.00405597509682984,-0.0182362747364116,-0.00233685235683862,0.0112216896513001
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39768,-0.0143273313565544,0.00565165667009714,-0.0254045784299448,-0.003250084283164,0.0112568543103823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,40021,-0.0171515377771889,0.0067768833583077,-0.030434229159472,-0.00386884639490576,0.0113914337479336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,42103,0.0212091151528131,0.00838377756838604,0.00477691111877645,0.0376413191868497,0.0114251920974854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42096,-0.0156960607510221,0.00621493285537993,-0.0278773291475667,-0.0035147923544774,0.0115639406668942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41651,0.0237557103683262,0.00940799232184865,0.0053160454175029,0.0421953753191496,0.0115802816705504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40020,-0.0242482792927752,0.0096121462437591,-0.043088085930543,-0.00540847265500736,0.0116609519217903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42223,-0.00890553390698513,0.00353067867372851,-0.015825664107493,-0.00198540370647725,0.0116698674468048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,42103,-0.0172172853876397,0.00682704014970704,-0.0305982840810655,-0.00383628669421386,0.0116833776882687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42256,0.010478339611723,0.0041619894511241,0.00232084028751977,0.0186358389359262,0.0118266782041154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39784,0.0223433939317953,0.00888138846477404,0.00493587254083818,0.0397509153227524,0.0118924566010655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41843,0.0309067837487681,0.0122985594611794,0.00680160720485651,0.0550119602926798,0.0119818739621778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40097,-0.0153589915914489,0.00611592668689444,-0.027346207897762,-0.00337177528513575,0.0120427217216556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39706,-0.0184046312040195,0.00733599864565041,-0.0327831885494944,-0.00402607385854473,0.0121287689872135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39784,0.0203827253339795,0.00814074171650302,0.00442687156963362,0.0363385790983255,0.0123019420360035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40054,-0.0180791945544915,0.0072239453643791,-0.0322381274686746,-0.00392026164030852,0.0123404082640307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42144,-0.0296856720769397,0.0118878872724514,-0.0529859311309446,-0.0063854130229349,0.0125324088360836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42144,0.0044925683853526,0.00179927692707209,0.000965985608291307,0.00801915116241389,0.0125416576517016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42213,0.00794245528593563,0.00318173496991165,0.0017062547449088,0.0141786558269625,0.0125631297242701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42144,-0.00892580110396923,0.00357822534627771,-0.0159391227826735,-0.00191247942526491,0.0126266517636865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,42237,-0.00882841796488722,0.00354718945593886,-0.0157809092985274,-0.00187592663124705,0.0128281214431984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,42256,0.0238617614803204,0.00960377329695183,0.00503836581829484,0.042685157142346,0.012981277098293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42105,-0.00830214014785931,0.00334668305707781,-0.0148616389397318,-0.0017426413559868,0.013124851792065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39804,-0.0153739134938529,0.00619885844250287,-0.0275236760411585,-0.00322415094654728,0.0131492099060259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40054,0.0162418365231174,0.00655051630943387,0.00340282455662707,0.0290808484896078,0.0131726785774752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39959,-0.00766714111472741,0.00309409922888407,-0.0137315756033402,-0.00160270662611464,0.0132277743539885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42146,-0.00811042181014181,0.00327748948931911,-0.0145343012092073,-0.00168654241107635,0.0133518677647055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39768,0.0126355810091043,0.0051226114737223,0.00259526252060859,0.0226758994976,0.0136549045983124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,40113,0.00538284253304156,0.00218336098572625,0.00110345500101812,0.00966223006506501,0.0137015772454406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42256,0.00905152519771743,0.00367180388902563,0.0018547895752272,0.0162482608202077,0.013708586726653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39784,0.020701269320706,0.008401726681843,0.00423388502429377,0.0371686536171183,0.0137580536514432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42144,0.00948856059033306,0.00385212490373774,0.00193839577900709,0.017038725401659,0.0137831530051088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41876,-0.0123639230514621,0.00502016281325835,-0.0222034421654485,-0.00252440393747578,0.0137968307143042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39758,0.00694473844443457,0.00282025487995374,0.00141703887972523,0.0124724380091439,0.0138149592358336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42296,0.0166511058277582,0.0067635086386406,0.00339462889602259,0.0299075827594937,0.013832966066947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41887,0.0171366140859533,0.00696633287316679,0.00348260165454636,0.0307906265173602,0.0139100708638685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40080,-0.00711533964755395,0.00289360706111217,-0.0127868094873338,-0.0014438698077741,0.013948446342497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39804,0.0099978510837743,0.00406929403083903,0.0020220347833298,0.0179736673842188,0.0140300375323931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42109,0.0044639229035593,0.00182020900087959,0.000896313261835307,0.0080315325452833,0.0142028992340925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39881,-0.0185149498232756,0.00755257148414639,-0.0333179899322025,-0.00371190971434863,0.0142430508323184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,42175,-0.00753473402155024,0.00307493606857127,-0.0135616087159499,-0.00150785932715056,0.014284015261739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39752,0.014049030510913,0.00574177342147413,0.00279515460482366,0.0253029064170023,0.014428855893063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40021,0.00776221886799576,0.00317311860133731,0.00154290640937463,0.0139815313266169,0.0144511701386735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40113,-0.00393418047483899,0.00160910337606351,-0.00708802309192347,-0.000780337857754505,0.0145028363440634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41861,0.0203825496495942,0.00834198125606769,0.00403226638770158,0.0367328329114869,0.0145643525085923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41876,-0.0273788005400148,0.0112059434565443,-0.0493424497148416,-0.00541515136518799,0.0145696272867093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42094,0.0166789714997321,0.00685483046819075,0.00324350378207824,0.030114439217386,0.0149807418535293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,40054,0.00728608216027661,0.00299495195310163,0.00141597633219741,0.0131561879883558,0.0149991196639027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,42166,-0.0107640908772493,0.00442693810133385,-0.0194408895558637,-0.002087292198635,0.0150499805445773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42103,0.0104958755628332,0.00432249617914195,0.00202378305171495,0.0189679680739514,0.0151876375724306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41716,-0.0301197762066037,0.0124075652908515,-0.0544386041766728,-0.00580094823653473,0.0152158997843072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,42103,0.0210532596154745,0.00868957330189623,0.00402169594375788,0.0380848232871911,0.0154142826817242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,40001,0.0105625766253838,0.00437551316432491,0.00198657082330701,0.0191385824274607,0.0157941061997668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41829,-0.00824416887025368,0.00341582977436775,-0.0149391952280145,-0.00154914251249289,0.015813452163016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,40080,-0.0175630630789088,0.00727902886240283,-0.0318299596492183,-0.00329616650859921,0.0158455962140231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39700,0.00849866069987267,0.003525161281543,0.0015893445880484,0.0154079768116969,0.015932131252397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39804,-0.011918589274433,0.00494964562448223,-0.0216198946984181,-0.00221728385044778,0.0160585296828775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41829,-0.0139172374280515,0.00578160606844422,-0.0252491853222021,-0.00258528953390079,0.0160914759571509
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39863,-0.0217708742197075,0.00904505654304357,-0.0394991850440729,-0.00404256339534212,0.0161038591022279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41797,-0.0120457776687452,0.00500805093409742,-0.0218615574995762,-0.00222999783791428,0.0161742843618517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42103,-0.0201018556383229,0.00835944552427364,-0.0364863688658992,-0.00371734241074654,0.0162002834273903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41965,-0.00756650078516443,0.00315361656610832,-0.0137475892547367,-0.00138541231559213,0.0164402836651363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41967,-0.00855278923242572,0.00356544708738756,-0.0155410655237053,-0.00156451294114611,0.0164632086166652
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42168,-0.0121663197891284,0.00507481849205777,-0.0221129640335616,-0.00221967554469519,0.0165263827626516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42213,0.0113413376822055,0.00473220282600065,0.00206622014324424,0.0206164552211668,0.0165606535125363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41861,0.0238351667826315,0.0099620258747775,0.00430959606806755,0.0433607374971954,0.0167438390317653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,42296,0.0144145523508975,0.00603172770028821,0.00259236605833265,0.0262367386434624,0.0168721342773004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42094,-0.012956794179054,0.00542439880717008,-0.0235886158411074,-0.00232497251700067,0.0169263558737638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40080,0.0153675562610695,0.00643871554081763,0.002747673801067,0.0279874387210721,0.0170153637279906
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39707,0.024164317894955,0.0101321688364864,0.00430526697544159,0.0440233688144685,0.0171008829816123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,42162,-0.00790698669762375,0.00332346940395217,-0.01442098672937,-0.0013929866658775,0.0173676416252713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41876,0.0280537797519751,0.0118025202536965,0.00492084005472983,0.0511867194492203,0.017472087636886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,42154,-0.0135092912919895,0.00569639979606213,-0.0246742348922712,-0.0023443476917077,0.0177282255692136
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40020,-0.0108920260386468,0.00459339357053859,-0.0198950774369024,-0.00188897464039117,0.0177460450939856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39863,0.00788578644251088,0.00333105263752862,0.00135692327295477,0.014414649612067,0.017933444777101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39793,0.0191715548492457,0.00811859897824783,0.00325910085187998,0.0350840088466115,0.0182222827235561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,40080,-0.00681786660776941,0.002889335952651,-0.0124809650749654,-0.00115476814057345,0.0183089660501008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39706,-0.00841931110358015,0.00356923321097687,-0.0154150081970948,-0.00142361401006548,0.0183495058658706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41861,0.00766489559178821,0.0032565745153504,0.00128200954170143,0.014047781641875,0.0186043925320381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39804,0.0203851272858337,0.00867454709534385,0.00338301497895976,0.0373872395927077,0.0187919694858401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42076,-0.0104519610236453,0.00444947423734334,-0.0191729305288383,-0.00173099151845235,0.0188372701429043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41810,0.0113137028741972,0.00482269524199644,0.00186122019988419,0.0207661855485102,0.0189950954115281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42223,0.00823918927459488,0.00351540731874219,0.00134899092986019,0.0151293876193296,0.0191065896069006
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,40113,-0.00750772285205298,0.00320878854158763,-0.0137969483935647,-0.00121849731054122,0.0193152200175189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42186,-0.00842474798044665,0.00360396099350287,-0.0154885115277123,-0.00136098443318103,0.0194212523983398
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,40020,0.0100255840333101,0.00429070869452443,0.00161579499204225,0.018435373074578,0.0194791781242214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41876,-0.00930236927226318,0.00398606189412441,-0.017115050584747,-0.00148968795977933,0.0196257062949588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,42103,-0.0160278664318879,0.00687439713053773,-0.0295016848077419,-0.00255404805603396,0.0197407115232122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,42126,-0.00672652181239234,0.00288557133465876,-0.0123822416283235,-0.00107080199646117,0.0197639871944871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,40085,0.0132593580139598,0.00569750787626091,0.00209224257648838,0.0244264734514311,0.0199717595548668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42120,-0.0106984265782468,0.0046079903339946,-0.0197300876328762,-0.00166676552361735,0.0202639101970695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39804,0.0102748426924994,0.00443416870281866,0.00158387203497482,0.0189658133500239,0.0205119376411687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,42144,0.0204317099527587,0.0088237226575191,0.00313721354402125,0.0377262063614961,0.0205987751308501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,40097,-0.00660478052482131,0.00285288380968053,-0.0121964327917952,-0.00101312825784747,0.0206246059688939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42091,0.00643686627598406,0.00278445525052239,0.000979333984960172,0.011894398567008,0.0208090863168105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41861,0.0103584278028124,0.00448099902419804,0.0015756697153842,0.0191411858902405,0.0208138492110469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42094,-0.0132562762979796,0.00574110074141071,-0.0245088337511446,-0.00200371884481459,0.0209585827804333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40080,-0.0143254523797779,0.00620684289883315,-0.0264908644614908,-0.00216004029806489,0.0210172622746486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,42144,-0.00718064944631243,0.00311184854784643,-0.0132798726000914,-0.00108142629253344,0.0210415974227835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40054,0.0064551123626631,0.00279918196189807,0.000968715717342892,0.0119415090079833,0.0211254054479323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,42179,0.00991742757741676,0.00430142146531461,0.00148664150540012,0.0183482136494334,0.0211477612222292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39784,0.0110021048264545,0.00477241400568776,0.00164817337530644,0.0203560362776025,0.0211659764788939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40026,0.025472332140585,0.0110741554647882,0.00376698742960015,0.0471776768515699,0.0214580588198716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,40080,0.0213952944314775,0.00931815539883181,0.00313170984976717,0.0396588790131878,0.0216898225173119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40020,0.0155623672082843,0.0067943267797585,0.00224548671995765,0.028879247696611,0.0220118081910923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40021,-0.0207300123428236,0.00907211134153221,-0.0385113505722268,-0.0029486741134205,0.0223305387436631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39867,0.015147157867411,0.00663825867096116,0.00213617087232716,0.0281581448624949,0.0225209322335646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42103,-0.0112635442986916,0.00493725152788081,-0.020940557293338,-0.00158653130404521,0.0225446067179608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41974,0.0158075570850139,0.00693335398970577,0.00221818326519058,0.0293969309048372,0.0226282797807111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41953,-0.00801856478662928,0.00351752808487702,-0.0149129198329882,-0.00112420974027032,0.0226477241835197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41887,-0.00843707281326534,0.00371457973840223,-0.0157176491005337,-0.00115649652599698,0.0231430838062851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39804,-0.0129274310140271,0.00569264878206832,-0.024085022626881,-0.00176983940117318,0.0231730373679322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41829,-0.0243437247559742,0.0107343089482548,-0.0453829702945537,-0.00330447921739465,0.0233556014677903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,42073,-0.0177256918551924,0.00781919422098964,-0.0330513125283321,-0.00240007118205269,0.023410024985773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41861,0.00902397607086228,0.00398243134912733,0.00121841062657271,0.0168295415151519,0.0234714648071601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41861,0.00999383913342499,0.00441350589214417,0.00134336758482242,0.0186443106820276,0.0235677962034511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,40013,-0.00668649028623189,0.00295437192623011,-0.0124770592616429,-0.000895921310820872,0.0236398439171463
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41829,0.0140984482047486,0.00622941621032131,0.00188879243251885,0.0263081039769784,0.023639926175108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,40097,-0.0110997256032728,0.00490719686936768,-0.0207178314672334,-0.00148161973931212,0.0237214617910576
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39804,0.00703527455981339,0.00311220041427393,0.000935361747836485,0.0131351873717903,0.0238075140145764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41887,-0.0088437276897309,0.00393089299601402,-0.0165482779619184,-0.00113917741754342,0.0244786291735107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39863,-0.0245459157282538,0.0109303869922275,-0.0459694742330197,-0.00312235722348794,0.0247462805560145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,42223,0.0139736414697933,0.0062300750247502,0.00176269442128293,0.0261845885183037,0.0249178701970554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42144,0.00586060654242795,0.00261774528935198,0.000729825775298065,0.0109913873095578,0.0251858888618653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,40021,0.00790706113908046,0.00353252868126963,0.000983304923791986,0.0148308173543689,0.0252180116184761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42144,-0.0108266049754031,0.00484180528599953,-0.0203165433359622,-0.00133666661484404,0.0253642940675236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40054,0.0178629704433338,0.00799575320705014,0.00219129415751556,0.0335346467291521,0.0254995787186867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,42256,0.0079433815912465,0.00356467853784354,0.000956611657073165,0.0149301515254198,0.0258735750541478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,42146,-0.00783292233039974,0.0035184626617868,-0.0147291091475019,-0.000936735513297616,0.026015626243762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41861,0.00756068498384679,0.00339988389152162,0.000896912556464412,0.0142244574112292,0.0261790096912611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39625,0.00747452393540836,0.0033614714525944,0.00088603988832333,0.0140630079824934,0.0261975856201715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41985,-0.0113631353764323,0.0051246761757222,-0.0214075006808479,-0.00131877007201683,0.0266175645660654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39706,0.0144370772200831,0.00652034105696424,0.00165720874843315,0.027216945691733,0.0268391620879469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40054,0.0193327816535783,0.00874135442340478,0.00219972698370493,0.0364658363234517,0.027011876808993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39881,-0.00843417589519055,0.00382592220708587,-0.0159329834210789,-0.000935368369302233,0.0275117092893057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39706,0.00643950094030276,0.00292229072209637,0.000711811124993873,0.0121671907556116,0.0275755100000968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41876,-0.00717311670327941,0.00325971904796995,-0.0135621660373005,-0.000784067369258301,0.0277871199927702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39724,0.00967160120124117,0.00440091879901037,0.00104580035518084,0.0182974020473015,0.0279970160093241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,42103,-0.00767536686086344,0.00349384877932517,-0.0145233104683408,-0.000827423253386116,0.02805081044002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",40113,0.00376806778283392,0.00171529445816866,0.000406090644823359,0.00713004492084449,0.0280594674993649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,42186,0.0127452868361239,0.00580536668258185,0.00136676813826343,0.0241238055339843,0.0281502570190709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40054,-0.0281398320765352,0.0128172469415018,-0.0532616360818788,-0.00301802807119155,0.0281512554696487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,42184,-0.00802361417119004,0.00365491935478302,-0.0151872561065647,-0.000859972235815329,0.0281603056544544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,42051,-0.0112710005829717,0.00513655858851012,-0.0213386554164516,-0.00120334574949192,0.0282337734501907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42126,0.00661339358466004,0.00301759240297198,0.000698912474834953,0.0125278746944851,0.0284252599463597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,40021,0.0232912046945561,0.0106349722331102,0.00244665911766005,0.0441357502714522,0.0285412970701042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41876,0.0095025981394377,0.00433940663453783,0.000997361135743559,0.0180078351431318,0.0285541294841488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,42213,0.00718503170400812,0.00329027321204375,0.000736096208402379,0.0136339671996139,0.0290006995603488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40102,-0.00610859906916305,0.00280005486633817,-0.0115967066071859,-0.000620491531140232,0.029160356970002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41829,0.0146585769440661,0.00672063887802475,0.00148612474313758,0.0278310291449946,0.0291922878643317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39804,0.0070891148980617,0.00325298871299953,0.00071325702058262,0.0134649727755408,0.0293341260700312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42174,-0.0248511581310698,0.0114073031473081,-0.0472094722997936,-0.00249284396234593,0.0293844924008623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39961,0.00992221914186656,0.00456267424501187,0.000979377621643294,0.0188650606620898,0.0296780575451218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39986,0.00964277476833974,0.00443477418721267,0.000950617361402905,0.0183349321752766,0.0297001144583102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41859,-0.00859821423072293,0.0039630712918476,-0.0163658339627442,-0.000830594498701642,0.0300569435617066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40054,0.00938235719220336,0.00432537475829745,0.000904622665940364,0.0178600917184664,0.0300934383771352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,42153,-0.00619102730287665,0.00285494183497879,-0.0117867132994351,-0.000595341306318223,0.030136508495393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,42176,-0.00620079621597926,0.00286019483530657,-0.0118067780931801,-0.000594814338778381,0.0301796204375032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39804,0.0138964066659094,0.00641795322053559,0.00131721835365966,0.0264755949781592,0.0303915537349873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,42163,-0.00705530317377828,0.00326319269110088,-0.013451160848336,-0.000659445499220551,0.0306297771366154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42144,0.00834962044530785,0.00386653181555924,0.000771218086811733,0.015928022803804,0.0308328038024161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40080,-0.0215657754320948,0.0100028302762533,-0.0411713227735512,-0.00196022809063844,0.031108055348019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42213,0.00785153122392588,0.00364356546226546,0.000710142917885588,0.0149929195299662,0.0311876821849472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40054,0.00887163161744906,0.00411973621919802,0.000796948627820945,0.0169463146070772,0.0313055467270661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39706,0.016916298748181,0.00787859888433545,0.00147424493488351,0.0323583525614785,0.0318065167783408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39863,-0.0259653538410781,0.0121057787249324,-0.0496926801419456,-0.0022380275402106,0.0319855427627852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,40020,0.0103532653921069,0.00482984715456231,0.000886764969164733,0.019819765815049,0.0320870796704256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39804,-0.0140488783129529,0.00657622365509078,-0.0269382766769309,-0.00115947994897499,0.0326766475041566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,40055,0.00564480782334876,0.00264232662692251,0.000465847634580643,0.0108237680121169,0.0326770884941321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,42172,0.0039685722669273,0.00185895556253877,0.0003250193643513,0.0076121251695033,0.0327927767523475
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39784,0.00977423599582197,0.00458876427366106,0.000780258019446289,0.0187682139721976,0.0331915758417053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,42144,-0.00891067491782351,0.00419186780888852,-0.017126735823245,-0.000694614012402004,0.0335466889835388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,42226,0.00474124100433029,0.00223047748516346,0.000369505133409903,0.00911297687525068,0.033550173338695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41779,0.015043924791525,0.00708668932152484,0.00115401372133635,0.0289338358617137,0.0337865239831165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42184,0.00546922531225585,0.00258039731540366,0.000411646574064675,0.010526804050447,0.0340647530475362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41813,0.0124477297340058,0.00588046001179057,0.000922028110896294,0.0239734313571153,0.0342967467284812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,42193,0.0107856076556045,0.00510670285132812,0.000776470067001406,0.0207947452442076,0.0347012542778361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39719,-0.0213109744012116,0.0100975689255931,-0.0411022094953741,-0.00151973930704902,0.0348383689634326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,42103,0.020128171121585,0.00954942623670427,0.00141129569764459,0.0388450465455253,0.0350685127260318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42213,0.00504966076743835,0.00239807927200422,0.000349425394310069,0.00974989614056662,0.0352486039574888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42197,0.00997042123919115,0.0047384813562985,0.00068299778084608,0.0192578446975362,0.0353855122027057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,42094,0.00702299407107973,0.00333836752660242,0.00047979371893898,0.0135661944232205,0.0354220943629761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42103,0.00775991621294464,0.00369245723832497,0.000522700025827703,0.0149971324000616,0.0356112672738232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40080,-0.0208194549530598,0.00992009860731839,-0.0402628482234038,-0.00137606168271571,0.0358650521619035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,42103,-0.0136553302026315,0.00651009950916291,-0.0264151252405908,-0.000895535164672157,0.0359633475866618
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41661,0.0130171887643122,0.00620629452424467,0.000852851496792602,0.0251815260318317,0.0359767473154766
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,42208,-0.0129882220985223,0.00619556868076628,-0.0251315367128242,-0.000844907484220442,0.0360683855577975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,42256,0.0131443649398776,0.00627690920874158,0.000841622890744131,0.0254471069890111,0.0362718675422242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40020,0.0111488422258104,0.00532663927093474,0.000708629254778294,0.0215890551968425,0.0363692496024958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42193,0.0121789018505382,0.00582354426072218,0.000764755099522754,0.0235930486015537,0.0365186388678305
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,42120,-0.0108459522818728,0.0051886110714797,-0.0210156299819731,-0.000676274581772631,0.0366069117877318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39706,-0.00880435872875474,0.00421269178574069,-0.0170612346288065,-0.00054748282870299,0.0366453339960188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42067,-0.00461278626086642,0.00220753797903044,-0.00893956069976608,-0.000286011821966748,0.0366767932169821
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,40054,-0.00614161239592806,0.00294238720752919,-0.0119086913226853,-0.000374533469170849,0.0368852745059511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40054,0.0103060037023321,0.00494037515979742,0.000622868389129151,0.019989139015535,0.036994913321739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,42103,0.0189661407719826,0.00909316373870333,0.00114353984412408,0.0367887416998411,0.0370201199356138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40102,-0.031011115508161,0.0148841117239357,-0.0601839744870749,-0.00183825652924711,0.0372284756249554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39706,-0.00444820663124692,0.00213590658720686,-0.00863458354217237,-0.00026182972032147,0.0373132018414477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39706,-0.00694079098870372,0.00333666748243328,-0.013480659254273,-0.000400922723134482,0.0375353343406678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40054,-0.00505449566583088,0.00243157655055378,-0.00982038570491629,-0.000288605626745478,0.0376692036670643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40080,0.00570667712545668,0.0027455817355855,0.000325336923709099,0.0110880173272043,0.0376871842914163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,42223,0.00848775266176122,0.00408825893246295,0.000474765154133836,0.0165007401693886,0.037901588832005
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,42103,0.0177466082576962,0.00856021624653979,0.000968584414478165,0.0345246321009142,0.0381781566939436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39863,-0.0069821134114636,0.00337010478667955,-0.0135875187933555,-0.000376708029571685,0.0383099984388392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42223,-0.0126275350616728,0.00610374457213377,-0.0245908744230549,-0.00066419570029057,0.0385828697675634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42219,0.012403989860761,0.00600245856409173,0.000639171075141217,0.0241688086463808,0.0388024383706847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39916,-0.00723231566695025,0.00350124025587834,-0.0140947465684718,-0.000369884765428699,0.0388860852180731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40021,0.02263603485359,0.0109616836654036,0.00115113486939881,0.0441209348377811,0.038945386801782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42213,-0.0141501318214483,0.0068675890219897,-0.0276106063045481,-0.00068965733834849,0.0393780350664838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39804,0.00707286564532208,0.0034328408875166,0.000344497505789549,0.0138012337848546,0.0393890879094475
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41861,0.0125211160511263,0.00607796434983137,0.000608305925456801,0.0244339261767958,0.0394109080972397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,42144,-0.00807644913002882,0.00392059489613642,-0.0157608151264562,-0.000392083133601431,0.0394179003828296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,40092,-0.00468706095983928,0.00227622994128697,-0.00914847164476174,-0.000225650274916826,0.0395051732436234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39881,-0.00744663128924401,0.00361702140330012,-0.0145359932397123,-0.000357269338775773,0.0395400306182496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39665,0.0195698780987038,0.00951232957781309,0.000925712126190147,0.0382140440712174,0.0396804440188064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,42103,-0.0100947977776074,0.00490742613268153,-0.0197133529976632,-0.000476242557551578,0.0397019162808675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,40113,-0.0031328530070355,0.00152513549878939,-0.0061221185846627,-0.000143587429408296,0.039985188129808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39706,0.00945107413664123,0.00460457890431677,0.000426099484180351,0.0184760487891021,0.0401420898019872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40041,-0.00862750292802684,0.00420805600466996,-0.01687529269718,-0.000379713158873711,0.040365505964997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39863,0.0140559496225775,0.00686281291088639,0.0006048363172402,0.0275070629279148,0.0405714496411532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,42255,-0.00754735969142744,0.00368514050312264,-0.0147702350775478,-0.000324484305307074,0.0405748479059769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39804,-0.0180942644462112,0.00883887792591636,-0.0354184651810073,-0.000770063711415164,0.0406706528777277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40002,-0.0144358628902186,0.00706122336881945,-0.0282758606931047,-0.000595865087332496,0.0409396546230657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,42123,-0.00906636642572703,0.00443737433838518,-0.017763620128962,-0.000369112722492081,0.041054587851729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42094,0.00954277721330006,0.00467570707946444,0.000378391337549759,0.0187071630890504,0.0412783866495656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41861,0.00845366103730817,0.00414469433042446,0.000330060149676237,0.0165772619249401,0.0414074607362364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39881,0.00720190806324986,0.00353166198250636,0.000279850577537398,0.0141239655489623,0.0414505819764095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40113,-0.003541634453936,0.00173707555223757,-0.00694630253632163,-0.000136966371550362,0.0414891517917045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,42094,-0.00625461970412006,0.00306999020117798,-0.0122718004984289,-0.000237438909811216,0.0416361572040444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,42144,-0.00882983566507648,0.00433683377579187,-0.0173300298656285,-0.000329641464524412,0.0417696888970003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39706,0.0128646719092606,0.0063191115456184,0.000479213279848508,0.0252501305386726,0.0417918935709235
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41887,-0.00619050455352197,0.00305122551623976,-0.0121709065653519,-0.000210102541692032,0.042493544480579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,42120,-0.00421978088112911,0.00208128688073665,-0.00829910316737295,-0.000140458594885266,0.0426331681440802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41821,-0.022346286006153,0.0110225417079662,-0.0439504677537667,-0.000742104258539308,0.0426500418989429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39863,-0.0107794221780453,0.00532270864471159,-0.02121193112168,-0.000346913234410584,0.0428741381601203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39863,0.0238284176531573,0.0117702519633117,0.000758723805066509,0.0468981115012482,0.0429475902772913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42004,-0.0107930013591084,0.00533722882361988,-0.0212539698534034,-0.000332032864813455,0.043175328845582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39804,0.0152827849099352,0.00757258395453085,0.00044052035905472,0.0301250494608157,0.0435983579876744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40021,0.0060656508109758,0.00300705233970725,0.000171828225149587,0.011959473396802,0.0437053549502143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39881,0.0144208297354967,0.00715143016181542,0.000404026618338504,0.0284376328526549,0.0437731108019309
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40021,-0.0215123061092572,0.0106708076345088,-0.0424270890728944,-0.00059752314562006,0.0438250405009274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39532,-0.0219405886589672,0.0109002781326198,-0.043305133798902,-0.000576043519032385,0.044156638467944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,40020,0.00735476634712484,0.00366471730170082,0.000171920435791222,0.0145376122584585,0.044783814163588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40036,0.0164023482165088,0.00817461570764808,0.00038010142951856,0.032424595003499,0.0448279524065471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42004,-0.0221033773226585,0.0110185570629342,-0.0436997491660095,-0.000507005479307526,0.0448757630885338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40080,-0.00750004142686984,0.0037434872724388,-0.0148372764808499,-0.0001628063728898,0.0451493981117273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,42213,0.0117978520292131,0.00589280957383023,0.000247945264505839,0.0233477587939203,0.0452972751234111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42120,0.00927515902347386,0.0046438197966143,0.000173272222109824,0.0183770458248379,0.0458121780253842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,40020,0.00808224939820905,0.00405356330707486,0.000137265316342321,0.0160272334800758,0.0461920853408041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41876,0.00477576664444868,0.00240176443983208,6.83083423777993e-05,0.00948322494651956,0.0467844071769105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40080,0.0150117161960257,0.0075537987478926,0.000206270650156177,0.0298171617418952,0.046913417782108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40054,0.00733928720150874,0.00369592701935243,9.52702435779718e-05,0.0145833041594395,0.0470831843775386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42094,-0.00533056378371043,0.00268480065515716,-0.0105927730678185,-6.83544996023955e-05,0.0471144761416815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42256,-0.00974411294180052,0.00491102419276923,-0.0193697203596282,-0.000118505523972825,0.0472621873978511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,42223,0.00803029287636543,0.00405262707804192,8.71438034032723e-05,0.0159734419493276,0.0475558736481378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,42185,-0.00750059287826064,0.00379261497650939,-0.014934118232219,-6.70675243022367e-05,0.0479854986296595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39784,0.0195819197148222,0.00990601330608714,0.000166133634891371,0.038997705794753,0.0480934223967599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40085,0.0222268726176536,0.0112702475605589,0.000137187398958207,0.044316557836349,0.0486151755707002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39719,-0.00692527793881788,0.00351210934483089,-0.0138090122546864,-4.15436229493343e-05,0.0486553122247938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,42103,-0.00625539749546777,0.00317626040506703,-0.0124808678893991,-2.99271015364042e-05,0.048925988222776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41813,-0.0114353069242799,0.00581588040880096,-0.0228344325255297,-3.61813230299809e-05,0.0492949598213068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,40054,0.00918263365294191,0.00467039231496448,2.86647156115365e-05,0.0183366025902723,0.0493081582767055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42184,0.00795655554823288,0.0040503552185182,1.78593199372124e-05,0.0158952517765285,0.0495039291544779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40000,-0.00559902499949028,0.00285107398182502,-0.0111871300038673,-1.09199951132469e-05,0.0495753926923679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42296,0.00473782405483581,0.00241836077073339,-2.16305580162494e-06,0.00947781116547325,0.0501216012783577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41887,0.00657728459187152,0.00336137345386625,-1.1007377706344e-05,0.0131655765614494,0.0504016618920297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39706,0.0143328241722837,0.00733549622864489,-4.47484358602791e-05,0.0287103967804277,0.0507395570702379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39863,0.0136611492261123,0.00701419292695685,-8.66689107231582e-05,0.0274089673629477,0.0514837958068443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41829,0.015532131458743,0.00797802463515599,-0.000104796826162724,0.0311690597436487,0.0515731331086861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,40102,-0.00446084759530723,0.00229253501136955,-0.00895421621759154,3.25210269770861e-05,0.051702689971216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41782,-0.00922348457044793,0.00475408245500521,-0.0185414861822581,9.45170413622822e-05,0.0523875624007725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39804,0.00827472853605277,0.00426745331439302,-8.94799601575454e-05,0.0166389370322631,0.0525239216332995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40021,0.0167209620037827,0.00862972949131354,-0.000193307799191886,0.0336352318067572,0.0526980405171536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42111,-0.0216239167964152,0.0111611304868211,-0.0434997325505846,0.000251898957754279,0.0527144891015476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42213,-0.0101552662823694,0.00524666015609897,-0.0204387201883234,0.00012818762358454,0.0529422866795719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,42103,-0.0117412240608542,0.00606900063975306,-0.0236364653147702,0.000154017193061811,0.0530584818039689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39804,-0.00465785038542373,0.00240789643087743,-0.0093773273899435,6.1626619096043e-05,0.0530897282145408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39863,-0.0185762657213584,0.00962125314705211,-0.0374339218895806,0.000281390446863719,0.0535400400887932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42120,-0.00642233649821644,0.00332750259843551,-0.01294424159115,9.95685947171631e-05,0.0536191405947298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39784,0.00735566610109467,0.00381498871126939,-0.000121711772993329,0.0148330439751827,0.0538698379919474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,42004,0.0118367431248566,0.00614395749280539,-0.000205413561041914,0.0238788998107552,0.0540557644161628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39804,-0.00778176659004599,0.00404039348072572,-0.0157009378122684,0.00013740463217641,0.0541320270917636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,42094,-0.0160441310094207,0.00833658056955988,-0.032383828925758,0.000295566906916719,0.0543081757492933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39719,-0.00573454253586815,0.00298238237967274,-0.0115800120000267,0.000110926928290412,0.0545313798486155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42217,0.00621640322638942,0.00323615034805828,-0.000126451455804805,0.0125592579085836,0.0547629268207807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,42081,-0.0056384883205719,0.002938218372024,-0.0113973963297389,0.00012041968859514,0.0550043595644207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42004,0.0115239274519679,0.00600541773489111,-0.000246691308418649,0.0232945462123545,0.0550164172355057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42120,0.0111375842861356,0.00580943771547117,-0.000248913636187894,0.0225240822084591,0.0552404425432567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42144,0.00604170490324134,0.00315173735511525,-0.000135700312784552,0.0122191101192672,0.055266990879533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41984,-0.00643366429351017,0.00336536065658438,-0.0130297711804156,0.000162442593395226,0.0559330277043942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42030,-0.00849928213959736,0.0044484027522149,-0.0172181515339386,0.000219587254743834,0.0560735232382225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39706,-0.0165189186585274,0.0086511111939079,-0.0334750965985869,0.000437259281532102,0.0562304496503007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42094,-0.00889711222651627,0.00466470873764276,-0.0180399413522961,0.000245716899263537,0.0565007945998795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,42144,0.00701090453837834,0.00368170944620226,-0.000205245976178084,0.0142270550529348,0.0568994416361464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,42127,0.00653109621827445,0.00344273994429749,-0.000216674072548625,0.0132788665090975,0.057841816119628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39784,0.00636158772231952,0.00335445698267801,-0.000213147963729376,0.0129363234083684,0.0579266602846749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39804,0.00853160808850851,0.00449902497072796,-0.000286480854118283,0.0173496970311353,0.0579443816456023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42184,-0.0168465860717849,0.00889152763806853,-0.0342739802423992,0.000580808098829457,0.0581571971303592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39863,0.016146711783489,0.00853317993459798,-0.000578320888323047,0.032871744455301,0.0584878178944879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,42156,0.011710587511274,0.00619338247745247,-0.000428442144532798,0.0238496171670809,0.0586703110902839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,42004,-0.00850569300355981,0.0044990918043976,-0.0173239129401791,0.00031252693305949,0.0587089192172482
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42103,0.00891857449932533,0.00471998283658389,-0.000332591860379081,0.0181697408590298,0.0588425161433775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39768,0.00928254692323092,0.00491849879376845,-0.000357710712555246,0.0189228045590171,0.0591510638767306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41861,0.0142760385410498,0.00757449954499377,-0.000569980567137965,0.0291220576492376,0.0594864623211667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,42094,0.0106213889006413,0.00563666541045324,-0.000426475303846997,0.0216692531051297,0.0595415897804313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41876,-0.00595369446448221,0.00316378482654742,-0.0121547127245152,0.000247323795550745,0.0598824432750298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39719,-0.0091101902184775,0.00484551587690443,-0.0186074013372102,0.00038702090025519,0.0601182262492061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,40054,0.0125689971901137,0.0066866109163403,-0.00053676020591327,0.0256747545861407,0.0601721632821902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39719,0.0150999920935877,0.00803511576450243,-0.000648834804837038,0.0308488189920125,0.0602379594696461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,42256,0.011144877411679,0.00593370479239439,-0.000485183981413981,0.022774938804772,0.060371617820739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42184,-0.0130556630429049,0.00695272168610921,-0.0266829975476789,0.000571671461869172,0.0604340208169089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42004,-0.00699560336001225,0.00373253338183279,-0.0143113687884045,0.000320162068380019,0.0609223096497895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42144,-0.0159192170881366,0.00849644507919298,-0.0325722494433548,0.000733815267081654,0.0610035742639213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40054,-0.0185311023848488,0.009903816812149,-0.0379425833366608,0.000880378566963269,0.0613570992462161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41948,-0.00731856390989088,0.00391286557497126,-0.0149877804368345,0.000350652617052784,0.0614533008539989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40054,0.00525944900717754,0.00281380940386669,-0.000255617424401178,0.0107745154387563,0.0616279941156708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42151,0.00972058348655627,0.00520560125636146,-0.000482394975912183,0.0199235619490247,0.0618778634298671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39640,0.0137774020488839,0.00738501384488881,-0.000697225087098153,0.028252029184866,0.0621268719396149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40020,-0.0075600767308251,0.0040666080660055,-0.0155306285401959,0.000410475078545674,0.0630454569844736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39989,0.00985738023935124,0.0053028143172317,-0.000536135822422894,0.0202508963011254,0.0630690769176808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41829,-0.00742845352267594,0.00400175807973084,-0.0152718993589484,0.000414992313596512,0.0634344276898534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39784,0.0078332266745442,0.00422030335751458,-0.000438567906184363,0.0161050212552728,0.063469710465025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41983,0.00545528335010784,0.00294101335569693,-0.000309102827058134,0.0112196695272738,0.0636336187501091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41861,0.0118959912914227,0.00641866298985388,-0.000684588168690894,0.0244765707515363,0.0638562883347545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,42090,0.00808387097628952,0.00436191940017833,-0.000465491048060014,0.0166332330006391,0.0638646344053165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41876,-0.011782876291306,0.00635815205670965,-0.0242448543224569,0.000679101739844888,0.0638780601509702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42103,-0.017165473956307,0.00926780706473902,-0.0353303758031955,0.000999427890581484,0.0640254723164013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,42004,-0.0171546976824104,0.00926232540989007,-0.035308855485795,0.000999460120974096,0.0640353113317101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39863,-0.00714633770997589,0.00386003497613991,-0.0147120062632101,0.000419330843258326,0.0641445240500902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39784,0.0102715241954259,0.00554836165257859,-0.000603264643628169,0.0211463130344799,0.0641583154034158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39753,0.00927065041478543,0.00500951610481914,-0.000548001150660093,0.019089301980231,0.0642538848151199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39719,-0.0117456850748786,0.00635002318529784,-0.0241917305180624,0.000700360368305163,0.0643837430528831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39881,0.00858700216409076,0.00464398551505722,-0.000515209445421393,0.0176892137736029,0.0644769243580898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42186,0.00850214602413583,0.00460634438203535,-0.000526288964653461,0.0175305810129251,0.0649516956774977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,42172,-0.00475497341573061,0.00257757133376514,-0.00980701322991028,0.000297066398449054,0.065096759284314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39784,-0.00567086543857018,0.00307416402968981,-0.0116962269367622,0.000354496059621846,0.0651112267646404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42120,0.00760165208322765,0.00412176421114551,-0.000477005770617545,0.0156803099370729,0.0651664578062954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40057,-0.00376097377588561,0.0020406554353262,-0.00776065842912497,0.000238710877353749,0.065352960449906
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,42099,-0.0137785450571701,0.00748300181521336,-0.0284452286149883,0.000888138500648041,0.065598708686947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39816,0.00783355732910085,0.00425724452347392,-0.000510641936908035,0.0161777565951097,0.0657882786750944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,42213,-0.00539041100395825,0.00293316837169078,-0.0111394210124722,0.000358599004555676,0.0661229893418798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40080,0.0146346910944102,0.00796445724039391,-0.000975645096761906,0.0302450272855822,0.0661633381619114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39975,0.00908363519566051,0.00494406072726662,-0.000606723829782069,0.0187739942211031,0.0661957401745753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39881,0.0101985801250947,0.00555262194613142,-0.000684558889322878,0.0210817191395123,0.0662798389728314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39706,0.00903359847021929,0.00491949588132159,-0.000608613457171024,0.0186758103976096,0.0663436809390039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39719,-0.00529912627285529,0.0028866253660191,-0.0109569119902527,0.000358659444542138,0.0664226419926183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39665,-0.0129513670122795,0.0070574677167429,-0.0267840037370956,0.000881269712536591,0.0665148564201607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,40000,0.00470506617634645,0.0025741769153753,-0.000340320577789139,0.00975045293048205,0.0676079718038845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,42144,0.00701464717355708,0.00383840069010376,-0.000508618179046291,0.0145379125261604,0.0676488033006572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,42146,-0.00401209515757817,0.00219609815798178,-0.00831644754722245,0.000292257232066114,0.0677348339764061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41829,-0.00909384546148266,0.00498630222632005,-0.01886699782507,0.000679306902104639,0.0682111584621893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,42074,-0.0135735276632648,0.00744278890187557,-0.028161393910941,0.00101433858441129,0.068218293927588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39768,-0.0134303905880143,0.00737230249828196,-0.027880103484647,0.0010193223086183,0.0685232553622466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41985,0.0206627661026682,0.0113536584496246,-0.00159040445859598,0.0429159366639325,0.0687943356285584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42120,-0.00563351368168239,0.00309828078360106,-0.0117061440175405,0.000439116654175684,0.0690458774947744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39706,-0.00705869195895267,0.00388666795498208,-0.0146765611507176,0.000559177232812208,0.0693789964019928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42184,-0.0241929855552315,0.0133407273610615,-0.0503408111829121,0.00195484007244907,0.069782697175825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,42296,-0.00518541773384987,0.00286068625323835,-0.010792362790197,0.000421527322497302,0.0699089786424309
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42148,0.0074532304422109,0.00411195381929585,-0.000606199043608968,0.0155126599280308,0.0699203200024483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39863,-0.0159693914283259,0.00881922580577895,-0.0332550740076526,0.00131629115100085,0.0702080565484899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39719,0.0159645576910679,0.0088206192762016,-0.00132385609028719,0.0332529714724231,0.0703377167775545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,42144,0.0101534841647401,0.00561752335308992,-0.000856861607316101,0.0211638299367964,0.0707127991768341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,42144,-0.0124442017055807,0.0068982826576177,-0.0259648357145114,0.00107643230334998,0.0712613574988553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,42296,-0.00756349666878796,0.00419970235725165,-0.0157949132890012,0.000667919951425274,0.0717321440437773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39784,0.00647104480942716,0.00360119706150115,-0.000587301431115091,0.0135293910499694,0.0723776077571052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39784,0.0104964368939057,0.00584171379229996,-0.000953322139002226,0.0219461959268136,0.072394622857713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39833,0.00607081782640236,0.00338032277405509,-0.000554614810745617,0.0126962504635503,0.0725342610756035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39948,-0.0180397752530799,0.0100671228941777,-0.0377713361256681,0.00169178561950831,0.0731691681780184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41953,0.0109465174249909,0.00611667991696749,-0.00104217521226541,0.0229352100622471,0.0735391310700195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,42004,-0.00778220090975442,0.00435266857464647,-0.0163134313160615,0.000749029496552668,0.0738133706628366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39863,-0.0227482844671592,0.0127294375089482,-0.0476979819846976,0.0022014130503792,0.0739559696382066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,42144,0.01987181597788,0.0111202877967692,-0.00192394810378754,0.0416675800595476,0.0739628803307357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42097,-0.00457881650712949,0.0025663499601862,-0.00960886242909444,0.000451229414835453,0.0744187835784627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39706,-0.00873121932044021,0.00489478168106203,-0.0183249914153218,0.000862552774441361,0.0744880715594558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39803,0.0101590233475836,0.00570015457927106,-0.00101327962778767,0.0213313263229549,0.0747392698800203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42094,0.0140116844166423,0.00786437533462585,-0.00140249123922437,0.029425860072509,0.0748273518243455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41861,0.00560914530388322,0.00314906158398774,-0.00056301540073274,0.0117813060084992,0.0749018297650966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39784,0.00792580539973459,0.00445913765765868,-0.000814104409276427,0.0166657152087456,0.0755261981453136
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39768,0.00663617949735466,0.003737823019889,-0.000689953621627779,0.0139623126163371,0.075858479615116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41887,0.00783253143973716,0.0044146997701014,-0.000820280109661576,0.0164853429891359,0.0760551228816223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39863,-0.0201293668945598,0.0113474681260547,-0.042370404421627,0.00211167063250753,0.0761068502305433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,40021,0.0105761827715326,0.00597379758884028,-0.00113246050259432,0.0222848260456596,0.0766838845533281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42296,0.0074749523072776,0.00422433143051849,-0.00080473729653863,0.0157546419110938,0.0768338126515571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39665,-0.00759272169122639,0.00429570871592021,-0.01601231077443,0.000826867391977223,0.0771714471644727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40054,-0.00471085774792692,0.00267216310048567,-0.00994829742487884,0.000526581929024996,0.0779390759630132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42116,-0.0172761377474668,0.00980978405818932,-0.0365033145015179,0.00195103900658424,0.0782429356587856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41985,-0.0172156835356344,0.00978700768107977,-0.0363982185905508,0.00196685151928195,0.0785955666341767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,40102,-0.0163250846591626,0.00928373058479968,-0.03452119660537,0.00187102728704476,0.0786970220976542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40080,-0.0162480382473709,0.00924791482547466,-0.0343739513053012,0.00187787481055948,0.0789560217224701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,40097,-0.00584627976095222,0.00333476632252096,-0.0123824217530933,0.000689862231188873,0.0796077507060202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42296,-0.00740752521190663,0.00423074564493196,-0.0156997866759733,0.000884736252160013,0.0799900947101734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,42103,-0.0111175039603488,0.00635293356877168,-0.0235692537551413,0.00133424583444369,0.0801455968883745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39784,0.014421633238009,0.00827118376273805,-0.00178988693695756,0.0306331534129756,0.0812579399318341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39706,0.0079735264994806,0.00457499767993128,-0.000993468953184707,0.0169405219521459,0.0813893734558765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39881,-0.0161891691029867,0.00928982342852324,-0.0343972230228922,0.00201888481691888,0.0814186735905358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,40080,0.0132084800656096,0.00758096870462376,-0.00165021859545301,0.0280671787266721,0.0814805519459162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39804,0.0111018523242281,0.00637981678054135,-0.00140258856563294,0.0236062932140891,0.0818612869680922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,42182,-0.0103011328078125,0.00593502206561132,-0.0219337760564107,0.00133151044078567,0.0826491058603708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42186,0.00519359478433469,0.00300698136784493,-0.000700088696641381,0.0110872782653108,0.0841593058745832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,42162,-0.0151718899836647,0.00878979714074133,-0.0323998923795177,0.00205611241218832,0.0843569030211173
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39768,0.00914504154263776,0.00530058098398144,-0.00124409718596586,0.0195341802712414,0.084504367265462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40020,0.00591315224109022,0.00342868826083051,-0.000807076750137583,0.012633381232318,0.0846262087410352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41876,0.00617763847321502,0.00358582605287396,-0.000850580590417949,0.013205857536848,0.0849502197072541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42197,-0.005730446695751,0.0033267088121065,-0.0122507959674797,0.000789902575977738,0.0849923823530107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39719,-0.0131153740521591,0.00762683500070515,-0.0280639706535412,0.00183322254922295,0.0855281701445288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41887,-0.00790176552145969,0.004601463780558,-0.0169206345313534,0.00111710348843399,0.0859617929937813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41861,0.019319854402354,0.0112617941774412,-0.0027532621854307,0.0413929709901387,0.086274040763358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42103,-0.00484315629031538,0.00282660424269796,-0.0103833006060034,0.000696988025372634,0.0866595658842403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42184,-0.0149399596872793,0.00873734396858852,-0.0320651538657128,0.00218523449115417,0.0873087719311974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39804,0.0125936097615225,0.00736544404045148,-0.00184266055776243,0.0270298800808074,0.0873277434262855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41861,0.00810037578949264,0.00473840256690466,-0.00118689324164048,0.0173876448206258,0.0873798723771466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39804,-0.0203835032428776,0.0119296069755549,-0.0437655329149652,0.00299852642921011,0.0875453547520385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41953,-0.0201123354139265,0.0117762702139474,-0.0431938250332634,0.00296915420541047,0.0876848432555995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42094,0.0238870653930783,0.0140004958163326,-0.00355390640693359,0.0513280371930903,0.0880026375036376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39804,-0.00741256682683814,0.00434567661817004,-0.0159300929984514,0.00110495934477513,0.0880869507117564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40054,-0.0145181168111532,0.00852932170619879,-0.0312355873553028,0.00219935373299642,0.0887573699487917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,42296,0.0030425086536016,0.00178790166348249,-0.000461778606824079,0.00654679591402728,0.0888315277654116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41796,-0.0129843069368183,0.00763393752946669,-0.0279468244945731,0.00197821062093638,0.0889927708967447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39768,-0.00748706055463455,0.00441194162906557,-0.0161344661476031,0.00116034503833397,0.0897262785467143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40097,-0.0110014403982606,0.00648316638487883,-0.0237084465126232,0.00170556571610187,0.0897395791863735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42126,-0.0164662800807308,0.00970501386436281,-0.035488107254882,0.00255554709342027,0.0897816866040275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39768,-0.00854447322013945,0.00504035642894024,-0.0184235718208623,0.00133462538058343,0.0900646339052607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,40092,0.00633944740118295,0.00375073234982173,-0.00101198800446763,0.0136908828068335,0.0910203584346867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,42105,-0.022876655230382,0.0135492803411964,-0.049433244699127,0.00367993423836293,0.0913579080226772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,42296,-0.00520962726495784,0.00308621564175056,-0.0112586099227889,0.000839355392873261,0.0914291034805845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,40021,0.0459578494596758,0.0272481207091778,-0.00744846713031275,0.0993641660496643,0.0917008458919188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39784,0.00773130197527234,0.00458638755151038,-0.00125801762568801,0.0167206215762327,0.0918818600575457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,40021,-0.0130434102323627,0.00773995074415641,-0.0282137136909093,0.00212689322618383,0.0919776818290148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41876,-0.0134636387460909,0.00800491596133557,-0.0291532740303087,0.00222599653812678,0.0926087195859432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42126,-0.00692334414104807,0.00411723576316974,-0.0149931262368608,0.00114643795476461,0.0926799799580327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39719,-0.0121265097995757,0.00722842890770656,-0.0262942304586806,0.00204121085952911,0.0934522706037405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40080,0.00594044651218452,0.00354220878094262,-0.00100228269846301,0.0128831757228321,0.0935622280809346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,42021,-0.0223646600816814,0.0133505375153808,-0.0485317136118278,0.00380239344846498,0.0939217285116027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42211,0.00806767949940966,0.0048183016917914,-0.00137619181650149,0.0175115508153208,0.0940794945900104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41876,-0.00476294966135535,0.00284632755778364,-0.0103417516746113,0.000815852351900583,0.0942797979021031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40080,0.0127122551326164,0.00762590091272898,-0.00223451065633235,0.0276590209215652,0.0955463440802664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39784,0.00682955432626758,0.004101480274981,-0.00120934701269518,0.0148684556652303,0.0959136563031605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40113,-0.00320199496861191,0.0019230536441284,-0.00697118011110356,0.000567190173879747,0.0959299661959073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40054,-0.00801333843694193,0.0048140510510071,-0.0174488784969158,0.00142220162303198,0.096026863458293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39863,0.0065642118508617,0.00395985644292105,-0.00119710677726355,0.014325530478987,0.0974095842663584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39706,-0.00839065307545775,0.00506228530567597,-0.0183127322745827,0.00153142612366716,0.0974516533455693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39733,0.00650987954954863,0.00392926599588256,-0.00119148180238119,0.0142112409014784,0.0975962905426875
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,42088,0.018704256119625,0.0112959364013854,-0.00343577922709032,0.0408442914663403,0.0977786882543668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41861,0.0123000965456349,0.00745374643725071,-0.00230924647137652,0.0269094395626463,0.0989289096070963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39665,-0.00980455268285551,0.00594497527079351,-0.0214567042136108,0.00184759884789976,0.0991332384075777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41887,0.00670154740598198,0.00406449133760445,-0.00126485561572275,0.0146679504276867,0.0992126519992879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42079,-0.0146443258140975,0.00888278720245274,-0.0320545887309049,0.00276593710270983,0.0992502301799391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39784,0.0142337179177365,0.00864315583903126,-0.00270686752676478,0.0311743033622378,0.0996248147344357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42186,0.00609253811436705,0.00370137636379442,-0.00116215955867002,0.0133472357874041,0.0997839079044951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40054,0.00643090717633655,0.00391100204354091,-0.00123465682900363,0.0140964711816767,0.10014073786562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39665,0.00929147098930506,0.00565770684268627,-0.00179763442236002,0.0203805764009701,0.100564500819718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41985,-0.00566330641707686,0.00344894689147146,-0.0124232423243609,0.00109662949020721,0.100606437814726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,42109,-0.00512626856547998,0.00312732197447227,-0.0112558196354456,0.00100328250448567,0.101198474572825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42157,-0.00359600013692583,0.00219520680892952,-0.00789860548242768,0.000706605208576021,0.101422077641241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39706,-0.00729760424430142,0.00445841170762709,-0.0160360911912505,0.00144088270264767,0.101698638757191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39784,0.00693106636735144,0.0042378831714767,-0.00137518464874289,0.0152373173834458,0.101973576409825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42146,-0.00584636080712062,0.00357859926677544,-0.0128604153700005,0.00116769375575924,0.102345976433941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39706,-0.00457724556852543,0.00280625524202503,-0.0100775058428945,0.000923014705843635,0.102901985801038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,40113,-0.00372064223891212,0.00228426281033044,-0.00819779734715978,0.000756512869335531,0.10338097074345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41829,0.00715659055573225,0.00439491074792395,-0.00145743451019869,0.0157706156216632,0.103468988065835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,40069,0.00730407082994438,0.00448676403156023,-0.00148998667191367,0.0160981283318024,0.103571861396052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42126,-0.00876108292124335,0.00538313247225766,-0.0193120225668684,0.00178985672438166,0.103653937465062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40054,-0.0140716340082166,0.00864772612073547,-0.0310211772048581,0.00287790918842493,0.103722311006736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40054,-0.0163955733152228,0.01009976998406,-0.0361911224839804,0.00339997585353478,0.104541267312915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,40021,0.011601968146746,0.00715515215483194,-0.00242213007672464,0.0256260663702166,0.104942894863768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42184,-0.00467953827525527,0.00288733786581111,-0.0103387204922451,0.000979643941734509,0.105104051271007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,40020,0.00765668975358075,0.00472467365677663,-0.00160367061370144,0.0169170501208629,0.105137862232738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40080,0.0118917791584111,0.00734325917756509,-0.00250100882961648,0.0262845671464387,0.105387112195311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40054,-0.00740486496058744,0.00458452107628561,-0.0163905262701072,0.00158079634893235,0.1062989652874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39706,0.00752098149653909,0.00465735195326042,-0.00160742833185133,0.0166493913249295,0.106370557352346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39784,0.00903779035122416,0.00560039750612539,-0.00193898876078161,0.0200145694632299,0.106605689624675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39881,-0.00587567350517375,0.00364381170192382,-0.0130175444409444,0.00126619743059693,0.106881087973463
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42208,0.00595969548111565,0.00370317008444934,-0.00129851788440506,0.0132179088466364,0.107564162954992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39665,0.00592189171528905,0.00369542564961304,-0.00132114255795251,0.0131649259885306,0.109076918050384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39784,-0.00765636759426929,0.00478220789327615,-0.0170294950650905,0.00171675987655197,0.109404303307491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,42213,-0.00591756948532795,0.00369720059860359,-0.013164082658591,0.0013289436879351,0.109499984337288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40054,-0.0118670196057876,0.00741736315376935,-0.0264050513871755,0.00267101217560037,0.109650447252458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39706,-0.00805021055010963,0.0050385406285963,-0.0179257501821584,0.00182532908193911,0.110133885285848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,40054,-0.00593896565411076,0.00371858356338808,-0.0132273894383514,0.00134945813012988,0.110271563015174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,42043,-0.00748604025365044,0.00468773940632462,-0.0166740094900467,0.00170192898274581,0.110303593212205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39784,-0.00581789323441738,0.00364503500289709,-0.0129621618400957,0.00132637537126092,0.110493069448929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,42150,-0.0153693095357166,0.00964633650421388,-0.0342761290839758,0.00353751001254259,0.111121912967154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39881,0.0182074614267867,0.0114324089807293,-0.00420006017544269,0.0406149830290161,0.111275465818641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39719,-0.0149911448972898,0.00942748126273807,-0.0334690081722565,0.00348671837767677,0.111830181820796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42186,0.0148428727645429,0.00933953395006535,-0.00346261377758514,0.033148359306671,0.112027849224381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40020,0.00460210152805411,0.002896129386839,-0.00107431207015032,0.0102785151262585,0.112077750422324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,42126,-0.00398864484830197,0.00251061724139281,-0.00890945464143187,0.000932164944827933,0.112150134681397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40097,-0.013537850443877,0.00853162546238569,-0.0302598363501529,0.00318413546239895,0.112590474989563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40021,0.00714315397650849,0.00450386626592526,-0.00168442390470502,0.015970731857722,0.112767400847551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,40020,0.00845100366592687,0.00533320948964603,-0.00200208693377936,0.0189040942656331,0.113086457008167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42120,-0.0056091301827112,0.00354297354127293,-0.0125533583236061,0.00133509795818375,0.11340713796258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42296,-0.00430790865203498,0.0027212439732769,-0.00964154683965771,0.00102572953558775,0.113430571638576
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41853,-0.00824221865956305,0.00521522573086861,-0.0184640610920655,0.00197962377293943,0.114036944047593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39881,-0.00455620455004228,0.00288757774085517,-0.0102158569221184,0.00110344782203385,0.114626487013122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,42103,0.00629744360323504,0.00399580256072209,-0.00153432941578024,0.0141292166222503,0.115046918174513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42103,-0.0100740011601845,0.00639750988027667,-0.0226131205255268,0.00246511820515772,0.115355904135405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39804,-0.0122751997562143,0.00779694702555735,-0.0275572159263067,0.00300681641387812,0.115434113718265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40054,-0.0106887207307444,0.00679016062672853,-0.0239974355591323,0.00261999409764355,0.115482266557654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42133,-0.0121755632667547,0.00773643075258974,-0.0273389675418306,0.00298784100832123,0.11555908367961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41861,0.0124752481975836,0.00792810471669139,-0.00306383704713147,0.0280143334422988,0.115617107183204
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39768,-0.00611773248725552,0.0038909701500053,-0.0137440339812659,0.00150856900675487,0.115913288113383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39863,0.0046879782139507,0.00298374270228959,-0.00116015748253689,0.0105361139104383,0.116171949168799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41876,-0.00791978063432368,0.00504370911150301,-0.0178054504928696,0.00196588922422222,0.116386685748666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39665,-0.00848836619357154,0.00540772034131652,-0.0190874980625519,0.00211076567540884,0.1165208368663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41861,-0.0135657332602278,0.00864377207187975,-0.0305075265211121,0.00337606000065652,0.116574424631347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39881,-0.00560500826396144,0.00357439216237579,-0.012610816902218,0.00140080037429512,0.116887147247135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40021,0.00413329171814217,0.0026399094470007,-0.00104093079797921,0.00930751423426356,0.117449377951196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40054,0.00788760902592146,0.00503822084153767,-0.00198730382349236,0.0177625218753353,0.117482098426926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40054,0.00639706758518727,0.0040867628850564,-0.00161298766952327,0.0144071228398978,0.11753841393102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41829,-0.0177126471247663,0.0113223345775182,-0.0399044228967021,0.00447912864716941,0.117748975663018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42184,-0.00446690479434127,0.00286017026003285,-0.0100728385040057,0.00113902891532311,0.11836846260068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39768,0.0110239291469934,0.00705963003940489,-0.00281294573024023,0.0248608040242269,0.118425169245611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40080,-0.00474000490964158,0.00303626970568281,-0.0106910935327799,0.00121108371349673,0.118522679174611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42126,0.0475977527087657,0.0305346908632202,-0.0122502413831459,0.107445746800677,0.119066049884937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42162,0.0135321386256354,0.00871241486671257,-0.00354419451312119,0.0306084717643921,0.120399329550488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42120,-0.00471494968932732,0.00303601207540906,-0.0106655333571291,0.00123563397847444,0.120445811879837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39863,-0.00346658318309265,0.00223278035845523,-0.00784283268566491,0.000909666319479611,0.120551770236722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39784,0.0053488687082093,0.00344784056237436,-0.00140889879404445,0.012106636210463,0.120843457856218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40097,-0.00522028246406608,0.00336600120859898,-0.0118176448329201,0.00137707990478793,0.120958150504329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42103,-0.0157204051245586,0.0101431234792113,-0.0356009271438128,0.00416011689469554,0.121200020373104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41876,0.0133658181496178,0.0086353119423254,-0.00355939325733996,0.0302910295565756,0.121693112895033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,42197,-0.0157704778368622,0.0101894966648173,-0.035741891299904,0.0042009356261797,0.121714296084197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41984,0.00641651069394721,0.00415604217479029,-0.00172933196864176,0.0145623533565362,0.122637464930273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39719,-0.00989599379126956,0.00641201617891001,-0.0224635455019332,0.00267155791939407,0.122775616385236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,40055,-0.00485680624283418,0.00315273901854172,-0.011036174719176,0.00132256223350759,0.123466744914657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39804,-0.00684771355301599,0.00445796093757935,-0.0155853169906715,0.00188988988463954,0.124552489448751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41829,-0.00797037501315204,0.0051928919947318,-0.0181484433228264,0.00220769329652228,0.124842653418171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39706,-0.0108366211242228,0.00706039750507833,-0.0246750002341763,0.00300175798573077,0.124851816375916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42162,-0.0137383494075896,0.00895182662495096,-0.0312839295924934,0.00380723077731433,0.124882450523177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39706,-0.00682339429875023,0.00445658863444089,-0.0155583080222544,0.00191151942475393,0.125779681616716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42200,0.0065034145021716,0.00424865867005101,-0.00182395649112839,0.0148307854954716,0.125868300782804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41854,0.0116398508538831,0.00763148060181403,-0.00331785112567242,0.0265975528334386,0.127223854772758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40021,0.00679389522888497,0.00445980501877666,-0.00194732260791728,0.0155351130656872,0.127697496300067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39784,-0.00663189110268339,0.00435355131164334,-0.0151648516735043,0.00190106946813757,0.127706266813193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41727,-0.0108062466523248,0.0070946470759536,-0.0247117549211938,0.00309926161654428,0.127745179625593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39804,0.00804442697883056,0.00528183871812638,-0.00230797690869715,0.0183968308663583,0.127779669112283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41542,0.00439054969764728,0.00288346593837544,-0.00126104354156858,0.0100421429368631,0.127868403564008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40021,0.0062115126449271,0.00407975822613548,-0.00178481347829844,0.0142078387681526,0.127908094680445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42296,-0.0102523927416587,0.00674211144818408,-0.0234669311800995,0.0029621456967821,0.12837178745628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41887,-0.01015377445812,0.00668419621499725,-0.0232547990395146,0.00294725012327462,0.128769312463816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42103,-0.00756710764211421,0.00498609858766815,-0.0173398608739438,0.00220564558971537,0.129129413027488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,42223,0.00876541699833117,0.00577681385731659,-0.00255713816200934,0.0200879721586717,0.129203978707769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41876,-0.00863923776408318,0.00570826951696037,-0.0198274460173255,0.00254897048915915,0.130187765592187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39706,0.00829186597203441,0.00548239480236548,-0.00245362784060192,0.0190373597846707,0.130448652181539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41787,-0.0138432127606826,0.00917788109882566,-0.0318318597143809,0.00414543419301567,0.13149686518095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41829,-0.00787068202303661,0.00523143496298166,-0.0181242945504807,0.00238293050440745,0.13247825292351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39863,0.00413106849270562,0.00274584398591229,-0.00125078571968246,0.00951292270509371,0.132487314258964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39768,-0.00483612568101435,0.00321783477684548,-0.0111430818436315,0.0014708304816028,0.132891346403973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39804,-0.00541388177740533,0.00360423536327438,-0.0124781830894231,0.00165041953461246,0.133103922029043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,41315,-0.00772814460916497,0.00514816217330365,-0.0178185424688401,0.00236225325051019,0.133343773007842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,42155,0.00542583040858128,0.00361491547728021,-0.00165940392688794,0.0125110647440505,0.133391206309363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41887,-0.00960546746498133,0.00640179209975796,-0.0221529799805069,0.00294204505054428,0.13352685242579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40054,-0.00806949880347579,0.00538113849059267,-0.0186165302450374,0.00247753263808585,0.133749836318157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42144,-0.00489272392646352,0.00326984261078131,-0.0113016154435949,0.00151616759066786,0.134595210424909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39719,-0.00703923798593473,0.00470575568743725,-0.0162625191333117,0.00218404316144227,0.134715345876859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39665,0.00848986673320057,0.00568508562031239,-0.00265290108261172,0.0196326345490129,0.135373693505915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,42296,0.00712836566199193,0.00477508096649065,-0.00223079303232974,0.0164875243563136,0.13550678288162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,42146,0.00375010053076307,0.00252370161575712,-0.00119635463612089,0.00869655569764703,0.137316045288968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,42120,-0.00375324427588361,0.00253089428252004,-0.00871379706962289,0.00120730851785567,0.138106343487146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41887,-0.00742355754875203,0.00500609912385423,-0.0172355118315063,0.00238839673400226,0.138125110280138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41828,0.011854859412008,0.00800768852199929,-0.00384021009111063,0.0275499289151266,0.138782229173237
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39804,0.0136858256002781,0.00927092035599295,-0.00448517829746812,0.0318568294980243,0.139917194928083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41887,0.0091513157548468,0.0062071146882107,-0.00301462903404616,0.0213172605437398,0.140418413692588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39768,0.00537989072355925,0.0036520112973285,-0.0017780514192046,0.0125378328663231,0.140745505911885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41861,-0.0117465041270878,0.00797500641510826,-0.0273775167007,0.00388450844652439,0.140798886292854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42091,-0.00309743185845069,0.00210411812711297,-0.00722150338759211,0.00102663967069073,0.14102346520275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42256,0.0147574594836125,0.0100281898138826,-0.00489779255159748,0.0344127115188224,0.141153680628706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39847,-0.0153328535313901,0.0104212147156428,-0.0357584343740499,0.00509272731126977,0.141236419809732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39706,-0.00752047633542482,0.00511153161979306,-0.0175390783102192,0.00249812563936958,0.141246290281546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42213,-0.00456670499083991,0.00310675434592747,-0.0106559435088577,0.00152253352717792,0.141605438573296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41876,-0.0050244183298462,0.00343315452773793,-0.0117534012042125,0.00170456454452014,0.14335566194768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,42223,-0.00246603307201818,0.00168625807804661,-0.00577109890498954,0.000839032760953166,0.143647749141413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41968,0.00446522212251349,0.00305377823091929,-0.00152018321008831,0.0104506274551153,0.143712125043455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,42248,0.0032707662922726,0.00223910970373184,-0.00111788872704181,0.00765942131158701,0.144109748629072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39784,0.00955905224534812,0.006544379799315,-0.00326793216130929,0.0223860366520055,0.144141020498226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41810,0.00645452814977034,0.00442073629380918,-0.00221011498609566,0.0151191712856363,0.144299236018777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39784,0.00579597814477446,0.00398330483897634,-0.00201129933961916,0.0136032556291681,0.145680164621892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41989,0.0070240537296246,0.00482891653901756,-0.0024406226868498,0.016488730146099,0.14580962456334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39881,0.00998199739034755,0.00686349474531512,-0.0034704523104701,0.0234344470911652,0.145875682297819
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,40054,-0.0137321940869127,0.00944222539966545,-0.032238955870257,0.00477456769643154,0.145881317511094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,42296,-0.00468287558193146,0.00322254584325159,-0.0109990654347046,0.00163331427084164,0.146203210412247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,42184,-0.00645282240428961,0.00444431910245132,-0.0151636878450942,0.00225804303651498,0.146546336612181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42094,-0.0171322554455121,0.0118094685986657,-0.040278813898897,0.00601430300787274,0.146881612161881
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40080,-0.00780203653316141,0.00537866228519277,-0.0183442146121392,0.00274014154581643,0.146933088510815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39719,-0.0115646663336466,0.00797820055155582,-0.027201939414696,0.00407260674740282,0.147218538962935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41861,0.00841629284094961,0.00580806260928327,-0.0029675098732456,0.0198000955551448,0.147342618610644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40097,0.00401852260142722,0.00277420960178448,-0.00141892821807036,0.0094559734209248,0.147497964609352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39863,-0.00462670199744096,0.00319564739781789,-0.010890170897164,0.0016367669022821,0.147698551484937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42103,0.00630859641505555,0.00436621081180546,-0.00224917677608315,0.0148663696061942,0.14851935862736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39904,-0.00824934064447186,0.00570940981928969,-0.0194397838902797,0.00294110260133594,0.148524364748607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42223,0.00394940580210625,0.002735629803782,-0.00141242861330646,0.00931124021751896,0.148849785321786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39706,-0.00834755437046515,0.00578564739812313,-0.0196874232707865,0.00299231452985619,0.149105528259813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42144,-0.0116251439068758,0.00807668314344086,-0.0274554428680199,0.00420515505426824,0.150076604380517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39706,-0.00498346734451439,0.00346315258912377,-0.011771246419197,0.0018043117301682,0.150181051823857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42184,-0.00417540240081473,0.00290635793627085,-0.00987186395590559,0.00152105915427613,0.150843188237389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41887,-0.0111453826176765,0.00776719808562133,-0.0263690908654943,0.00407832563014126,0.151331791672403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42184,-0.00323379506376756,0.00225401756596195,-0.00765166949305298,0.00118407936551786,0.151402235254011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,42101,0.003669848955219,0.00255822524005055,-0.00134427251528009,0.00868397042571808,0.151445513744197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41829,0.00521886572529859,0.00364449044785999,-0.001924335552507,0.0123620670031042,0.152172059926522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41861,-0.0115966661691779,0.00810801856501625,-0.0274883825566098,0.00429505021825397,0.152663836957709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39690,-0.00799366179477739,0.00558984747040136,-0.018949762836764,0.00296243924720928,0.152737547328128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40054,-0.0117401078757171,0.00822266034807139,-0.027856522157937,0.00437630640650283,0.153385420175831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40102,0.00595794017752685,0.00417435745286984,-0.00222380043009804,0.0141396807851517,0.153530362815532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39665,0.00539597387273438,0.00378390707323871,-0.00202048399081351,0.0128124317362823,0.153888817457279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,42262,0.00416110767641602,0.00291875200174792,-0.0015596462470099,0.00988186159984194,0.153994380722975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39706,-0.00465026190673813,0.00326213668495739,-0.0110440498092546,0.00174352599577835,0.154034791357064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,40102,0.0118304791331077,0.00831126480034723,-0.00445959987557283,0.0281205581417883,0.154640996561594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42103,0.00849963522821639,0.00597701828399148,-0.00321532060840692,0.0202145910648397,0.155035101184749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40021,0.0149243421470522,0.0104970701014548,-0.00564991525179923,0.0354985995459037,0.155123971554885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,42256,0.013394390153962,0.00942402710599919,-0.00507670297379636,0.0318654832817205,0.155252806858828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,42120,0.00363659491983015,0.00256158347641932,-0.00138410869395172,0.00865729853361202,0.155728834512936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39719,-0.00734666261103156,0.0051793070351588,-0.0174981043999428,0.00280477917787968,0.156084835813119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42084,0.0049899585013254,0.00351853645731855,-0.00190637295501896,0.0118862899576698,0.15615903719701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42213,0.00750395884240424,0.00531452412392175,-0.00291250844048238,0.0179204261252909,0.157982129124259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39881,-0.00793836572008681,0.00562953414633555,-0.0189722526469045,0.00309552120673087,0.158530888934654
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39784,0.0055717652177304,0.00396429301214043,-0.00219824908606485,0.0133417795215256,0.159905628652512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42120,-0.00560781749315528,0.0039933948540127,-0.0134348714070202,0.00221923642070962,0.160261529206559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40020,0.00640717910781117,0.00457015193540312,-0.00255031868557894,0.0153646769012013,0.160955280524502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39768,0.00995515342163597,0.00711632196410381,-0.00399283762800751,0.0239031444712794,0.16186679794135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41887,-0.00719565825054508,0.00514499992354018,-0.0172798581006838,0.00288854159959368,0.161965483622008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40020,-0.0129721576955001,0.00930001349156999,-0.0312001841389773,0.00525586874797709,0.163088595667399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39847,0.00906019196601742,0.00651115008285901,-0.00370166219638624,0.0218220461284211,0.164106329466439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40020,-0.00910841291074115,0.00654679695110451,-0.021940134934906,0.00372330911342369,0.164169808192117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41696,0.00952684868364872,0.00685641594466329,-0.00391172656789134,0.0229654239351888,0.164711766243723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,42213,-0.00920002147167395,0.00662254836069666,-0.0221802162586394,0.0037801733152915,0.164796743931405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39706,-0.00573375892029623,0.00413024987974783,-0.013829048684602,0.00236153084400952,0.165094806892542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39719,0.00812486719561908,0.00585563990304184,-0.00335218701434292,0.0196019214055811,0.165310045625233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39784,-0.0100992345053097,0.00728457202059757,-0.024376995665681,0.00417852665506151,0.165658010557179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40020,-0.00595999707256502,0.00430523323290169,-0.0143982542090523,0.0024782600639223,0.166276471528663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41829,0.00903722872974076,0.00653475214795735,-0.00377088548025564,0.0218453429397372,0.166704952785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40097,-0.00466912596358498,0.00338331753925663,-0.011300428340528,0.00196217641335803,0.167601494819525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39719,-0.00907821857753904,0.00658205846081225,-0.0219790531607311,0.00382261600565297,0.167850998612884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39706,0.00926579728412501,0.00673076012353761,-0.00392649255800871,0.0224580871262587,0.168654566289851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39863,-0.00633635893877827,0.00460329392993691,-0.0153588150414546,0.00268609716389808,0.168700824839313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42184,-0.0154255588506361,0.0112313780321695,-0.0374390597936883,0.00658794209241608,0.16964110288683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41887,0.00796058672358164,0.00580615271680817,-0.00341947260136236,0.0193406460485256,0.170380332914976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41876,-0.00744397921548868,0.00543514751918209,-0.0180968683530856,0.00320890992210821,0.170835982165088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,42296,-0.00748195426479712,0.00546507914985618,-0.0181935093985152,0.003229600868921,0.17100782071137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,42186,-0.00525659363257065,0.00384128909501977,-0.0127855202588094,0.00227233299366809,0.171196426210451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42171,-0.016634647497826,0.0121759944988996,-0.0404995967156691,0.00723030172001712,0.171904926626926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39706,-0.00813540745604379,0.00596492710010813,-0.0198266645722557,0.00355584966016814,0.172636508260203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39739,0.00960897315888553,0.00705446939416953,-0.00421778685368675,0.0234357331714578,0.173191826711551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41829,-0.00692547897921875,0.00509378964790391,-0.0169093066891104,0.00305834873067291,0.173983126427468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,40020,0.0153316661512864,0.0112851601568519,-0.0067872477561434,0.0374505800587161,0.174311583334036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41876,-0.0116578208267471,0.00858579803128816,-0.0284859849680719,0.00517034331457772,0.174550415752699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,42094,0.014159728018911,0.0104318061670429,-0.00628661206849316,0.0346060681063151,0.174690244110792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39768,0.00713434215306434,0.0052580452725885,-0.00317142658120913,0.0174401108873378,0.174860051540604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42128,-0.00685465992551148,0.00506345299493619,-0.0167790277955864,0.00306970794456346,0.175839147386818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,42197,0.00777583728336345,0.00574492851825445,-0.00348422261241528,0.0190358971791422,0.175915224187946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,42223,-0.0151174572834038,0.0111704148580364,-0.0370114704051551,0.00677655583834752,0.175967998196777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,42296,-0.00272202084772893,0.00201544629315501,-0.00667229558231276,0.00122825388685489,0.176853433446461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39881,0.00906581109605687,0.00671649959058138,-0.00409852810148263,0.0222301502935964,0.177114468827444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39768,0.00584171413495435,0.0043335721673169,-0.00265208731298678,0.0143355155828955,0.177682891204842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40054,0.0159694297164802,0.0118479341569657,-0.00725252123117259,0.0391913806641331,0.177729543133832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,42112,-0.0126287087894092,0.00937648880691697,-0.0310066268509665,0.00574920927214804,0.178052695726785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42144,0.0119355852641144,0.0088638581130693,-0.00543757663750142,0.0293087471657302,0.178150332034958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42094,-0.00914027872197978,0.00678909913474728,-0.0224469130260845,0.00416635558212488,0.178224002150978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39706,0.00924476957278489,0.00686666239236324,-0.00421388871624706,0.0227034278618168,0.17822627153699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,42094,-0.00631027854507203,0.00469331512690904,-0.0155091761938138,0.0028886191036697,0.178802385700348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,40020,0.00964795480086323,0.00717731256651035,-0.00441957782949706,0.0237154874312235,0.178902373394626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42285,0.00820173146611959,0.00610621885480354,-0.00376645748929534,0.0201699204215345,0.179238018502994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40021,0.0113544296877209,0.0084577193721674,-0.00522270028172715,0.027931559657169,0.179464320743988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39665,-0.00731912258116206,0.00545279486873688,-0.0180066005238864,0.00336835536156224,0.179537591013736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39706,0.0075529025562534,0.00562724929250843,-0.00347650605706312,0.0185823111695699,0.179559650520996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42004,0.00538612626389257,0.00402075873140442,-0.00249456084966009,0.0132668133774452,0.180405832898566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40080,-0.00959762872883526,0.0071648944624133,-0.0236408218751653,0.00444556441749481,0.180424449284665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39227,0.0075421338787152,0.00563664078601222,-0.00350568206186876,0.0185899498192992,0.1809089205112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,40097,-0.0113227037921539,0.00846297746279823,-0.0279101396192384,0.00526473203493061,0.180953618380813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41829,0.0052609311624317,0.00393355078693186,-0.00244882837995474,0.0129706907048181,0.181099563724162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42296,0.00702934130592436,0.00527033194541265,-0.00330050930708443,0.0173591919189331,0.182306743029722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39768,0.0140903622175445,0.0105798312279874,-0.00664610698931072,0.0348268314243998,0.182950182013079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42111,0.00475253753844085,0.00357207058897122,-0.00224872081594274,0.0117537958928244,0.183386510975122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39881,-0.00961675561354928,0.00723084686130034,-0.0237892154616979,0.00455570423459939,0.183558989585525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41829,-0.0067188440459757,0.00505978203136994,-0.0166360168274608,0.00319832873550938,0.184237778101236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,40021,-0.0138220065967861,0.0104177188722036,-0.0342407355863052,0.00659672239273291,0.184609908556044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42262,0.00625496460684133,0.00471576266217126,-0.00298793021101434,0.015497859424697,0.184732032225627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39959,-0.0042946804746265,0.00323854184468518,-0.0106422224902094,0.00205286154095644,0.184829584497739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42120,-0.00329373691834123,0.00248700477539801,-0.00816826627812134,0.00158079244143888,0.185400618359341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,40020,-0.00716205960859718,0.00542932628228876,-0.0178035391218831,0.00347941990468878,0.187149095853951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,42204,-0.0208419004664802,0.0158229982496848,-0.0518549770358623,0.0101711761029019,0.187798028602745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39804,0.00405431826308783,0.00307931720554163,-0.00198114345977377,0.0100897799859494,0.1879914595623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42004,0.00731091649838035,0.00555956065127714,-0.00358582237812286,0.0182076553748836,0.188527744836471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39881,0.00600203127369243,0.00456640685925359,-0.0029481261704446,0.0149521887178295,0.188743808832284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42256,0.00899306899704994,0.00684572581078139,-0.00442455359208158,0.0224106915861815,0.188978171189128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40054,-0.00509628338654817,0.00388085620195839,-0.0127027615423866,0.00251019476929027,0.189148254996444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42178,-0.00975716345213835,0.00743256009748426,-0.0243249812432075,0.00481065433893079,0.189287222685403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39706,-0.00537536290776123,0.00410285584413255,-0.013416960362261,0.00266623454673856,0.190173202664439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42094,0.0113373422120926,0.00866198135337145,-0.00564014124051543,0.0283148256647006,0.190604260729327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39651,-0.00696248190434914,0.00532461854937579,-0.0173987342611257,0.00347377045242741,0.191037082833307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,42103,-0.0047559083320089,0.00363934525835502,-0.0118890250383847,0.00237720837436693,0.191302808910886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42144,-0.00873032914199277,0.00668227899199606,-0.0218275959663051,0.00436693768231952,0.19140925800093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41984,-0.00359411084379169,0.00275168968459446,-0.00898742262559684,0.00179920093801346,0.191526108728074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41985,0.00967284611358385,0.00744321286912576,-0.00491585110990263,0.0242615433370703,0.193777799108956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39784,0.00438972911425421,0.00338252015124873,-0.00224001038219331,0.0110194686107017,0.194395060313351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39719,-0.00658694011208652,0.00507929050420889,-0.0165423495003359,0.00336846927616291,0.19472056705331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39863,-0.00328828464743557,0.00253887834598696,-0.00826448620557,0.00168791691069887,0.195288857992265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42197,-0.00368841503888092,0.00285432415627654,-0.00928289038518295,0.00190606030742111,0.196303897783415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39804,-0.0116266141908059,0.00900447831279366,-0.0292753916838815,0.00602216330226967,0.196661241503769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42186,0.00374069478442742,0.00289981399217196,-0.00194294064022962,0.00942433020908447,0.197081432901847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42094,-0.00742981463555287,0.00576650415091207,-0.0187321627713405,0.00387253350023479,0.197614741811777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39784,0.00464106861206387,0.00361029187011866,-0.00243510345336871,0.0117172406774964,0.198642011451355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,40097,-0.0121996250032334,0.00949108363703864,-0.0308021489318292,0.00640289892536229,0.198687714610606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39784,0.00803607805821166,0.00625556397909276,-0.00422482734081016,0.0202969834572335,0.198950105600492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39783,-0.00918133126445764,0.00715300318119023,-0.0232012174995905,0.00483855497067522,0.19932293951902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39980,0.014243305079489,0.0111098182358826,-0.00753193866284096,0.036018548821819,0.199853842726013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42120,-0.00566484046461817,0.00443114400152787,-0.0143498827076128,0.00302020177837646,0.201126131149956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42296,-0.0035865878660644,0.00281759679041198,-0.00910907757527187,0.00193590184314307,0.20306743562097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39768,0.0052239950303825,0.00411016615673868,-0.00283193063682532,0.0132799206975903,0.203758872032586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39706,-0.00792800676215809,0.00623787831826201,-0.0201542482659516,0.00429823474163545,0.20377596877347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,42103,-0.00721834541839418,0.00568031737426133,-0.0183517674719464,0.00391507663515802,0.203835356936335
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,42213,-0.0170734027570172,0.0134382729875049,-0.0434124178125269,0.00926561229849239,0.20392724846144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40054,0.00852396312711713,0.00672168701392502,-0.00465054342017591,0.0216984696744102,0.204779236710466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39719,-0.0057884333187612,0.00456708830142514,-0.0147399263895545,0.00316305975203207,0.205032076600895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,42004,-0.00730915462732146,0.00576806762813804,-0.018614567178472,0.0039962579238291,0.205115540048034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40020,-0.0071604868417195,0.00565459733484995,-0.0182434976180254,0.0039225239345864,0.205428497622998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40097,0.00528948624882868,0.00418034531406677,-0.0029039905667422,0.0134829630643996,0.205782675907322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42193,-0.00889317651624522,0.00703743172530218,-0.0226865426978375,0.00490018966534704,0.20636171125558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39665,-0.00538430039458777,0.00426269646297232,-0.0137391854620135,0.00297058467283798,0.206573909263281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39784,0.0113673682283074,0.0089999007572477,-0.00627243725589805,0.0290071737125129,0.206597279185291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39768,0.00637910141172565,0.00505629355230254,-0.00353123395078732,0.0162894367742386,0.20711478551069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,42120,0.00667334609613968,0.00530370674355812,-0.00372191912123423,0.0170686113135136,0.208327009886189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,42107,-0.013227480681508,0.0105183143807786,-0.033843376867834,0.00738841550481794,0.208571286867144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42226,-0.00367922144688831,0.00292630289003769,-0.00941477511136218,0.00205633221758556,0.208669927341533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39784,-0.00630554949279892,0.00503300698841286,-0.0161702431900881,0.00355914420449029,0.210291819929363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42120,0.00647727081181409,0.00517787744045631,-0.00367136897148028,0.0166259105951084,0.210975007301432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40021,0.00638409101420764,0.00510528420426537,-0.00362226602615248,0.0163904480545678,0.211148762308073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39863,-0.0106815975417241,0.00855716644949693,-0.0274536437827381,0.00609044869928984,0.211962011394355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42103,-0.00625593680260088,0.00501259053675848,-0.0160806142546475,0.00356874064944575,0.212037342889377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40020,-0.00640461741080327,0.00514280264831082,-0.0164845106014925,0.00367527577988594,0.213028067428974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39768,-0.00860649936465437,0.00692591972210046,-0.0221813020199713,0.00496830329066253,0.214024114144565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39768,-0.00906879913616251,0.00730172296717386,-0.0233801761518233,0.00524257787949825,0.214261116317966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41861,-0.015716251697252,0.012656136106364,-0.0405222784657255,0.00908977507122148,0.214337382348949
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39651,0.0102301901657591,0.00825057650111655,-0.00594093977642935,0.0264013201079475,0.215026740393632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41861,0.00604637813078064,0.00487999949178333,-0.00351842087311468,0.015611177134676,0.215363996285129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42094,0.00253799875045654,0.00204864714436929,-0.00147734965250728,0.00655334715342035,0.215417765919139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41840,-0.0109337876005842,0.00882674237396527,-0.0282342026535561,0.00636662745238771,0.215475336873874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42186,-0.00910111782401311,0.00735180095369895,-0.023510647693263,0.00530841204523682,0.215759198787533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40021,0.00518082851377349,0.00418662990754189,-0.00302496610500862,0.0133866231325556,0.215939516622458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,42004,0.00152305738802248,0.0012336028435503,-0.00089480418533611,0.00394091896138108,0.216986566303723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,42186,-0.00877000046276318,0.00710331364541041,-0.0226924952077676,0.00515249428224123,0.216988663259854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40021,-0.00449947256938482,0.0036451995014308,-0.0116440635921892,0.00264511845341955,0.217097200730594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39847,-0.00383373290697653,0.00310644005774035,-0.00992235542014762,0.00225488960619456,0.217183844653152
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39752,-0.00564917034652209,0.00458328665211439,-0.0146324121846663,0.00333407149162212,0.217767857369438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39881,0.00379618449926192,0.00308204005482262,-0.00224461400819041,0.00983698300671426,0.218083934801313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39706,0.0146803046632938,0.0119471995220397,-0.00873620639990398,0.0380968157264917,0.219187307542585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40054,0.00606809451107561,0.0049396038375684,-0.00361352901055847,0.0157497180327097,0.219301809133517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41866,-0.0112308308316443,0.00914253097361885,-0.0291501915399372,0.00668852987664867,0.219313678741346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41829,-0.00871734348023489,0.00710605846963511,-0.0226452180807197,0.00521053112024991,0.219940154990635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39784,-0.00713794996665362,0.00582030117758362,-0.0185457402747175,0.00426984034141028,0.220079809016523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39665,0.00819972421826861,0.00668648629342652,-0.00490578891684737,0.0213052373533846,0.220108534957555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42103,0.0189595746808232,0.0155093788554733,-0.0114388078759046,0.0493579572375509,0.221556542307262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40020,-0.00757338714743659,0.00619602423589658,-0.0197175946497939,0.00457082035492071,0.221621619947578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42144,-0.00415983810863131,0.00340478802694082,-0.0108332226414353,0.00251354642417269,0.221820161959999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39706,-0.00928750272306857,0.00760326029138807,-0.0241898928941892,0.00561488744805204,0.221918173015252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39719,-0.00714079243686901,0.00585399049678412,-0.0186146138105659,0.00433302893682786,0.222561891598542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41476,-0.0054994140682353,0.00451785114633051,-0.0143544023150431,0.0033555741785725,0.223527468149017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42068,0.00439689125693089,0.00361302284496016,-0.00268463351919102,0.0114784160330528,0.223643115064716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40021,-0.00580090675131153,0.00476770513716085,-0.0151456088201468,0.00354379531752373,0.223741714890636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41829,0.00807715743801669,0.00664242401284066,-0.004941993627151,0.0210963085031844,0.224009369135498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,42120,0.00558253922311403,0.00459176054039252,-0.00341731143605531,0.0145823898822834,0.224093548819205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39768,-0.00754569116302936,0.00621696774629593,-0.0197309479457694,0.00463956561971067,0.224879741301636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42077,0.0130813983134277,0.0107806500819003,-0.00804867584709694,0.0342114724739523,0.224993589494101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41991,-0.00867019447448132,0.00714902901326672,-0.0226822913404841,0.00534190239152146,0.225236595028928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,40020,0.0056624429268221,0.00467123029131164,-0.00349316844414871,0.0148180542977929,0.225464123134172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,42135,-0.00822176123683262,0.00678429384528425,-0.0215189771735897,0.00507545469992452,0.225579812663325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41887,-0.00422310355672714,0.00348627227226764,-0.0110561972103717,0.00260999009691743,0.22578300551055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39706,-0.00507883207594469,0.00419859324560763,-0.0133080748373356,0.00315041068544626,0.22644008263502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42223,0.00664113819931715,0.00549110360657966,-0.00412142486957898,0.0174037012682133,0.226517342539119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39916,0.0134580505690004,0.011131223442058,-0.00835914737743321,0.0352752485154341,0.22667565079296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,40020,0.0102177341980412,0.00846330602405112,-0.00637034560909897,0.0268058140051814,0.227343696829213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41887,-0.00689521304001628,0.00571894349754425,-0.018104342295203,0.00431391621517045,0.22796356011922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41829,0.00635590729892078,0.00528057601718494,-0.00399402169476171,0.0167058362926033,0.228751684059107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39804,-0.0124665305040258,0.0103621747081538,-0.0327763929320071,0.00784333192395559,0.22897200849314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39518,-0.00861696431981918,0.00716864913671185,-0.0226675166277744,0.00543358798813605,0.229377692142772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42177,-0.00298191696621368,0.00249229302740128,-0.00786681129992018,0.00190297736749283,0.231540817535669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40054,-0.00328916114628921,0.0027514017563014,-0.00868190858863995,0.00210358629606154,0.231937659079892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41887,-0.0170951504759024,0.0143238521018278,-0.045169900595485,0.0109795996436801,0.232705946862512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41861,0.00398833381604584,0.00335186851538641,-0.00258132847411153,0.0105579961062032,0.234114394573993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40102,-0.00322790978391241,0.00271474391826199,-0.00854880786370591,0.0020929882958811,0.23445406051931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39784,-0.00900289945662195,0.00757341271869356,-0.0238467883852613,0.00584098947201742,0.23456444987477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,40054,-0.00453730590088303,0.00382217576660201,-0.012028770403423,0.00295415860165692,0.235214035618491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41861,-0.00684953080415497,0.00578418974812778,-0.0181865427104854,0.00448748110217548,0.236363422045669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,40113,0.00500752190951941,0.00423214123720041,-0.0032874749153934,0.0133025187344322,0.236750747929542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42121,0.00740544069202127,0.00626074597544942,-0.0048656214198596,0.0196765028039021,0.236895589480009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42094,0.00412820839610669,0.00349664212712179,-0.00272521017305202,0.0109816269652654,0.237775168169684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39784,0.0107468677390989,0.00910701330187444,-0.00710287833257504,0.0285966138107728,0.238000866343798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41829,-0.00599684008533964,0.00508248620421084,-0.0159585130455929,0.0039648328749136,0.238061060280984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39706,0.00806785085578121,0.00683928470971509,-0.00533714717526036,0.0214728488868228,0.238172621643523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40054,-0.00464966516430837,0.00394187948046976,-0.0123757489460291,0.00307641861741237,0.238202935593034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,42296,-0.00869491366545712,0.00737454643698985,-0.0231490246819572,0.00575919735104298,0.238402123363245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41486,-0.00354286218158984,0.00300562018886054,-0.0094338777517565,0.00234815338857681,0.238522227942024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39706,0.00801926879868519,0.00680906066109047,-0.00532649009705214,0.0213650276944225,0.238928946503633
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39665,-0.00511071222948489,0.00434067410476923,-0.0136184334748326,0.0033970090158628,0.239062417408975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39706,-0.00625120108701003,0.00532045120189286,-0.01667928544272,0.00417688326869998,0.240046074837424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39784,0.00754699336287683,0.00642608741155363,-0.00504813796376828,0.0201421246895219,0.24024902343494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41829,0.00756779759586292,0.00644712130353788,-0.00506856015907132,0.0202041553507972,0.240486915836578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39784,0.0100358133295344,0.00854986371957563,-0.00672191956083381,0.0267935462199027,0.240502323877368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39706,-0.00612098980965896,0.0052250280379215,-0.0163620447639851,0.00412006514466717,0.241434445916331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39706,-0.00412623318963707,0.0035237726238338,-0.0110328275323513,0.00278036115307718,0.241637246470214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40031,-0.00452393892017536,0.00386766979764287,-0.0121045717235554,0.00305669388320466,0.242155191074222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,42103,-0.00807758310116291,0.00691204967333487,-0.0216252004608992,0.00547003425857343,0.242576969884276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42296,0.00414904592412112,0.00355572749455156,-0.00282017996519994,0.0111182718134422,0.243287042417097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41861,0.00892091315012371,0.00764616085666293,-0.00606556212893563,0.0239073884291831,0.243346253973087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,40102,-0.00286819387512651,0.00245917154568638,-0.00768817010467182,0.00195178235441881,0.243508465978603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,40040,-0.0116446155028237,0.00999848285052259,-0.031241641889848,0.00795241088420059,0.244191072140106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41887,0.00438666761309869,0.00377131251852883,-0.00300510492321782,0.0117784401494152,0.244783474140284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39768,-0.00768373167205329,0.00661054389094785,-0.0206403976983111,0.00527293435420449,0.245121647052679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39768,-0.00905724273751547,0.0078090181026754,-0.0243629182187592,0.00624843274372831,0.246138516930049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,40054,-0.00988248929018005,0.00852469079193196,-0.0265908832423667,0.00682590466200659,0.246368240859855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40080,0.00577687288637085,0.00498565244973122,-0.00399500591510234,0.015548751687844,0.246604121324689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41810,-0.00576099726440499,0.00497213336417024,-0.0155063786581787,0.00398438412936869,0.24661794486276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,40020,0.00384052167372344,0.00332442166530525,-0.00267534479027484,0.0103563881377217,0.248015587811077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42071,0.00836903144229645,0.00724530681624389,-0.00583176991754157,0.0225698328021345,0.248072181118216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39784,0.00474399815621547,0.00411270809254083,-0.00331690970516456,0.0128049060175955,0.248732310604228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40020,-0.00621282007317463,0.00538651737953273,-0.0167703941370588,0.00434475399070952,0.248770872905098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,40054,0.00618522538730536,0.00536369610791867,-0.00432761898421523,0.0166980697588259,0.248868140580763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40102,-0.00552335867818205,0.00480256368130427,-0.0149363834935384,0.00388966613717432,0.25013388601039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,42111,-0.00474896996893541,0.00413943692697045,-0.0128622663457975,0.00336432640792668,0.251299465768615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,42083,-0.00521417667368894,0.0045657488117061,-0.0141630443446329,0.00373469099725503,0.253466901768041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40102,-0.00308687737716791,0.00270588199623213,-0.00839040608978289,0.00221665133544706,0.253977099275185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42213,-0.00540624891631449,0.00473911424731728,-0.0146949128410564,0.00388241500842738,0.253985792643606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39665,0.00684383587750151,0.00602392786410519,-0.00496306273614467,0.0186507344911477,0.255937143602996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40021,-0.00734593367632489,0.00646785689442579,-0.0200229331893994,0.00533106583674965,0.256082127586377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,42004,-0.00416776110872364,0.00367243033867829,-0.0113657245725331,0.00303020235508582,0.256447592353632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,42079,-0.00771938349120073,0.00680684726508706,-0.0210608041307714,0.00562203714836989,0.256789845461313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,40054,-0.0044646631943685,0.00394028499946316,-0.0121876217933163,0.00325829540457929,0.257205133385677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39881,-0.00652412868812902,0.00575800824929535,-0.0178098248567479,0.00476156748048987,0.257217403176408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42213,0.00727664781626177,0.00642382564483506,-0.00531405044761495,0.0198673460801385,0.257336236092622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,40021,-0.00695332786139532,0.00613962100652265,-0.0189869850341797,0.00508032931138908,0.257435193213459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39881,0.0100339743567193,0.00887079419619378,-0.00735278226782046,0.0274207309812592,0.258027994672267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41984,0.0039573878741517,0.00349885851697317,-0.00290037481911571,0.0108151505674191,0.25805477976093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41876,0.0107152932972489,0.00949825188926972,-0.00790128040571972,0.0293318670002176,0.259285011298219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40054,-0.00711712136587874,0.0063206918116557,-0.0195056773167239,0.00527143458496642,0.260188902062575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39804,-0.00456074204039831,0.00405733252704734,-0.0125131137934111,0.00339162971261447,0.261007061267254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40020,-0.00485727058289242,0.00432439024912447,-0.0133330754711764,0.00361853430539155,0.261366133773079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39881,-0.0044265596868166,0.00394639808033446,-0.0121614999242721,0.00330838055063894,0.262027616897583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40020,-0.0045850934626744,0.00408798499699007,-0.0125975440567749,0.00342735713142614,0.262056440893508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39719,-0.00396077473917517,0.00353251536150642,-0.0108845048477277,0.0029629553693774,0.262214043225161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41861,-0.0191264968560466,0.0171022527556053,-0.052646912257033,0.0143939185449399,0.263433943503048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42091,0.00778681220874524,0.00696351074457994,-0.00586166885063144,0.0214352932681219,0.263489260099792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42248,-0.0046399361498203,0.00415279901646645,-0.0127794222220945,0.00349954992245394,0.263885217237615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39784,0.00357147906710638,0.00319871444891339,-0.00269800125276388,0.00984095938697663,0.26421820448408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39804,-0.00566262143141682,0.00507463405834445,-0.0156089041857719,0.00428366132293829,0.264503940129006
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39706,0.00708240095839472,0.00634720716566582,-0.0053581250863103,0.0195229270030997,0.264520632774475
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,42184,-0.00522622057329891,0.00469556005617912,-0.01442951828341,0.00397707713681216,0.265723333222038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41732,-0.00312591918205517,0.0028125839780741,-0.00863858377908041,0.00238674541497006,0.266415481674495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39719,-0.00875729080492784,0.00788282235961671,-0.0242076226297766,0.0066930410199209,0.266622386673781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,40054,-0.00889684037383118,0.00800925058675061,-0.0245949715238624,0.00680129077620002,0.266670179491316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39719,-0.0110914091667004,0.00999188633174277,-0.0306755063769162,0.00849268804351543,0.267006474839756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,40092,0.00318604925750287,0.00287075605057217,-0.00244063260161858,0.00881273111662431,0.267097066984721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39867,-0.00572231713585248,0.00517333949868107,-0.0158620625532674,0.00441742828156241,0.268700948983251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,40054,0.0116484435728704,0.0105694339030017,-0.009067646877013,0.0323645340227539,0.27044795009203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39719,-0.00647354912935648,0.00587894949736892,-0.0179962901441996,0.00504919188548661,0.270860713493414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39665,-0.00505608323511447,0.0045979365922777,-0.0140680389559788,0.00395587248574982,0.271513506207469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,42094,0.00669853458642818,0.00609859663022002,-0.00525471480880306,0.0186517839816594,0.272062096242169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40054,-0.00530967735721985,0.00483661048336691,-0.014789433904619,0.00417007919017929,0.272311983651788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41861,-0.00431768667059194,0.00393488661000499,-0.0120300644262017,0.00339469108501784,0.272538282242361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39768,0.00948635918451623,0.00865337524171228,-0.00747425628923984,0.0264469746582723,0.272989467533914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41861,-0.00847705802522025,0.00773442367081193,-0.0236365284200116,0.00668241236957113,0.27309227401379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41702,0.00966698682149821,0.00883289669866509,-0.00764549070788537,0.0269794643508818,0.273787522642993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,42144,-0.00435316152391254,0.00397767661417042,-0.0121494076876866,0.00344308463986148,0.27380079433293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42184,0.00325770709273538,0.00297829636590216,-0.00257975378443285,0.0090951679699036,0.274056133583779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39784,-0.00375668579070255,0.00343605485985021,-0.010491353316009,0.00297798173460388,0.274280966458181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39665,-0.00932905248218781,0.00855313349428792,-0.0260931941309921,0.00743508916661652,0.27542230061221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40113,-0.00291027618259481,0.00267062056151954,-0.00814469248317311,0.00232414011798349,0.275852707705418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39719,-0.00541830758190793,0.0049730733899548,-0.0151655314262193,0.00432891626240348,0.275945626789481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40054,-0.00455579255842158,0.0041838357678635,-0.012756110663434,0.00364452554659089,0.276220695372195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,42094,-0.00371235861822755,0.00341007616644482,-0.0103961079044594,0.00297139066800429,0.276331287040286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39706,-0.00288844994588463,0.00265581084910346,-0.00809383921012742,0.00231693931835816,0.276798318448648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39804,0.00759544471936626,0.00699003064172347,-0.00610501533841173,0.0212959047771443,0.277233413120507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39768,0.0034800477963049,0.00320336871916457,-0.00279855489325766,0.00975865048586745,0.277339524171899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42144,-0.0141308721054645,0.0130272885968353,-0.0396643577552616,0.0114026135443326,0.278068885687931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41887,-0.00944059516006885,0.00870496280490908,-0.0265023222576906,0.00762113193755294,0.278160558193862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40021,0.00305637684917695,0.00281864192125972,-0.0024681613164921,0.008580915014846,0.278236543474031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42120,0.00509471521511628,0.00469865137948964,-0.00411464148868341,0.014304071918916,0.278255092200263
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41741,0.00918565268487204,0.00849901483558545,-0.00747241639287544,0.0258437217626195,0.279811183080234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40080,-0.00362251601124695,0.00335388907522216,-0.0101961385986824,0.00295110657618848,0.280124179784724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41887,-0.00434214616370296,0.00402178896761922,-0.0122248525402366,0.00354056021283072,0.280316177521289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39804,-0.00802624452085957,0.0074364097005846,-0.0226016075340054,0.00654911849228625,0.280470905371672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39706,-0.00429006573614949,0.00398878195869728,-0.0121080783751962,0.00352794690289718,0.282160950129362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39881,0.00522660844544787,0.00486161720765282,-0.00430216128155166,0.0147553781724474,0.282364931533581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42186,-0.00331916547297925,0.00308752829935446,-0.00937072093971399,0.00273238999375549,0.282384171929733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39665,0.00317255745282812,0.00296386357913304,-0.00263661516227263,0.00898173006792887,0.284458221911781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,42120,0.00300772792150434,0.00281685271435025,-0.00251330339862214,0.00852875924163082,0.2856478829079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42120,-0.0129988120534296,0.0122010771369462,-0.036912923241844,0.0109152991349849,0.286722846999923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,40020,0.00845966435555093,0.00795417883923365,-0.00713052616934703,0.0240498548804489,0.287556470228379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39706,-0.00495741651121398,0.00466473717531066,-0.0141003013748229,0.00418546835239492,0.287922954148011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40080,-0.00569953484064906,0.00537086841518611,-0.0162264369344138,0.00482736725311572,0.288625160732124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39706,0.00712584532438629,0.00671945223035204,-0.0060442810471037,0.0202959716958763,0.288950606487886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39719,0.00920517279177792,0.0086850302517569,-0.0078174865016656,0.0262278320852214,0.28921917288569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39719,-0.00847880186079927,0.00800556899951171,-0.0241697170998422,0.00721211337824369,0.289572644649645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39784,0.00531169241602005,0.00502180230926152,-0.00453104011013253,0.0151544249421726,0.290204364115859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39719,-0.013061779620125,0.0123596565132044,-0.0372867063860056,0.0111631471457555,0.290623635451937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40054,0.00704417706479813,0.00666625504947385,-0.00602168283217063,0.0201100369617669,0.290675772402564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39665,-0.003714844221036,0.00351829494700398,-0.0106107023171638,0.00318101387509181,0.29105429229885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40054,0.00627756710340273,0.005946668099253,-0.00537790237113314,0.0179330365779386,0.291154173637451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41633,-0.00530790292557086,0.00503712743210002,-0.0151806726924869,0.00456486684134517,0.292015140550599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41829,0.00913282196617086,0.00866937360680574,-0.00785915030316838,0.0261247942355101,0.292151226689133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39881,0.0080663569507254,0.00765773218344876,-0.00694279812883416,0.023075512030285,0.2921993549274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41861,0.00977028543467145,0.00928885593428056,-0.00843587219651844,0.0279764430658613,0.292898205100856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41829,-0.00442635514536985,0.00420830081387731,-0.0126746247405694,0.00382191444982968,0.292904417375809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39863,0.00710677340384049,0.00677236817639855,-0.00616706822190066,0.0203806150295816,0.294028001363644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39646,-0.00537399201343154,0.00512828206518398,-0.0154254248611921,0.00467744083432906,0.294703051742284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40020,-0.00749146432979075,0.00715727373035133,-0.0215197208412794,0.00653679218169784,0.295264818077318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40102,0.00237299020382481,0.00226829669990452,-0.00207287132798805,0.00681885173563767,0.295512601572408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41829,-0.00343850342540206,0.00329576830711472,-0.00989820930734692,0.00302120245654279,0.296825349169732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42144,0.00781213174231138,0.00750047545637771,-0.00688880015218893,0.0225130636368117,0.297639091242294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42109,-0.00516558813853097,0.00496012126278009,-0.0148874258135799,0.004556249536518,0.297698414111113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39835,0.00516683201491743,0.00496612375410723,-0.00456677054313275,0.0149004345729676,0.298170552560853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41887,0.00498434282903364,0.00479324213665712,-0.00441041175881431,0.0143790974168816,0.298420678160511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39719,0.00578445092408009,0.00556270745441214,-0.00511845568656771,0.0166873575347279,0.298427669972591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42223,0.00422434937078521,0.00408135400800734,-0.00377510448490917,0.0122238032264796,0.300671189791355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39768,0.00809616335577028,0.00782601753552035,-0.00724283101384961,0.0234351577253902,0.300917286336827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,42213,0.00303240706938194,0.00293458780900639,-0.00271938503627058,0.00878419917503446,0.30146718060435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41829,-0.0090608048188412,0.00878220099451206,-0.0262739187680848,0.00815230913040244,0.3022213240887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40021,-0.00314793549030205,0.00305271928266268,-0.00913126528432091,0.0028353943037168,0.302474472425519
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39768,0.00549425443461264,0.00533235897922573,-0.00495716916466978,0.0159456780338951,0.302864166538882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39784,-0.0061836725782972,0.00601904333173132,-0.0179809975084906,0.00561365235189619,0.304278493049157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42223,0.00851674193757798,0.00829060639003723,-0.00773284658689498,0.0247663304620509,0.304309535915346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,42103,-0.00983678733544315,0.00958731116020066,-0.0286279172094364,0.00895434253855013,0.304900677124293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41968,0.00437479880938101,0.00427081441271067,-0.00399599743953191,0.0127455950582939,0.305690485105344
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41876,0.00650645505519531,0.00637873827512221,-0.00599587196404421,0.0190087820744348,0.307737359539423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42184,0.00314915930708378,0.00309823278298683,-0.00292337694757041,0.00922169556173797,0.309440130527736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42103,-0.0036868994846072,0.00362967805762662,-0.0108010684775554,0.00342726950834097,0.309760402515884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,40021,0.00369860388477356,0.00365006599435126,-0.00345552546415492,0.010852733233702,0.310940575918743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42094,-0.00276562992925736,0.00273162258896308,-0.00811961020362499,0.00258835034511026,0.311342169121295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39804,0.00544618064637391,0.00539586503512289,-0.00512971482246696,0.0160220761152148,0.312841885050148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41876,0.00747534767297907,0.0074184234598458,-0.00706476230831871,0.0220154576542768,0.313630524765833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39719,-0.00934463551927652,0.00927625046326069,-0.0275260864272675,0.00883681538871442,0.313779172168992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,40021,0.00626906067725163,0.00622727616095855,-0.00593640059822713,0.0184745219527304,0.314096692043044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41834,0.003003828306815,0.00298607599173768,-0.00284888063699085,0.00885653725062086,0.314461269180947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41887,-0.00401462165351161,0.00399450235159705,-0.0118438462626418,0.00381460295561862,0.314898313918893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41829,-0.00290939100102481,0.00289892622664037,-0.00859128640523994,0.00277250440319031,0.315585910166291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39881,-0.00505297169914754,0.00503754270733896,-0.0149265554055319,0.00482061200723683,0.315853271582162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41861,0.00407756117442264,0.00408183543264897,-0.00392283627356934,0.0120779586224146,0.317836610294591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40054,0.00631887757351853,0.00632564160512289,-0.00607937997252234,0.0187171351195594,0.317850521452567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41861,0.0038536996601215,0.00385841040950897,-0.00370878474251609,0.0114161840627591,0.317920793419396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39651,0.0089304474455077,0.00894761883300824,-0.00860688546718845,0.0264677803582038,0.318263226314932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39719,-0.00309613187560091,0.00310279593460524,-0.00917761190742719,0.00298534815622537,0.318373953935879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,42141,-0.00278512379558137,0.00279500173899591,-0.00826332720401336,0.00269307961285061,0.319042472515439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39665,0.00604685613037275,0.00607221130483035,-0.00585467802709474,0.0179483902878402,0.319358488008613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41861,-0.00421496916666701,0.00423689834764827,-0.0125192899280576,0.0040893515947236,0.319840758987103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40080,0.0107694992440721,0.0108788605894952,-0.0105530675113385,0.0320920659994827,0.32222185517807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39784,-0.00459341359057509,0.00464042495535289,-0.0136886465030668,0.00450181932191657,0.322260687046277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41861,-0.00762357734438483,0.00770377179857115,-0.0227229700695843,0.00747581538081462,0.322393347086079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42115,-0.0114769826668877,0.0115990497243217,-0.0342111201265582,0.0112571547927828,0.322448778443024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39706,-0.00497087753695985,0.00502660165999474,-0.0148230167905495,0.00488126171662985,0.322727905409142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39768,0.00433745404945334,0.00438972087846527,-0.00426639887233859,0.0129413069712453,0.323129536666479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42208,0.00298421552593062,0.00302202972082306,-0.00293896272688258,0.00890739377874382,0.323422236434079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39432,0.0114319601132866,0.0115927016315433,-0.0112897350845382,0.0341536553111115,0.324090543295881
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,42093,-0.00390123462779618,0.00396047915295349,-0.011663773767585,0.00386130451199265,0.324622372985396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41959,-0.00577427067816391,0.00586632244082712,-0.0172722626621851,0.00572372130585724,0.324982537666371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,42094,0.00324711868187853,0.00330087210401829,-0.00322259064199733,0.00971682800575438,0.325273920896283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39719,-0.0110708057604461,0.0112602583549723,-0.0331409121361918,0.0109993006152995,0.325543861573339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40021,0.0149659077856134,0.0152256390957136,-0.0148763448419852,0.044808160413212,0.325658348603028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40080,0.0039559357156284,0.00402694550127995,-0.00393687746688031,0.0118487488981371,0.325941234351957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39863,0.00581186620763907,0.0059172100307791,-0.00578586545268796,0.0174095978679661,0.32602505503775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39984,-0.00939422155614605,0.00956619555180252,-0.028143964837679,0.00935552172538688,0.326110664281923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39881,-0.00409221889561118,0.0041691923637837,-0.0122638359286272,0.00407939813740487,0.326349941484964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39855,0.00375358396273992,0.00382439702268833,-0.00374223420172921,0.0112494021272091,0.326376460632409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39706,0.00592761892177724,0.00604446376786789,-0.00591953006324382,0.0177747679067983,0.326778508906327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42213,0.00524826602203459,0.00535473610084975,-0.00524701673563092,0.0157435487797001,0.327046752568464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39665,0.0060957878931053,0.00622878981056636,-0.00611264013560478,0.0183042159218154,0.327776923892375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39665,0.00733935487568478,0.00750038431461161,-0.00736139838095398,0.0220401081323235,0.327834616771203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39665,-0.00413144932124523,0.00422617121331424,-0.0124147448993411,0.00415184625685067,0.328301297993737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40021,-0.00215947674209618,0.00221062140969651,-0.00649229470510135,0.00217334122090899,0.328658251524853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40020,0.00786443905154477,0.00806017461300034,-0.0079335031899359,0.0236623812930254,0.329227162648496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39719,0.0044542872803295,0.00456899496102893,-0.0045009428432872,0.0134095174039462,0.329635084429922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39804,0.0045521776462601,0.00466994432395257,-0.00460091322868694,0.0137052685212071,0.329690633195969
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39881,-0.00286674275814718,0.00294938944731811,-0.00864754607489068,0.00291406055859632,0.331083305626727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41887,0.0112690539907104,0.0115947155999612,-0.0114565885852135,0.0339946965666342,0.33111238786873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39719,-0.00378909184664959,0.00390211840657661,-0.0114372439235397,0.00385906023024057,0.331553381221119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39863,-0.0034810126217591,0.00358588390081648,-0.0105093450673594,0.0035473198238412,0.331692595168048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40054,-0.00664684579874981,0.00685900754738658,-0.0200905005916275,0.00679680899412788,0.332532765444017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39719,-0.00641593517292898,0.00662385865076528,-0.0193986981284289,0.00656682778257098,0.332762110943097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39784,0.00243388910072744,0.00251288381602822,-0.00249136317868788,0.00735914138014276,0.332784832164177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41984,0.00504428233684638,0.00521221497175924,-0.00517165900780173,0.0152602236814945,0.333172081124413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39706,-0.00472023321063854,0.0048782437400367,-0.0142815909411105,0.0048411245198334,0.333261873656436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42144,-0.00579894410985931,0.00599724359463903,-0.0175535415553518,0.00595565333563319,0.333594637754873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40054,-0.00374859608114303,0.00388547912336277,-0.0113641351629341,0.003866943000648,0.334681199727024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40080,0.010508002652715,0.0108938330753155,-0.0108439101749034,0.0318599154803333,0.334775306968481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39719,0.00602821328257342,0.00625641999489656,-0.00623436990742383,0.0182907964725707,0.335306564921368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41887,-0.00622113182456509,0.0064567466712732,-0.0188763553002606,0.00643409165113038,0.335310637422751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40054,-0.0105289972647253,0.010929164523212,-0.0319501597302207,0.0108921652007702,0.335375613261877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41829,-0.0066140179184818,0.00686634017165894,-0.0200720446549333,0.00684400881796972,0.335439362338735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39804,-0.00755735650538542,0.00786095167119691,-0.0229648217809314,0.00785010877016053,0.336383378400861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,42094,-0.00281143583782754,0.00292471844434025,-0.00854388398873443,0.00292101231307935,0.336435865033603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41963,-0.00665721067434745,0.00693118970655818,-0.0202423424992015,0.00692792115050658,0.336836118161176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42213,0.00935325988853591,0.00975287556673191,-0.00976237622225863,0.0284688959993304,0.337563526605245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39784,-0.0053159018347647,0.00554500627063438,-0.0161841141252081,0.00555231045567869,0.337740479430001
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39768,-0.00611583385018622,0.00638838396204317,-0.0186370664157908,0.0064053987154184,0.338419269289813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39784,-0.00382978634163826,0.0040115307022362,-0.0116923865180212,0.0040328138347447,0.339753997826835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39674,-0.00853192591119486,0.00895576477803793,-0.0260852248761492,0.00902137305375948,0.340777148315226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39665,-0.00562539588337175,0.00591238051458451,-0.0172136616919574,0.0059628699252139,0.34139267666488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39719,0.00566357439729274,0.00597227676568651,-0.00604208806345282,0.0173692368580383,0.3429930406993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,40054,-0.00450515848826269,0.00476395005333007,-0.0138425005927896,0.00483218361626423,0.344334343811724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40020,-0.00453680137642844,0.00480635951542967,-0.0139572660266706,0.00488366327381371,0.345233455761234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39665,-0.00301920853850336,0.0032021491713141,-0.00929542091427899,0.00325700383727228,0.345769450229978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40097,0.00611113424210141,0.00648622524599146,-0.00660186724004186,0.0188241357242447,0.346125901372978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,42144,-0.00393207616949432,0.00418128165626489,-0.0121273882157735,0.00426323587678485,0.347030097625065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41861,-0.00502352881350022,0.00534796641170898,-0.0155055429804498,0.00545848535344938,0.347576993703164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39477,-0.00235653409558051,0.00251968548319575,-0.00729511764264419,0.00258204945148317,0.349681796624948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39706,-0.00654004057853521,0.0070137024416777,-0.0202868973642235,0.00720681620715307,0.351117053906157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42180,-0.0064699514540746,0.00693896581528317,-0.0200703244520296,0.00713042154388042,0.351142732814075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,42049,-0.0056300464678796,0.00604387970164622,-0.0174760506831062,0.00621595774734699,0.351597719489911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,40054,0.0059676441964866,0.00640889088354082,-0.00659378193525341,0.0185290703282266,0.351796236319535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39706,-0.00316468253602868,0.00340142277672235,-0.00983147117840448,0.00350210610634711,0.352185568917611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41829,-0.00287674732492008,0.00309279908930904,-0.00893863353996581,0.00318513889012564,0.352314501618448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,42186,0.00209260597061349,0.00225282793475735,-0.0023229367815109,0.00650814872273789,0.352968729575264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39784,-0.00835364349426915,0.0089941571871932,-0.0259821915811678,0.00927490459262952,0.353021388216638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39804,0.00309737306647148,0.00333553466003722,-0.00344027486720147,0.00963502100014443,0.353118233193388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42213,0.00547695037461689,0.00590923240076247,-0.00610514513087755,0.0170590458801113,0.354023506471928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42004,0.00895890948932736,0.00968912537485665,-0.0100317762453917,0.0279495952240464,0.355172946717239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39768,0.00678440951250836,0.00734782239122145,-0.00761732237428568,0.0211861413993024,0.355860250039343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39665,-0.00757185309852229,0.0082016555718066,-0.0236470980192632,0.00850339182221864,0.355918882249494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40080,-0.00849127445589561,0.00921813870374355,-0.026558826315233,0.00957627740344175,0.356993324889619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,42197,0.00452492080783439,0.00491695045571545,-0.00511230208536789,0.0141621437010367,0.357448880412378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41854,0.00477394738703573,0.00518912236400777,-0.00539673244641951,0.014944627220491,0.357594838783953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39881,0.0070504761407846,0.00766358347117094,-0.00797014746271043,0.0220710997442796,0.357594932594568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41887,-0.00460968153610955,0.00501464845700961,-0.0144383925118484,0.0052190294396293,0.357985843591754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,42063,-0.0023224433126496,0.00252732628294917,-0.00727600282722998,0.00263111620193078,0.358147884385794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41876,-0.0057495953495818,0.00625873946493312,-0.0180167247008507,0.00651753400168713,0.358295778643974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39881,0.00784955840747758,0.00854514167894434,-0.00889891928325332,0.0245980360982085,0.358326098369155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42296,-0.00305949236837443,0.00334362216407249,-0.00961299180995651,0.00349400707320766,0.36019620926954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39768,-0.00383995555217672,0.00420255169354595,-0.0120769568715268,0.00439704576717335,0.360884823183193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41887,-0.00269150438440372,0.00295030513939791,-0.00847410245762362,0.00309109368881618,0.361638663833085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42296,-0.00669070007502596,0.00734280398489434,-0.0210825958854189,0.00770119573536694,0.362211281545595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39863,0.00297053828967226,0.00327615333720412,-0.00345072225124781,0.00939179883059233,0.364577858481886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39665,-0.00396773588135677,0.00439501882951078,-0.0125819727871979,0.00464650102448436,0.366663339968043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39784,-0.00514628104737372,0.00570570272562259,-0.016329458389594,0.00603689629484655,0.36710184941912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39706,-0.00403841289071474,0.00448922320650421,-0.012837290375463,0.00476046459403351,0.368364709697659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,40035,-0.00220876285300396,0.00245831232449089,-0.0070270550090061,0.00260952930299818,0.368945669859685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40054,0.00435839976034771,0.0048566144748224,-0.00516056461030419,0.0138773641309996,0.369517286344825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40080,0.00751727665319903,0.00838068381686897,-0.00890886362786415,0.0239434169342622,0.369751278876559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,40054,0.00975089531837145,0.0108963105556887,-0.0116058733707784,0.0311076640075213,0.370870829924419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42144,-0.00260382815720839,0.00291482592817235,-0.0083168869764262,0.00310923066200942,0.371710538002348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40054,0.00297110008130092,0.00334354914870269,-0.00358225625015635,0.0095244564127582,0.374234185154348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41861,0.00604175660645922,0.0068020392204103,-0.00729024026554497,0.0193737534784634,0.374435387927608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39784,-0.00269604513865293,0.00304291222155915,-0.00866015309290886,0.00326806281560299,0.375633234137006
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41959,0.00257338119388422,0.0029056783834944,-0.00312174843776481,0.00826851082553326,0.375828939241594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39881,-0.0156826539276933,0.0177117828992539,-0.0503977484102308,0.0190324405548443,0.375941331455282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39706,0.00594884497534891,0.00672850745394116,-0.00723902963437576,0.0191367195850736,0.376648692885837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,42126,0.00333160456713938,0.00376855299404062,-0.00405475930118023,0.010717968435459,0.376683467036061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40054,0.00604614554621587,0.00684094752811727,-0.00736211160889398,0.0194544027013257,0.37681458669259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41861,0.00526819610211678,0.00596379788067759,-0.0064208477440113,0.0169572399482449,0.377057146541999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39665,0.00243339232618791,0.00275489163349746,-0.0029661952754671,0.00783297992784292,0.377095159719869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39706,-0.00649018517901367,0.00734861138998922,-0.0208934635033926,0.0079130931453652,0.377156387073767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42004,0.00559801684776523,0.00633921980613833,-0.00682685397226589,0.0180228876677963,0.377211442761973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39706,-0.0047232173035342,0.00535706323862071,-0.0152230612512308,0.00577662664416239,0.377969858041005
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39942,-0.00308257592108376,0.00349800281823863,-0.00993866144483148,0.00377350960266396,0.378208270587769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,42101,-0.00598494997880305,0.00679862084169829,-0.0193102468285317,0.0073403468709256,0.37870332121233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39706,-0.00433648960963985,0.00493252036034334,-0.0140042295159128,0.0053312502966331,0.379332975371992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39665,0.00454838782598419,0.0051812769308863,-0.00560691495855295,0.0147036906105213,0.380044862069352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41876,0.00399595978790603,0.00455351926625055,-0.00492893797394504,0.0129208575497571,0.380202337296164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41876,0.00789316086834252,0.00899934106737643,-0.00974554762371529,0.0255318693604003,0.380458666093174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39768,0.00756492557724575,0.00864497668684241,-0.00937922872896539,0.0245090798834569,0.381557845440121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41824,0.00315074089432407,0.00360098331667984,-0.00390718640636841,0.0102086681950166,0.381608601747266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39804,0.00436332569357109,0.00499305855538706,-0.00542306907498756,0.0141497204621297,0.38220429323974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,40054,0.00348649376629713,0.00399124699374319,-0.00433635034143952,0.0113093378740338,0.382390876657738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39881,-0.00724383452843744,0.00830714274126308,-0.0235258343013131,0.0090381652444382,0.383227569246931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40020,-0.00732152053139038,0.00839637210825912,-0.0237784098635783,0.0091353688007975,0.383235248688935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42094,-0.00285289046727455,0.00327741379736326,-0.00927662151010655,0.00357084057555744,0.38405979132984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40021,-0.00673608189972502,0.00774338593738877,-0.021913118337007,0.00844095453755696,0.38436654338877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41887,0.00463490454315967,0.00533054701006934,-0.00581296759657624,0.0150827766828956,0.384590773289142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41969,-0.00505634492750455,0.00582479042592349,-0.0164729341623146,0.00636024430730548,0.385370524097141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39784,0.00524366567435375,0.0060490595747607,-0.00661249109217723,0.0170998224408847,0.386040365327063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41935,-0.015265139085112,0.0176440943983593,-0.0498475641058962,0.0193172859356722,0.386961842219843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41829,-0.00489681538935687,0.00566015274250723,-0.0159907147646711,0.0061970839859573,0.386979265277111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41829,0.00465190998544125,0.00537719274402595,-0.00588738779284961,0.0151912077637321,0.386990067897201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41783,-0.00271708063287865,0.00315242628789805,-0.00889583615715883,0.00346167489140153,0.388758195123385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39665,0.00661289327259995,0.00768990113743562,-0.00845931295677387,0.0216850995019738,0.389838960231326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42004,-0.0030883451086631,0.00359513836357086,-0.010134816301262,0.00395812608393579,0.390337982664734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39863,0.00444388940611795,0.00519461292577746,-0.00573755192840587,0.0146253307406418,0.392304476102702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42128,0.00497980673849914,0.00582404198556846,-0.00643531555321504,0.0163949290302133,0.392543142233856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39665,-0.0041806823564518,0.00490508728401652,-0.0137946534331242,0.00543328872022059,0.394058449681705
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40028,0.00498474359129826,0.00589536768679168,-0.00657017707481343,0.01653966425741,0.39783050596289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41876,-0.0122926065376362,0.0145715967889793,-0.0408529362440355,0.0162677231687631,0.398908588347094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40020,0.00293957454686064,0.00348879998585696,-0.00389847342541899,0.00977762251914027,0.39948496801083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39706,0.00522557576271458,0.0062065868707046,-0.00693933450386643,0.0173904860292956,0.399840510917749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39768,0.00421952997921227,0.00501200856617828,-0.00560400681049717,0.0140430667689217,0.399871908971043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39665,0.0124054190924671,0.0147365159013947,-0.0164781520742665,0.0412889902592008,0.399910779171014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,42144,0.00335368143461008,0.00398454566025229,-0.0044560280594844,0.0111633909287046,0.399986988116393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39784,0.00876497384476966,0.0104330328553324,-0.0116837705516818,0.0292137182412211,0.400861455581889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,40020,0.00372784052549639,0.00444352831971889,-0.00498147498115264,0.0124371560321454,0.401523160838319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41963,0.00187591270285083,0.00224536366571848,-0.00252500008195739,0.00627682548765906,0.403474096933064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38671,0.00944228372490441,0.0113220555213436,-0.0127489450969291,0.0316335125467379,0.404317461451345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42066,-0.00280965257559218,0.00336961271027613,-0.0094140934877334,0.00379478833654903,0.404397543726959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39719,-0.00299220816723276,0.00358889218027734,-0.0100264368405763,0.00404202050611084,0.404445616385528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39706,-0.00332173995452638,0.00398870079437156,-0.0111395935114946,0.00449611360244187,0.40498353489272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42144,0.00570416188850095,0.00685410490740608,-0.00772988373001497,0.0191382075070169,0.405296936468275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,40020,-0.00224623251856447,0.00270285040867473,-0.00754381931956695,0.003051354282438,0.405957716622912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39784,-0.00263828501150522,0.00318249447818149,-0.00887597418874094,0.00359940416573049,0.407123608968373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39768,-0.00539484487132254,0.00651145469178004,-0.0181572960672114,0.00736760632456635,0.407396996289248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39706,-0.00372495244728114,0.00450079687779425,-0.0125465143277579,0.00509660943319558,0.407904156127193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39784,-0.00347428645869275,0.00420065380102311,-0.011707567908698,0.00475899499131253,0.408209044273992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41829,-0.00337784395198591,0.00408579915700431,-0.0113860102997143,0.00463032239574253,0.408406944220298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40054,-0.0024349883084136,0.00294944663734737,-0.00821590371761445,0.00334592710078724,0.40906356784579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42094,0.00375146463657971,0.00454928727331284,-0.00516513841911345,0.0126680676922729,0.409598694815614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39784,0.00761357530944023,0.00923406946719203,-0.0104852008462562,0.0257123514651366,0.40966885559046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40020,0.00738807631328239,0.00896088581824278,-0.0101752598904734,0.0249514125170382,0.409684711789036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,40041,-0.0028797257529401,0.00349463930920865,-0.00972921879898906,0.00396976729310886,0.409934432220313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39548,-0.00193485988713128,0.00234919627577944,-0.00653928458765899,0.00266956481339642,0.410170885587423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39719,-0.00419868029376342,0.00510619511357832,-0.0142068227163769,0.00580946212885008,0.410940844854128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41887,0.00433837577308876,0.00528288988021798,-0.00601608839213847,0.014692839938316,0.411540599868834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42104,-0.00246195243480006,0.00300128283883029,-0.00834446679890742,0.0034205619293073,0.412060228251674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42186,-0.0070153342463144,0.00856099357491246,-0.0237948816531428,0.00976421316051402,0.41254288030931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39863,-0.00592163216176033,0.00722908767674764,-0.0200906440081857,0.00824737968466505,0.412725053851149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41985,-0.00674325519765416,0.00823375899191687,-0.0228814228218112,0.00939491242650291,0.412815074131445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41829,-0.012561264284355,0.015340295438569,-0.0426282433439503,0.0175057147752404,0.412892525804052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41810,-0.00389614746137134,0.00478791375413304,-0.0132804584194721,0.00548816349672942,0.415805618888907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39881,-0.00592400442146052,0.00728086052482043,-0.0201944910501086,0.00834648220718753,0.4158689443791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39706,0.00324955235069702,0.00401981794159972,-0.00462929081483843,0.0111283955162325,0.418888448428895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42004,0.00572442786518229,0.00709114608869404,-0.00817421846865804,0.0196230741990226,0.419529314642522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,42256,0.00360931207384302,0.00447451722976973,-0.00516074169650565,0.0123793658441917,0.419890218092127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,42296,-0.0071710458701466,0.00889096825354926,-0.0245973436471031,0.0102552519068099,0.41993813360003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,42057,0.0027225376607653,0.00337553485097542,-0.00389351064714652,0.00933858596867711,0.419940697343566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39768,-0.00326101383381462,0.00404323229822388,-0.0111857491383334,0.00466372147070418,0.419951794623274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39784,-0.00309403683270574,0.00383690241124612,-0.0106143655587481,0.00442629189333665,0.420036555162084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39719,-0.00586880835063399,0.0072876635696401,-0.0201526289471286,0.00841501224586061,0.420660587763536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42256,0.0030183500090746,0.00374852189042482,-0.00432875289615804,0.0103654529143072,0.420712748259653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40054,-0.00304859587262403,0.00379486413775565,-0.0104865295826251,0.00438933783737705,0.421791301450626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40054,-0.00447321097360089,0.00558128880314561,-0.0154125370277663,0.0064661150805645,0.422879686878586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42004,-0.00249997472420832,0.00312066070955457,-0.00861646971493529,0.00361652026651865,0.423086123248747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42296,0.00205267225063502,0.00256924219733163,-0.00298304245613497,0.00708838695740501,0.424339259497506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39881,-0.00617916869888491,0.00774059312114623,-0.0213507312163315,0.0089923938185617,0.42472515846902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42103,0.00581961670622817,0.00729988727647847,-0.00848816235566963,0.020127395768126,0.425337889794288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42120,-0.00273463161309098,0.00343376195825473,-0.00946480505127026,0.0039955418250883,0.425816981325521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39706,0.00395181111145846,0.00496597391300977,-0.00578149775804068,0.0136851199809576,0.426179246346908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39665,0.00298386436106221,0.00376430369687301,-0.00439417088480889,0.0103618996069333,0.427985943601219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42186,0.00204494747113641,0.00258284671200904,-0.00301743208440132,0.00710732702667413,0.428525751514504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39881,0.00442928835609905,0.00559665436517945,-0.00654015419965267,0.0153987309118508,0.428718158104031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39847,0.00687207324929661,0.00868747485987327,-0.010155377476055,0.0238995239746482,0.428942751498842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,42184,-0.00522936348331251,0.00661249701070424,-0.0181898576242928,0.0077311306576678,0.429057420690014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39665,-0.00766744526795226,0.00971141516380216,-0.0267018189890045,0.0113669284531,0.429820682371027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41876,0.00631296619074063,0.008017933435276,-0.00940218334240032,0.0220281157238816,0.431088342369596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41861,0.00364598362855242,0.0046356634227007,-0.00543991667994095,0.0127318839370458,0.431584993529986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42103,-0.0048470811721289,0.00616755743372889,-0.0169354937422375,0.00724133139797973,0.431940709811908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39706,-0.00389210594756848,0.00497654239899593,-0.0136461290496005,0.00586191715446354,0.434179074109994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,42067,0.00666456674409432,0.00852181423581652,-0.0100381891581061,0.0233673226462947,0.434193924454836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39706,-0.00268530775609586,0.00344320651537851,-0.00943399252623774,0.00406337701404602,0.435475675115917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39706,-0.00302818902794724,0.00388871173186677,-0.0106500640224061,0.00459368596651162,0.436166529408514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40054,0.0042547791161656,0.00549113097275922,-0.00650783759044248,0.0150173958227737,0.438447722557213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40020,0.00492071872324527,0.00635943652997138,-0.00754377687549865,0.0173852143219892,0.439085802793507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41876,0.00543050877712543,0.00702499381385568,-0.0083384790980317,0.0191994966522826,0.439520902901132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39665,-0.00207210642316218,0.00268175897251688,-0.00732835400929525,0.0031841411629709,0.439736973655436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40054,0.00566487921486057,0.0073386311753726,-0.00871883788886973,0.0200485963185909,0.440175134037588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41861,-0.00383069485578961,0.00496831771978924,-0.0135685975865765,0.0059072078749973,0.440706770750249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40021,-0.00683023645511799,0.00887084636468255,-0.0242170953298958,0.0105566224196598,0.44133777191957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41876,-0.00593991546404361,0.00772995649112966,-0.0210906301866578,0.00921079925857053,0.442247224207998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42103,-0.00384913855049479,0.00501883211459052,-0.0136860494950922,0.00598777239410264,0.443131754653144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40054,0.00523816718871798,0.00683820305882086,-0.00816471080657091,0.0186410451840069,0.443683932316594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40102,-0.00460662723051604,0.00602218323432002,-0.0164101063697833,0.0071968519087512,0.4443220040819
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39784,-0.00250911675254649,0.00328065093510678,-0.00893919258535578,0.0039209590802628,0.444394090040631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42103,0.00306255663512045,0.00400908448961416,-0.00479524896452331,0.0109203622347642,0.444938272868565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42103,-0.002964266296378,0.00388443696603964,-0.0105777627498157,0.00464923015705969,0.445409653312391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39784,-0.0017134993030645,0.00224606453799076,-0.00611578579752639,0.00268878719139739,0.445546224920218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41887,0.00302888832346987,0.00397867864869129,-0.00476932182796506,0.0108270984749048,0.44650401041167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,42120,-0.00576543072208816,0.00757472332170277,-0.0206118884326256,0.00908102698844928,0.446586877770808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39768,-0.00328493546391018,0.00432671979551135,-0.0117653062631124,0.00519543533529207,0.447737437302478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41887,-0.00349019403317803,0.00460507087605257,-0.0125161329502411,0.00553574488388501,0.448523514566935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40080,0.00249371518045096,0.00329069555750011,-0.00395604811224925,0.00894347847315117,0.448582379532396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39784,0.00421486197769471,0.00556255964693248,-0.00668775493029296,0.0151174788856824,0.448635560509891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39665,0.00490084992742185,0.00648173179241695,-0.00780334438571537,0.0176050442405591,0.449605093479865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42103,0.00860279838006554,0.0113856738298158,-0.0137131223263734,0.0309187190865044,0.449914260254914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39804,0.00566420785682747,0.00750030623386121,-0.00903639236154051,0.0203648080751955,0.450147624608131
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40080,-0.00219964330635204,0.00291966140341543,-0.00792217965704629,0.00352289304434221,0.451231965338489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39706,0.00532882262405289,0.00707768643708621,-0.00854344279263608,0.0192010880407419,0.451524108388971
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39768,-0.00320813086607251,0.00426386851065018,-0.0115653131469469,0.00514905141480184,0.451827830981285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41829,-0.00449120542213133,0.0059780265869412,-0.0162081375325361,0.00722572668827341,0.452494772865869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39665,-0.00443620054251225,0.00591203742198733,-0.0160237938896074,0.00715139280458291,0.453050279703959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42094,-0.00559427207524023,0.0074646189525372,-0.0202249252222131,0.00903638107173267,0.453606680332248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39768,-0.00418675634768627,0.0055929200346372,-0.0151488796155752,0.00677536692020264,0.454126149133789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39768,0.00525631615739794,0.00702606212724471,-0.0085147656120017,0.0190273979267976,0.454406258129787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41887,0.00334079845303521,0.00447951034780866,-0.00543904182866978,0.0121206387347402,0.455804797350128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41887,-0.00365207850721973,0.00490018447091945,-0.0132564400702218,0.00595228305578238,0.456107755438195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41861,-0.00295638582174665,0.00397989472778076,-0.0107569794881969,0.00484420784470365,0.457598290936101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41861,0.00442196032030836,0.00596003129783484,-0.00725970102344793,0.0161036216640646,0.45814001745084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40020,0.002190399038657,0.00296097281439451,-0.00361310767755624,0.00799390575487024,0.459463767424666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41928,-0.00365994828292047,0.00495064923847493,-0.0133632207903313,0.00604332422449039,0.459746655686402
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39784,-0.00936088058411271,0.0126707599114701,-0.0341955700105942,0.0154738088423688,0.46005809380375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39665,0.00360811579472773,0.0048919864019533,-0.00598017755310074,0.0131964091425562,0.460800596007901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42186,0.0073854321814458,0.0100372288429663,-0.0122875363507681,0.0270584007136597,0.461863327683431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42296,-0.00244718103495698,0.00332744148671718,-0.00896896634892265,0.00407460427900869,0.462076048076052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42103,0.00655587062854533,0.00891653862935142,-0.0109205450849834,0.0240322863420741,0.462201593513362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39706,0.00289075731512905,0.00393602639782544,-0.0048238544246088,0.0106053690548669,0.462699770171074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39719,-0.00313008472296796,0.00426869668753499,-0.0114967302305365,0.00523656078460062,0.463413313743026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39784,0.00252324338296024,0.0034416588695448,-0.00422240800134756,0.00926889476726804,0.463484737616904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,42120,-0.00180921905559905,0.00246860634731291,-0.00664768749633235,0.00302924938513424,0.463638281503155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39706,-0.00292862825101426,0.00399951325518903,-0.0107676742311848,0.00491041772915625,0.464034655478082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40097,0.00225275381268363,0.00307776239081401,-0.00377966047331183,0.00828516809867909,0.46421766831408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39804,0.00521999617428864,0.00713950599341053,-0.00877343557279599,0.0192134279213733,0.464708270664533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,42213,-0.00565085379172461,0.00773104003762662,-0.0208036922654728,0.00950198468202357,0.464834693507705
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,40080,0.0027005936942863,0.0036987596395641,-0.00454897519925933,0.00995016258783193,0.46532340965549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,42091,-0.00468191713736744,0.00641465485935996,-0.017254640661713,0.00789080638697809,0.46547785731999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39768,0.00406118431592354,0.00557116027897707,-0.00685828983087152,0.0149806584627186,0.466038836945415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39768,0.00206930220098425,0.00284624577266777,-0.00350933951344458,0.00764794391541309,0.467224504657277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39804,-0.00209344710036367,0.00288336388865855,-0.00774484032213442,0.00355794612140709,0.467828227242312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39719,0.0054393600082493,0.00751232029449552,-0.00928478776896193,0.0201635077854605,0.469045861608955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41829,-0.00340739665723631,0.00470663043754031,-0.0126323923148153,0.0058175990003427,0.469105719735952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42184,0.00772236254802643,0.0106757879922441,-0.0132021819167721,0.0286469070128249,0.469476105000506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42256,-0.0040596960006878,0.00561576887197831,-0.0150666029897653,0.00694721098838968,0.469748065460878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42004,-0.00435029667449275,0.00602023246422484,-0.0161499523043734,0.00744935895538794,0.469931030960392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39768,-0.00956484369157904,0.0132420710155901,-0.0355193028821356,0.0163896154989775,0.470121579621269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41887,0.00422220175376761,0.00584880650406743,-0.00724145899420456,0.0156858625017398,0.470374690204214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39804,-0.00153768309084187,0.00213622424111479,-0.00572468260342686,0.00264931642174312,0.471655674707022
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41861,-0.00380499604297203,0.00528981522049059,-0.0141730338751336,0.00656304178918952,0.471965644409683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41876,-0.00228826782580401,0.00318264187198756,-0.00852624589489962,0.0039497102432916,0.472164171898816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41887,0.00839396265509868,0.0116748719889919,-0.0144887864433255,0.0312767117535229,0.47216842072219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,42162,-0.006102695476126,0.00851512399486023,-0.022792338506052,0.0105869475538,0.473578937807233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,42103,0.00263600133606729,0.00368550696180631,-0.00458759230907308,0.00985959498120765,0.474477155300428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,42107,-0.00343017841011658,0.00480749986627213,-0.01285287814801,0.0059925213277768,0.47554580089205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,42223,0.00219101627156179,0.00307364732632442,-0.00383333248803408,0.00821536503115766,0.475958037568217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41947,0.00549131546846753,0.00770814646804495,-0.00961665160890057,0.0205992825458356,0.476227584579796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39706,-0.00642631151369924,0.00902458359239699,-0.0241144953547973,0.0112618723273989,0.476425138812172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41887,-0.00668952144233265,0.00941586150652832,-0.0251446099951281,0.0117655671104629,0.477436689040551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39719,0.00439082452944591,0.00621324135076023,-0.00778712851804413,0.016568777576936,0.479775890004194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41876,-0.00353893729088506,0.00500903150194743,-0.013356639034702,0.00627876445293191,0.479883215951009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40054,0.00412629337519642,0.00584037460618328,-0.00732084085292281,0.0155734276033157,0.479885095695893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,40102,0.00194191039676894,0.00275240760031092,-0.00345280849984046,0.00733662929337833,0.48049457185478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,40054,-0.00349371422547601,0.0049553783790324,-0.0132062558483795,0.0062188273974275,0.480803697332616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,42197,-0.00219023504673427,0.00310761640371031,-0.00828116319800647,0.00390069310453793,0.480949934507085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,42144,-0.00483269864656077,0.00689060245571413,-0.0183382794597605,0.00867288216663893,0.483099518508156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39719,-0.00440124407461505,0.00630331442272871,-0.0167557403431633,0.00795325219393321,0.485040774294913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42094,-0.00628096304777987,0.0090143884669783,-0.0239491644430573,0.0113872383474976,0.485958771174631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39863,0.00299479941769105,0.00430060870628115,-0.00543439364662001,0.0114239924820021,0.48621456756004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39665,0.00558248667783638,0.00802053470835236,-0.0101377613505342,0.021302734706207,0.486429089603504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41949,0.00304747996337694,0.0043795825179867,-0.005536501771877,0.0116314616986309,0.486542963270619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39804,0.00460156470620034,0.00661880921120109,-0.0083713013477538,0.0175744307601545,0.486929241912408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39601,-0.00574469128534735,0.00827529173758565,-0.0219642630910152,0.0104748805203205,0.487573518611153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39784,0.00404364695620024,0.00582695261747384,-0.00737718017404848,0.015464474086449,0.4877252153757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,40048,-0.00590671867623427,0.00858170168528817,-0.0227268539793991,0.0109134166269305,0.491283477176948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39719,-0.0037787616059294,0.00549078121541446,-0.0145406927881417,0.00698316957628295,0.4913413261569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39784,0.00333014497640756,0.00484294956597096,-0.00616203617289553,0.0128223261257107,0.491702487898485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39863,-0.00578676322280129,0.00842933302679161,-0.0223082559553128,0.0107347295097103,0.492410831815612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39999,-0.00276436978915442,0.00403776814751191,-0.0106783953582778,0.00514965577996894,0.493593275264059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39665,-0.00240929341297654,0.00352060507487273,-0.00930967935972709,0.00449109253377401,0.493775184796506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39865,0.00698930234506384,0.0102184596036102,-0.0130388784780121,0.0270174831681398,0.493997682674458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42213,0.0043964349718812,0.0064389265228999,-0.0082238610130026,0.017016730956765,0.494751666041592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39784,-0.00280995491633511,0.00412829402834685,-0.0109014112118949,0.00528150137922472,0.496103019754001
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,42004,0.00279670244773931,0.00411016251472928,-0.00525921608113009,0.0108526209766087,0.49624074465522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,42168,-0.00211561150400911,0.00311171808753824,-0.00821457895558406,0.00398335594756583,0.496589196577714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40054,0.00332164055072934,0.00488819306497977,-0.006259217856631,0.0129024989580897,0.496820901214877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39784,0.00426878581620567,0.00628897989748269,-0.00805761478286041,0.0165951864152717,0.497296933348851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40054,-0.00804108127964544,0.0118976627999963,-0.0313605003676383,0.0152783378083474,0.499147828638537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39719,0.0036224422354226,0.00537111419990653,-0.0069049415963942,0.0141498260672394,0.500052588516719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39706,0.00262809689240129,0.00390146161378381,-0.00501876787061498,0.0102749616554176,0.500568670587671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42094,0.00232134531967282,0.0034465220007947,-0.0044338378018848,0.00907652844123044,0.50062050998643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41861,-0.00300199622372495,0.00445709569945128,-0.0117379037946494,0.00573391134719955,0.500621237414523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39881,-0.00479682337361506,0.00712887141251787,-0.0187694113421501,0.00917576459491995,0.501042793040485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40054,-0.00248833839446972,0.00371006939294504,-0.009760074404642,0.00478339761570255,0.502426809805117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42186,-0.00477121234322556,0.00711875882303282,-0.0187239796363699,0.00918155494991876,0.502722502595645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39719,0.00354104222117225,0.00528937778873899,-0.00682613824475617,0.0139082226871007,0.503214921054471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39881,-0.00372765404726335,0.00557163553182593,-0.0146480596896422,0.00719275159511547,0.503483611462474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,42180,-0.00259063690189651,0.00390333489594046,-0.0102411732979398,0.00505989949414679,0.506895182502347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40054,-0.00512883894413534,0.00772988528978921,-0.0202794141121222,0.0100217362238515,0.50701948941013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41861,0.00863989580548108,0.0130410201323403,-0.0169205036539059,0.0342002952648681,0.507652082309715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39719,0.00615005401656133,0.00929218501722837,-0.0120626286172063,0.0243627366503289,0.508080374748826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39768,-0.00472869189331789,0.00715275698887297,-0.0187480955915089,0.00929071180487313,0.50856220798297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41829,-0.00320696327636508,0.00485608540479634,-0.0127248906697659,0.00631096411703574,0.50900862011223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41876,0.00405699045066865,0.00614510184606088,-0.00798740916761069,0.016101390068948,0.509138086889836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41876,0.00369381307835996,0.00559624857481535,-0.00727483412827812,0.014662460284998,0.509232674897242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42248,0.00355703735402497,0.00538908134099877,-0.00700556207433263,0.0141196367823826,0.509236459235566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41813,0.00246531473365385,0.00375079448422424,-0.00488624245542567,0.00981687192273336,0.511014161119658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39784,0.00300029375633404,0.00456913066968677,-0.00595520235625203,0.0119557898689201,0.511423904788176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,42172,0.00216321390121613,0.00329658456851807,-0.00429809185307928,0.00862451965551154,0.511708037343952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42296,-0.00213199693037956,0.00326487327629156,-0.00853114855191101,0.00426715469115189,0.513760888412738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,40113,0.00177517588257878,0.00272282221253283,-0.00356155565398557,0.00711190741914312,0.514439583118973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39653,-0.0029458610207764,0.00452714372505989,-0.0118190627218938,0.00592734068034099,0.515247526345458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39719,0.00746120530556033,0.0114685782633331,-0.0150172080905725,0.0299396187016932,0.515333103303282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39881,-0.00410926319802025,0.0063259117478312,-0.0165080502237694,0.00828952382772889,0.515969606394239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39706,-0.00269269311986881,0.00414699774798592,-0.0108208087059212,0.00543542246618359,0.516151272810761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41861,-0.0030756609950153,0.00475659348959704,-0.0123985842346255,0.0062472622445949,0.517896089123659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,42154,0.00303813150172988,0.00470665501922842,-0.00618691233595781,0.0122631753394176,0.518616615920033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39992,-0.00300182816395525,0.00465039130040858,-0.0121165951127561,0.00611293878484556,0.518616853188165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42167,0.00462820290779311,0.00717130164290552,-0.00942754831230171,0.0186839541278879,0.518693435793482
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42120,-0.00502237431509331,0.00781594121392097,-0.0203416190943784,0.0102968704641918,0.520507495478743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39665,0.0030474466073975,0.00475609863547827,-0.00627450671813991,0.0123693999329349,0.521702368492223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39665,0.002241282664039,0.0035022121539454,-0.00462305315769399,0.00910561848577199,0.522211311956392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39784,0.00283144179809058,0.00443147422672734,-0.005854247686295,0.0115171312824762,0.522876421466311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41829,0.00466511928204545,0.0073144663413786,-0.00967123474705662,0.0190014733111475,0.523619651879951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39881,-0.00241570099031666,0.00378777650869647,-0.00983974294736173,0.00500834096672842,0.523642099357196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42256,-0.00179009537113506,0.0028151327114666,-0.0073077554856096,0.00372756474333947,0.524863746455778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40097,0.00150683153722033,0.00237480042952676,-0.00314777730465212,0.00616144037909277,0.525762202781477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,42178,-0.00398930385161814,0.00628806323114939,-0.016313907784671,0.00833530008143467,0.52581474493274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40054,0.00512811584638414,0.00811086397851846,-0.010769177551512,0.0210254092442803,0.527235060117591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39665,0.00374113169262127,0.00591954360872753,-0.00786117378048468,0.0153434371657272,0.527402868352856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39665,0.00517235226289295,0.00818585913691915,-0.0108719316454686,0.0212166361712545,0.527489338766834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39881,0.00289634278816064,0.00459567872137822,-0.00611118750574067,0.0119038730820619,0.528556423368137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39665,0.00469320307898985,0.00744855760017377,-0.00990596981735075,0.0192923759753304,0.528654596169474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,40054,0.00625159422733384,0.00994140451955072,-0.0132335586309856,0.0257367470856532,0.529464308752887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39804,0.0055098892480402,0.00878108460220429,-0.0117010365722802,0.0227208150683606,0.530363049575294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42240,0.0020124796348824,0.00320970018884348,-0.00427853273525083,0.00830349200501563,0.530670693994856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,40021,0.00430129359569797,0.00686615386340229,-0.00915636797657051,0.0177589551679664,0.531033840877865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42243,-0.0033695532873951,0.00539193689174128,-0.013937749595208,0.00719864302041781,0.532031560364484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,42103,0.00363351134114872,0.00582794360234981,-0.00778925811945691,0.0150562808017543,0.532990857939992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42126,0.00174752767867728,0.00280837951343934,-0.00375689616766383,0.00725195152501839,0.533785297297072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39719,-0.00396995763618385,0.00638433320414765,-0.0164832507163133,0.00854333544394555,0.534068391298241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39784,0.0039657015521441,0.00638174252069805,-0.00854251378842408,0.0164739168927123,0.534340906103808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39665,-0.00488384545829689,0.00785998949134753,-0.020289424861338,0.0105217339447443,0.534379458266256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,42094,0.0122321981909399,0.019747307326162,-0.0264725241683376,0.0509369205502175,0.535639939920499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41887,0.00409632822317431,0.00662538209741195,-0.00888942068775311,0.0170820771341017,0.536403172122391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39768,0.00264492883451299,0.0042956318817524,-0.00577450965372171,0.0110643673227477,0.538089149548615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39665,-0.00368693180468921,0.00599864320942492,-0.0154442724951621,0.00807040888578364,0.538814024044109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39873,0.00154223854246305,0.00251691689590948,-0.00339091857351952,0.00647539565844563,0.540055304688144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39784,0.00344480846312242,0.00562638215692093,-0.00758290056444261,0.0144725174906874,0.540378927775697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39768,-0.00269421635342909,0.00441047897728103,-0.0113387551488999,0.00595032244204173,0.54130071957343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39784,-0.00181502403209703,0.00297378107979868,-0.00764363494850244,0.00401358688430838,0.541648257192189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41861,0.0055256289690777,0.00905519987849824,-0.0122225627927788,0.0232738207309343,0.541729597338175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41829,-0.00418895460632412,0.00686581507055156,-0.0176459521446052,0.00926804293195693,0.541794881962392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39784,0.00178243532281874,0.00292198803520887,-0.00394466122619065,0.00750953187182813,0.541869767969428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39768,0.00749080208053793,0.0123125022745516,-0.0166417023775833,0.0316233065386591,0.542941973605659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40080,0.0017228571865667,0.00283296436641409,-0.00382975297160492,0.00727546734473832,0.543103043018744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40054,-0.00314770700492134,0.00518310771320786,-0.0133065981228087,0.00701118411296606,0.543663806966992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42094,-0.0036865110745893,0.00607849718210217,-0.0156003655515096,0.00822734340233096,0.544204099236093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,40054,0.00432588506299437,0.00714741190924476,-0.00968304227912536,0.0183348124051141,0.545033537962744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,42184,0.00226293655787101,0.00374401105052316,-0.00507532510115438,0.0096011982168964,0.545578300616777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39755,-0.00180461727971622,0.00299368304969724,-0.0076722360571228,0.00406300149769036,0.546649103817036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,42213,-0.00232333195281031,0.00385779300573687,-0.00988460624405458,0.00523794233843397,0.547022346820698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39922,-0.00264082250561467,0.00439020943311931,-0.0112456329945285,0.00596398798329919,0.547502806732976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42095,-0.00259511718497652,0.00432126401399153,-0.0110647946523999,0.00587456028244687,0.548153060982693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41887,0.00340989029362007,0.00570402098578763,-0.00776999083852369,0.0145897714257638,0.54998094984593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40054,-0.00470969402823256,0.00788626665093225,-0.0201667766640598,0.0107473886075947,0.550384990506944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41887,0.00353766036834313,0.00594696245048135,-0.00811838603460031,0.0151937067712866,0.551942008300116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41887,-0.00178899520944228,0.00301371141834089,-0.00769586958939043,0.00411787917050587,0.552777803043983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41861,-0.0035172530719962,0.00594109085840783,-0.0151617911544755,0.00812728501048314,0.553846808284432
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42262,0.00116817915976959,0.00197719783423798,-0.00270712859533685,0.00504348691487604,0.554647476818615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,40054,0.00140686556850378,0.00238312306220612,-0.00326405563342021,0.00607778677042776,0.554971438930242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39665,-0.00349538940544761,0.00594297229037889,-0.0151436150945902,0.00815283628369502,0.55644088295823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39706,-0.00237079788244369,0.0040316336576187,-0.0102727998513763,0.00553120408648898,0.556512079273626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39706,-0.00214637673262098,0.00365372488380865,-0.00930767750488593,0.00501492403964397,0.55691486513494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39784,-0.00443482077600546,0.00755148823996307,-0.0192357377263331,0.0103660961743222,0.55702972422415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41829,0.00310748747448553,0.00530080111040921,-0.00728208270191651,0.0134970576508876,0.557731583242942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39706,0.00210372889883767,0.00359145616704033,-0.00493552518856137,0.00914298298623671,0.558049843970816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39863,0.00243457724931334,0.00415904575569808,-0.0057171524318549,0.0105863069304816,0.558311880521011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39863,-0.0050525687106358,0.00863720539978077,-0.0219814912942061,0.0118763538729345,0.558575380983893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,42078,0.00277907597436562,0.00476063589508454,-0.00655177038000007,0.0121099223287313,0.55939099996649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39881,-0.00181650947584937,0.00311356207562194,-0.00791909114406837,0.00428607219236963,0.559623970305648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39881,0.00259323158089692,0.0044533080887225,-0.00613525227299918,0.011321715434793,0.560366281594523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,42061,-0.00356975057601119,0.00613099169628814,-0.0155864943007359,0.00844699314871356,0.560410625031007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41810,-0.00207853686578001,0.00358310438908791,-0.00910142146839231,0.00494434773683229,0.561861682017958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39665,-0.00154660047634215,0.00267353355050271,-0.00678672623532746,0.00369352528264316,0.562948804642333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39706,0.00414680175071735,0.00717818611163795,-0.00992244302809304,0.0182160465295277,0.563482473460579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40054,0.00549030378985316,0.00950940141017637,-0.0131481229740925,0.0241287305537989,0.563711397975982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39706,-0.00400785580643868,0.00694827204026325,-0.0176264690053546,0.00961075739247728,0.564077927350084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40020,0.00261489420399593,0.00454805107632766,-0.00629928590560627,0.0115290743135981,0.56533821512514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39784,0.00330949581397838,0.00576069649347325,-0.00798146931322918,0.0146004609411859,0.565644559615718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39651,0.00210623567656354,0.00367703432221296,-0.00510075159497385,0.00931322294810094,0.566786833289179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,42223,-0.00129587484759394,0.0022625061803259,-0.00573038696103271,0.00313863726584483,0.566816548537158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39784,0.00164911141515596,0.00289149905285056,-0.00401822672843113,0.00731644955874306,0.568465349530912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39706,0.00198982662637888,0.00349673199891482,-0.00486376809149416,0.00884342134425193,0.569332176839564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39881,0.00368186828106451,0.00647110962534941,-0.00900150658462033,0.0163652431467493,0.569388346995091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39706,0.00406079799965116,0.0071552634895731,-0.00996351843991212,0.0180851144392144,0.570368993317948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39719,-0.00208558834406887,0.00368575586184748,-0.00930966983328993,0.0051384931451522,0.571507191475374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41829,0.00420504346635456,0.00744601189809983,-0.0103891398539211,0.0187992267866302,0.572262228460743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39881,-0.00237797017079978,0.00421768244812595,-0.0106446277691267,0.00588868742752708,0.572895496990083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42186,-0.00142150231723069,0.00252293397968083,-0.00636645291740513,0.00352344828294374,0.573150319741239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39784,0.00512567001081384,0.00910632082266788,-0.0127227188016152,0.0229740588232429,0.573535683677156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42280,0.00165509816396569,0.00294144240163047,-0.00411012894323003,0.00742032527116142,0.573660742007127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,42122,-0.0022506123778208,0.00400030657619517,-0.0100912132671633,0.00558998851152173,0.573710254420078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39768,0.00224264731872498,0.00398955355014161,-0.00557687763955258,0.0100621722770025,0.574039436679057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39863,0.00165024697077773,0.00294584965903152,-0.00412361836092405,0.00742411230247951,0.575358958168743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39706,0.00419770112414042,0.00750345830583839,-0.0105090771553028,0.0189044794035837,0.575876442103717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39706,0.00399815190239626,0.00714808671573835,-0.0100120980604509,0.0180084018652434,0.575947242046815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39665,0.00315819902707186,0.00567128629705775,-0.00795752211516133,0.014273920169305,0.577624561193582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42103,-0.00324563383474154,0.00583223975517498,-0.0146768237548845,0.00818555608540143,0.577879630151641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,42072,-0.00207931949456276,0.00374441378915612,-0.00941837052130876,0.00525973153218323,0.578690628596471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39719,0.00363508256026707,0.00655905997205141,-0.00922067498495369,0.0164908401054878,0.579448377690526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40113,0.00180735418106001,0.00326153657706725,-0.0045852575099918,0.00819996587211182,0.579493062968889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39706,0.00637185805732744,0.0115016765097358,-0.0161714279017547,0.0289151440164095,0.579594838306717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,42162,-0.00176741307189956,0.00319143623158273,-0.00802262808580171,0.00448780194200258,0.579726201700737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41887,-0.00182025054793839,0.00329314522396439,-0.0082748151869086,0.00463431409103183,0.58045172139889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41829,-0.00438261894721444,0.00793238373618491,-0.0199300910701369,0.011164853175708,0.580617599453594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42162,-0.00293962711422352,0.00532198200825678,-0.0133707118504068,0.00749145762195977,0.580714192961429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40054,-0.00424743495926454,0.00769376748740379,-0.019327219234576,0.0108323493160469,0.580917388024446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40020,-0.00433004760484486,0.00784527188844621,-0.0197067805061994,0.0110466852965097,0.581007121793076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42184,0.00228271406757107,0.00414463030715119,-0.00584076133444525,0.0104061894695874,0.581804787960899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41887,0.00263486228377698,0.00482060257118796,-0.00681351875575143,0.0120832433233054,0.584674449787193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39804,-0.00310608906513754,0.0056989704178889,-0.0142760710841998,0.0080638929539247,0.585746848600479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,42186,0.00389842566621116,0.00715553666750767,-0.0101264262021039,0.0179232775345262,0.585891846825264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40097,0.00206255387246132,0.00378838703860415,-0.00536268472320282,0.00948779246812545,0.586149055475578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40020,-0.0059772456092215,0.0109899349816338,-0.0275175181732237,0.0155630269547807,0.586532762178998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39784,0.00308501398933019,0.00567525895132282,-0.00803849355526254,0.0142085215339229,0.586735088068939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39768,0.00257667629968065,0.00474306691354199,-0.00671973485086166,0.011873087450223,0.586968381834374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40080,-0.00204756290159373,0.00378657805705012,-0.00946925589341198,0.00537413009022451,0.588696286676389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,42074,-0.00212030379516437,0.00392578784100541,-0.00981484796353497,0.00557424037320623,0.589139906093638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39706,-0.00276144483583272,0.0051162683450632,-0.0127893307921566,0.00726644112049114,0.589389109633318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42144,-0.00150147678713092,0.00278653817135323,-0.00696309160298326,0.00396013802872141,0.590011832626549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40020,0.00297516363349571,0.00553346784505504,-0.00787043334281216,0.0138207606098036,0.590817945223589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39784,-0.00195464818229985,0.00363814187010014,-0.00908540624769612,0.00517610988309642,0.591095507324743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39719,0.00276844510892158,0.00515405610976632,-0.00733350486622041,0.0128703950840636,0.591182882396355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39881,-0.00355654929958982,0.00663789395377306,-0.016566821448985,0.00945372284980538,0.592111502025129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39706,-0.00238356557731491,0.00445498093931017,-0.0111153282183628,0.00634819706373302,0.592637771748071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39706,0.0052474879843874,0.00983884679959132,-0.0140366517428116,0.0245316277115864,0.593806885781294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,42256,-0.000481392834018826,0.000902652777494947,-0.00225059227790892,0.00128780660987127,0.593828784760132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39665,-0.00285854209929999,0.0053626735759567,-0.0133693823081751,0.00765229810957514,0.594014289748517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39881,-0.00701830081603477,0.0131681640595167,-0.0328279023726875,0.018791300740618,0.594062043261935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39665,-0.00136102078475429,0.00255873981312051,-0.0063761508184705,0.00365410924896191,0.594799212095923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41861,0.00194178261493557,0.00365410541071212,-0.00522026399006019,0.00910382921993133,0.595152645913464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40054,-0.00446056661623587,0.00839571934388798,-0.0209161765302563,0.0119950432977846,0.595228296566602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39719,-0.00329283101388293,0.00622176191724571,-0.0154874843716845,0.00890182234391865,0.596647264275547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41861,-0.00293846018682249,0.00555565574114264,-0.0138275454394621,0.00795062506581708,0.5968748659091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,40020,0.00207043649437206,0.00391564567764947,-0.00560422903382089,0.00974510202256502,0.596982844580598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39804,0.00228545885601489,0.00435173628574232,-0.00624394426404006,0.0108148619760698,0.599466805697134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39768,0.00489966012372439,0.00934579347272543,-0.0134180950828175,0.0232174153302662,0.600106140553685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42075,0.0014094641867452,0.00268851512773011,-0.0038600254636058,0.00667895383709621,0.60011106857975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41887,0.00421647201095103,0.00805298550591581,-0.011567379580644,0.020000323602546,0.600572073271988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,42004,0.00175307054100703,0.00334844493703167,-0.00480988153557504,0.0083160226175891,0.60060224420271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42079,-0.00472413527513119,0.00907128462344965,-0.0225038531370925,0.0130555825868301,0.60252962579932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39706,-0.00533751764104429,0.0102618470928392,-0.0254507379430092,0.0147757026609206,0.602982353649015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39706,0.00244318803811633,0.00469884328335886,-0.00676654479726703,0.0116529208734997,0.603105743552497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39665,-0.00347148973230903,0.00671734575316675,-0.0166374874085159,0.0096945079438978,0.605310285874431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42184,-0.00225684966529654,0.00436815830828711,-0.0108184399495393,0.0063047406189462,0.605402799497467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39706,0.00322169109711947,0.00626486534167235,-0.00905744497255834,0.0155008271667973,0.607089799316338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42103,0.00435318295615829,0.00851322685038824,-0.0123327416706027,0.0210391075829192,0.609119317089442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39754,0.00205756030755175,0.00402453564625804,-0.00583052955911401,0.0099456501742175,0.609183837128007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39646,-0.00139094803279465,0.00272408540222264,-0.00673015542115103,0.00394825935556172,0.60963423975165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41829,0.00351595700368509,0.00688992049297545,-0.0099882871625468,0.017020201169917,0.609847108600692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40020,-0.00190620425181167,0.00375839601909517,-0.00927266044923821,0.00546025194561486,0.612034945045412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39706,0.00312880516521232,0.00617075872080596,-0.00896588192756737,0.015223492257992,0.612139245999258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42004,-0.00513302911320622,0.0101502505662751,-0.0250275202231054,0.014761461996693,0.613072690791577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39686,0.00324434397657263,0.0064469792870307,-0.00939173542600753,0.0158804233791528,0.614809803403318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40102,0.00139963114147601,0.00278305628225213,-0.00405515917173816,0.00685442145469018,0.615036615744014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39706,-0.00257956738430319,0.00516597006950074,-0.0127048687205246,0.00754573395191826,0.617551436234435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,42085,0.0026879748364168,0.00538925217413909,-0.00787495942489582,0.0132509090977294,0.617952872338789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39768,0.00184399865465148,0.00370025666262095,-0.00540850440408558,0.00909650171338854,0.618252355915541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40054,-0.00381388196053487,0.00767505970491048,-0.0188569989821594,0.0112292350610897,0.619256326249155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42094,-0.00442977563373358,0.00897616397541215,-0.0220230570255414,0.0131635057580742,0.621664694706139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39804,0.00407934018320766,0.00826776671229172,-0.0121254825728841,0.0202841629392994,0.621738136511698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41876,0.00294235937269803,0.00596621481807945,-0.00875142167073769,0.0146361404161337,0.621900869217983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39651,0.00208313637807671,0.00422611814954125,-0.00620005519502415,0.0103663279511776,0.622079762737774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42213,-0.00153557469304133,0.0031182684527189,-0.00764738086037038,0.00457623147428772,0.622413328253931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40021,-0.00282699541521594,0.00574358931130077,-0.0140844304653654,0.00843043963493357,0.622587851015712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,42146,0.00171374954680578,0.00348590568710341,-0.0051186255999169,0.00854612469352846,0.622994590257974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41829,-0.00202774040087556,0.00415435919482649,-0.0101702844227355,0.00611480362098436,0.625487876914965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41876,-0.00238357067186682,0.00489049279502826,-0.0119689365501222,0.00720179520638857,0.62599136113081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42094,-0.0044493959826594,0.00916955191164935,-0.0224217177294921,0.0135229257641733,0.627517243097892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39804,-0.00257950648560737,0.00531893335194002,-0.0130046158554098,0.00784560288419506,0.627709855331423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42144,0.00144233706783927,0.00297683213015445,-0.00439225390726346,0.007276928042942,0.628024504965184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39768,0.00275884326601368,0.00571232866160151,-0.00843732091072528,0.0139550074427526,0.629132021830331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41861,-0.00236166949508982,0.00491786356108076,-0.0120006820748081,0.00727734308462847,0.63107737202336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39719,0.00271181097052456,0.00566707615264423,-0.00839565828865814,0.0138192802297072,0.63228987036348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41887,-0.00414194804545562,0.00868022492663221,-0.0211551889016547,0.0128712928107435,0.633248867521512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39784,-0.00129390628072496,0.00271807438623221,-0.0066213320777401,0.00403351951629017,0.634057234616763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39706,0.00230843627519669,0.00486434090621396,-0.00722567190098266,0.011842544451376,0.635108332761679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39793,-0.00268284437903635,0.00566793159067876,-0.0137919902967667,0.00842630153869403,0.635982184342459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39768,0.00295289737725933,0.00624982912060715,-0.00929676769913068,0.0152025624536493,0.636596463946663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,40033,0.00350481346233696,0.0074385770090152,-0.0110747974753328,0.0180844244000068,0.637530825918468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42144,-0.00221692031980502,0.00470849388693252,-0.0114455683381928,0.00701172769858271,0.637767014390221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40021,-0.0024694704751985,0.00524640840358146,-0.0127524309462182,0.00781348999582116,0.637866367130278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39881,-0.00190464006220954,0.00404744500079578,-0.00983763226376927,0.00602835213935019,0.637951462179804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39881,0.00297040752670485,0.00633222106043209,-0.00944074575174205,0.0153815608051517,0.63901194668023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,40020,0.00266807800792182,0.00570571266654907,-0.00851511881851437,0.013851274834358,0.640069200608791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39804,-0.00256402887297037,0.00550149265777581,-0.013346954482211,0.00821889673627021,0.641181704361248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,42255,0.00132548672610111,0.00284435414574112,-0.00424944739955148,0.0069004208517537,0.641218818872838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39768,0.00377739830877251,0.00811403259043957,-0.012126105568489,0.0196809021860341,0.641555130044757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39804,0.00153675246068528,0.00330228488731569,-0.00493572591845347,0.00800923083982404,0.64168297247912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39706,-0.00244768072990018,0.00526317778136318,-0.012763509181372,0.00786814772157166,0.641899854799536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42186,0.0025066687417053,0.00539811344797441,-0.00807363361632454,0.0130869710997351,0.642397520550542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39768,-0.00143042146755835,0.00308318260306812,-0.00747345936957187,0.00461261643445517,0.64269802275186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39719,-0.00245823539155561,0.00530105725432457,-0.0128483076100318,0.00793183682692056,0.642854019544291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42186,0.00114367531510378,0.00246707295036869,-0.00369178766761885,0.00597913829782642,0.642959462305933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40069,-0.00224465092128839,0.00484519453880271,-0.0117412322173417,0.00725193037476493,0.64317750704188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39719,0.00353546164291986,0.00768189687707757,-0.0115210562361522,0.0185919795219919,0.64535856915981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41829,-0.00251193131046974,0.00546162848697216,-0.0132167231449352,0.0081928605239957,0.645579042737519
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,40054,-0.00167283260021954,0.00364102597841206,-0.00880924351790718,0.00546357831746809,0.64592749964375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42186,-0.00326893577342729,0.00711665109750425,-0.0172175719245356,0.010679700377681,0.646000410727637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39768,-0.00229870412113309,0.00501051029143158,-0.012119304292339,0.00752189605007282,0.646404137826241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39784,0.00197920463150192,0.00433502944678662,-0.00651745308419985,0.0104758623472037,0.647996104107774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39719,0.0033947393731121,0.00744803040321219,-0.0112034002171838,0.017992878963408,0.648550245004544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39881,-0.00400359046655434,0.00879716017783435,-0.0212460244151097,0.013238843482001,0.649046308216995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39784,0.00130719262044339,0.00287635159927526,-0.00433045651413613,0.0069448417550229,0.649505621171377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39706,0.00277139338392809,0.00610504776679689,-0.00919450023899381,0.01473728700685,0.649873367164832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40020,-0.00159112144216971,0.00351736692250401,-0.00848516061027756,0.00530291772593815,0.651017628224412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39767,-0.00386825750193402,0.00856279013177368,-0.0206513261602104,0.0129148111563424,0.651456924628046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42120,-0.00292069103209642,0.00646952856469751,-0.0156009670189035,0.00975958495471071,0.651670337124769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39665,-0.00401383142751078,0.00890137438463905,-0.0214605252214033,0.0134328623663818,0.652054627426825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39784,-0.00133917057046788,0.00298412813253921,-0.00718806171024473,0.00450972056930896,0.653610780497029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39706,-0.00273142920366158,0.00608668770756537,-0.0146613371104897,0.00919847870316654,0.653617931340942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39719,0.00199586340611117,0.00445108735336351,-0.00672826780648131,0.0107199946187037,0.653874447111431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39881,-0.00201661222829251,0.00450069265562825,-0.0108379698333239,0.00680474537673887,0.654113866522212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40054,0.0021894655175636,0.0048881073063369,-0.00739122480285672,0.0117701558379839,0.654222158192855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39881,0.00202438893365925,0.00452210753420895,-0.00683894183339028,0.0108877197007088,0.654404112037613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,40054,-0.0073163236333595,0.016346049233602,-0.0393545801312193,0.0247219328645003,0.654458249502157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40113,-0.000906635328783896,0.00202612943881587,-0.004877849028863,0.00306457837129521,0.654543484310626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41887,-0.00149724863148703,0.00336011038564319,-0.00808306498734769,0.00508856772437363,0.655897370103133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40080,-0.00222411029691116,0.00499456228806052,-0.0120134523815098,0.00756523178768746,0.656107234943757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40021,-0.00408911314518069,0.0092057446386076,-0.0221323726368516,0.0139541463464902,0.656913044173596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40020,0.00204680835819821,0.00461078669726178,-0.00699033356843487,0.0110839502848313,0.657111189493857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41861,-0.00238067376937158,0.00537492203622754,-0.0129155209603776,0.00815417342163439,0.657829374159428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39784,-0.0013280383454631,0.00301160505478932,-0.00723078425285017,0.00457470756192396,0.659241105881844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40054,0.00437149771616302,0.00992689769810883,-0.0150852217721303,0.0238282172044563,0.659678659603653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,40054,-0.00216436039988606,0.00491492489701538,-0.0117976131980362,0.00746889239826408,0.659681608532364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41861,0.00222470188359857,0.00509107508639607,-0.00775380528573774,0.0122032090529349,0.662132747014125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40102,0.00168294519858779,0.00386771598278471,-0.00589777812767024,0.00926366852484582,0.663479315434926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39784,0.00116436269370036,0.00268942652604261,-0.00410691329734316,0.00643563868474387,0.665066535295824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41984,-0.00152147188980467,0.00352545154450812,-0.00843135691704059,0.00538841313743125,0.666062732063141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42099,-0.00104644116589734,0.00242604750743486,-0.00580149428046966,0.00370861194867498,0.666231421241157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39706,-0.0021286774419208,0.00494973900020365,-0.0118301658823199,0.00757281099847834,0.667161886422891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39881,0.00276000608041876,0.00644610075165946,-0.00987435139283378,0.0153943635536713,0.668538342388915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40544,-0.00139661997340322,0.0032668207585508,-0.00779958866016278,0.00500634871335634,0.669011236360802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,40113,0.000851801621642716,0.00199433521356624,-0.00305709539694711,0.00476069864023255,0.669307226354184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,42093,-0.00382563602614892,0.00896567410926746,-0.0213983572803131,0.0137470852280153,0.669606362350305
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41861,-0.0037429480846652,0.0088032640206803,-0.0209973455651986,0.0135114493958682,0.670714648498843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42213,0.00123705556775089,0.00293129440026457,-0.00450828145676768,0.00698239259226945,0.673019702243768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42181,-0.00249408796355268,0.00591056561238222,-0.0140787965638218,0.00909062063671648,0.673053085573882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39804,0.0116877833970826,0.0277157712676491,-0.0426351282875096,0.0660106950816748,0.673251424428328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39784,-0.00179298848553401,0.00428309791344257,-0.0101878603958814,0.00660188342481343,0.675502694862401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,42120,-0.00144885956105077,0.00346139781528415,-0.00823319927900771,0.00533548015690617,0.675532668206587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39784,-0.000928638490103764,0.00222293804846254,-0.00528559706509035,0.00342832008488282,0.676136367550478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,40097,-0.00384391498866593,0.00921869417120203,-0.0219125555642219,0.0142247255868901,0.676708871281776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40054,0.00317980136989212,0.00767642122790263,-0.011865984236797,0.0182255869765813,0.678714101578674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,40102,0.00291673756617582,0.007081737842868,-0.0109634686058454,0.0167969437381971,0.680444645818546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41861,-0.00126729700215701,0.00308860270095284,-0.00732095829602457,0.00478636429171056,0.681582545643041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39706,0.00221152837082047,0.00538991902872599,-0.00835271292548247,0.0127757696671234,0.681588185834111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42057,-0.00119998841960488,0.00293066682849053,-0.00694409540344631,0.00454411856423655,0.682209539377174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39768,0.0014041288629298,0.00344240285881544,-0.00534298074034846,0.00815123846620806,0.683361165745628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41887,0.00138599057933714,0.00339867085043036,-0.00527540428750636,0.00804738544618064,0.683424668184947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41783,0.00303564004995243,0.00745047277209234,-0.0115672865833486,0.0176385666832534,0.683689866987703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39863,-0.0043069351221285,0.0105886831012648,-0.0250607540006076,0.0164468837563506,0.684200586020602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39784,-0.00132507598893498,0.00327039021209243,-0.00773504080463615,0.00508488882676618,0.68535804555412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41861,0.00132895207478056,0.00328271476318997,-0.00510516886107179,0.00776307301063291,0.685606924842923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,42059,-0.00154049253505161,0.0038072703604952,-0.00900274244162221,0.00592175737151899,0.685764585587423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42004,-0.00331151630060763,0.00819222468414492,-0.0193682766815317,0.0127452440803164,0.686052738274643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39881,-0.00145132125820428,0.00359451879731779,-0.00849657810094714,0.00559393558453858,0.686397629727544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40021,-0.00216018409050025,0.00538081454164155,-0.0127065805921177,0.00838621241111718,0.688089093071563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39881,0.00259314758651188,0.00646809096281552,-0.0100843107006065,0.0152706058736303,0.688491529160058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41829,-0.00249444033028067,0.00626438575050757,-0.0147726364012755,0.00978375574071417,0.690493973887709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39881,-0.00277862954282372,0.00700062611979036,-0.0164998567376128,0.0109425976519654,0.691440593570051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40080,-0.00294112982278779,0.00743410863046001,-0.0175119827384894,0.0116297230929138,0.692388392571535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,40021,0.00147568217805757,0.00373209226913871,-0.0058392186694543,0.00879058302556945,0.692552949678815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39706,-0.00148797822923929,0.00378205231479935,-0.00890080076624601,0.00592484430776744,0.694008842811166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39665,0.00245395814008208,0.0062695603469459,-0.00983438013993187,0.014742296420096,0.695503401055653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41829,0.00217658351555055,0.00556751405591214,-0.00873574403403724,0.0130889110651383,0.695845579696276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40020,0.00194456309853607,0.0049824364189554,-0.00782101228261652,0.0117101384796886,0.696334545996455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,42184,-0.00364519726089207,0.00937959316048697,-0.0220291998554465,0.0147388053336624,0.69755576951619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39881,-0.00262766110855636,0.00678201932384052,-0.0159204189832838,0.010665096766171,0.698434332530099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,42094,0.00167030626842136,0.00431609846391719,-0.00678924672085633,0.010129859257699,0.698766680398693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39706,-0.00493390421069654,0.0127918248912163,-0.0300058809974805,0.0201380725760874,0.699721030984122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40054,0.00207372915361498,0.00541989628973601,-0.00854926757426759,0.0126967258814976,0.70201334539629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42103,-0.00163256263088306,0.00427029741153271,-0.0100023455574872,0.00673722029572104,0.702240297413723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42296,0.00154127707556492,0.00404080755675868,-0.0063787057356821,0.00946125988681193,0.702891885412983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,42127,0.00158143066490208,0.00415967015218498,-0.00657152283338048,0.00973438416318464,0.703816750953819
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39784,0.00113067770473536,0.00299099108406801,-0.00473166482003794,0.00699302022950866,0.705417537518983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39881,-0.0028197037207885,0.00746861654133401,-0.0174581921418032,0.0118187847002262,0.705779619371804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41876,0.000930725565628457,0.00246586315133856,-0.00390236621099513,0.00576381734225204,0.705849894792359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39706,-0.00149307083739398,0.00396060266223911,-0.00925585205538264,0.00626971038059468,0.706195543548692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41861,0.00122548851414668,0.00326927483459871,-0.0051822901616668,0.00763326718996016,0.707778110164444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39768,0.00157934461534073,0.00423303034838859,-0.00671739486750091,0.00987608409818237,0.709081323045777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39719,0.00252099689974891,0.00676039064229746,-0.0107293687591541,0.0157713625586519,0.709225181613604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42186,-0.00231596947027134,0.00622648171152737,-0.014519873624865,0.00988793468432232,0.709932603920538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39768,-0.00137510727710138,0.00371297359257218,-0.00865253551854286,0.0059023209643401,0.711127635196128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42004,0.00138624467833871,0.00374838291191119,-0.00596058582900722,0.00873307518568464,0.711519205275327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40021,-0.00288792435001212,0.00781080535833221,-0.0181971028523433,0.012421254152319,0.711587541611953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,42150,0.00257523471899377,0.00698771360880163,-0.0111206839542574,0.016271153392245,0.712478487277474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39881,-0.00088451204855156,0.002402784054837,-0.00559396879603208,0.00382494469892896,0.712791303074325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39784,-0.00115668051800754,0.00314499598587428,-0.00732087265032114,0.00500751161430606,0.713041338797802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41999,0.00379626454540221,0.0103796209953305,-0.0165477926054457,0.0241403216962501,0.714563557791922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42237,-0.00135524752547721,0.0037124351572523,-0.00863162043369173,0.0059211253827373,0.715075363366625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39719,0.00272401061372005,0.00749317812243254,-0.0119626185062477,0.0174106397336878,0.716214756159687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39804,0.00282017713824597,0.00776600253366051,-0.0124011878277286,0.0180415421042206,0.716504560219339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39665,-0.00294159022340093,0.00812775650869877,-0.0188719929804505,0.0129888125336487,0.717419798511192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39706,-0.00221662965740729,0.00612938974168739,-0.0142302335511146,0.00979697423630001,0.717628685163266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39863,0.00272162617496787,0.00752948169419868,-0.0120361579456616,0.0174794102955973,0.717760801836447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39847,0.000779397344681047,0.00215934487622255,-0.00345291861271515,0.00501171330207724,0.718150278891369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39706,-0.0013828811891286,0.0038467071853978,-0.00892242727250828,0.00615666489425108,0.719230251927447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,42144,-0.000916577459706924,0.00255193687085614,-0.00591837372658496,0.00408521880717111,0.719474273787166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39719,-0.00310330510255431,0.00866576728952339,-0.0200882089900202,0.0138815987849115,0.720267557514745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39768,-0.0013680913254625,0.00382204610534855,-0.00885930169194565,0.00612311904102065,0.72038984989679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39665,0.00318802579817229,0.00896563706135592,-0.0143846228420853,0.0207606744384299,0.72216023364157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,42106,-0.00148682909312846,0.00420466323542488,-0.00972796903456122,0.0067543108483043,0.723633721175351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39768,0.00134978014401032,0.00382054573132769,-0.00613848948939195,0.00883804977741258,0.723874250171685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41829,-0.00313066625642716,0.00886891746876587,-0.0205137444952083,0.0142524119823539,0.72409953699117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41861,-0.00288563416130289,0.00819519976227346,-0.0189482256953589,0.0131769573727531,0.724759579434311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42186,-0.00344509096332483,0.00980368432001578,-0.0226603122305558,0.0157701303039061,0.72528814349714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40021,0.00630437585346295,0.0179809883216781,-0.0289383612570262,0.0415471129639521,0.725885206519079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39768,0.00214198351604117,0.00612256926911639,-0.00985825225142696,0.0141422192835093,0.726457914613942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,40021,0.00249241597112335,0.00713597923596412,-0.0114941033313663,0.016478935273613,0.726889991849637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41861,-0.00130033175107675,0.00374114325871425,-0.00863297253815669,0.00603230903600319,0.728164379479076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41829,0.00189848710722668,0.00546989329278105,-0.00882250374662419,0.0126194779610775,0.728537473654287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40021,0.00486909036834254,0.01410794218173,-0.0227824763078483,0.0325206570445334,0.730002477510718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39784,-0.00144231575955613,0.00423432067580876,-0.0097415842841413,0.00685695276502904,0.733392613537359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39719,0.00141608518474956,0.00416528236229179,-0.00674786824534236,0.00958003861484148,0.733883347986149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,42213,-0.00154208302244662,0.00459368606549688,-0.0105457077108205,0.00746154166592726,0.737105370180434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39768,0.00266067131786241,0.00792935393023004,-0.0128808623853885,0.0182022050211133,0.737219116081291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42094,0.000744311492924098,0.00223302845043241,-0.00363242426992342,0.00512104725577161,0.738898685098824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39863,0.00256514258240426,0.00782898609233521,-0.0127796701585728,0.0179099553233813,0.743185127937405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41829,-0.00282668802532005,0.00867665337310751,-0.0198329286366108,0.0141795525859707,0.744595518577278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39622,-0.0011703080124769,0.003593880656241,-0.00821431409870927,0.00587369807375546,0.744703969870717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39706,0.0016138443537132,0.00497745981023597,-0.0081419768743493,0.0113696655817757,0.745769972830355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41829,0.00194535716656921,0.0060080551293636,-0.00983043088698345,0.0137211452201219,0.746101253037245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39665,0.00102253906207299,0.00315902556390366,-0.00516915104317818,0.00721422916732416,0.746180626525169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41887,0.00115789534975618,0.00358557394951791,-0.00586982959129892,0.00818562029081129,0.746752317462777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39719,-0.00248740987810537,0.00771074703503472,-0.0176004740667734,0.0126256543105627,0.74701217647272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39665,0.00161739597862755,0.00501968348795275,-0.00822118365775983,0.0114559756150149,0.747299474028434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,40054,-0.0033874658459374,0.0105752347739464,-0.0241149260028724,0.0173399943109976,0.748731449967025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42103,-0.00231222875864022,0.00721853796868177,-0.0164605631772565,0.011836105659976,0.748732346938481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41887,0.00190377976939083,0.00595892296288793,-0.00977570923786952,0.0135832687766512,0.74936487868868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39719,-0.00136211352450603,0.00428629537317062,-0.00976325245592044,0.00703902540690839,0.750655546364811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39881,0.00124364206823679,0.00391473759190655,-0.00642924361190006,0.00891652774837363,0.750732295331239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39768,0.00198134720458674,0.00623968200286647,-0.0102484295210315,0.014211123930205,0.750840335407031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39881,-0.00238793798229994,0.00755189102248416,-0.0171896443863689,0.012413768421769,0.751853863925858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42094,0.000689229502859962,0.00219148368076708,-0.00360607851144352,0.00498453751716344,0.753143670322103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39768,-0.000932601645551242,0.00299350928531829,-0.00679987984477509,0.0049346765536726,0.755395325645486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,40021,-0.00138476889620521,0.00448710451910353,-0.0101794937536481,0.00740995596123771,0.757623545201107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41861,-0.00210231564416347,0.00682255839554091,-0.0154745300994237,0.0112698988110967,0.757979478095558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42103,-0.00114983885517649,0.00373206856528427,-0.00846469324313365,0.00616501553278068,0.758013550683615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42126,-0.000814414306489854,0.00264757157955852,-0.00600365460242455,0.00437482598944484,0.758385554671037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39881,0.00186010798912742,0.00605896063013604,-0.0100154548459392,0.0137356708241941,0.758848464826549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42256,0.00146729134090855,0.00483390722399644,-0.00800716681812447,0.0109417494999416,0.76148207755841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41887,-0.00149043388094052,0.00492762672583726,-0.0111485822635816,0.00816771450170052,0.762302680673253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39719,-0.00180298401325698,0.00597586776582475,-0.0135156848342735,0.00990971680775953,0.762878473893421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42207,-0.000683282436996535,0.00226688432936348,-0.00512637572254896,0.00375981084855588,0.763099679543057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40097,-0.00435676141009091,0.01457063360877,-0.0329152032832802,0.0242016804630984,0.764938310530149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41861,-0.00148968982112831,0.00498382588156383,-0.0112579885489934,0.00827860890673679,0.765017535520344
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40054,0.000835173977505245,0.00279627173498959,-0.00464551862307435,0.00631586657808484,0.765194426055208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,42094,-0.000592395912026891,0.00198509186833158,-0.00448317597395678,0.003298384149903,0.765385588789789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39706,-0.00134339036835692,0.00451189504179119,-0.0101867046502677,0.00749992391355382,0.765904325514354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42256,0.00228077155349816,0.00769057491003204,-0.0127927552701646,0.017354298377161,0.766801741505247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40021,0.00168145250866012,0.00568325805565625,-0.00945773328042614,0.0128206382977464,0.767342165561297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,40054,-0.00246582871274203,0.00834451135849086,-0.0188210709753841,0.0138894135499001,0.767615257930474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39706,-0.00146707723581877,0.00497700523412571,-0.0112220074947052,0.00828785302306763,0.7681745767962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39804,-0.000872993719251404,0.00298080389703034,-0.00671536935743087,0.00496938191892806,0.769625790691275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42103,0.00115138724582288,0.00393491194171259,-0.0065610401599338,0.00886381465157957,0.769826397531066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39998,-0.000899199127595323,0.00308833487864476,-0.00695233548973905,0.00515393723454841,0.770934655321896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39768,0.00150917096518831,0.00519149483445896,-0.00866615891035125,0.0116845008407279,0.771285969352192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40021,-0.00425245095605101,0.0148425479305883,-0.0333438449000041,0.0248389429879021,0.774497529459311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41876,0.000807591212278764,0.00284776602740864,-0.00477403020144217,0.0063892126259997,0.776731048789196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,40054,0.000658338582978145,0.00232176525752251,-0.00389232132176598,0.00520899848772227,0.776759989373008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,40054,0.00159256560412263,0.00562541128084652,-0.00943324050633654,0.0126183717145818,0.777103987257909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,40038,0.0018770863042544,0.00664824711623732,-0.0111534780435707,0.0149076506520795,0.777685874398363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39768,0.00176206031149398,0.00627114299740587,-0.0105293799634215,0.0140535005864095,0.778731903658528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41770,-0.00192483541772172,0.00685147242846777,-0.0153537213775186,0.0115040505420751,0.778762972397407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41829,0.000932904797013349,0.00332316567378135,-0.00558049992359809,0.00744630951762479,0.778923825129216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39719,-0.00161587973703175,0.00576592590738242,-0.0129170945155013,0.0096853350414378,0.779294010061859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39719,-0.000921233662235649,0.0033197496375879,-0.00742794295190794,0.00558547562743664,0.7814009303627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42262,0.000950598401104542,0.0034367442371984,-0.00578542030380432,0.00768661710601341,0.782092768627468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40020,-0.00123111995697935,0.00445818072545323,-0.00996915417886767,0.00750691426490897,0.782439275545557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41985,-0.00210442114794069,0.00763967509552072,-0.0170781843351613,0.0128693420392799,0.782967679867492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39706,0.0023449317198183,0.00859801992616837,-0.0145071873354717,0.0191970507751083,0.785066688248604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42223,-0.000971224756651192,0.00358810604142203,-0.00800391259783837,0.00606146308453598,0.786642259818574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39784,0.00132831525728592,0.00492635228769848,-0.0083273352266031,0.0109839657411749,0.78744659668838
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42184,-0.00287728101660586,0.0107189277546863,-0.023886379415791,0.0181318173825793,0.788372667048661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39804,-0.000704341024409122,0.00262562909156562,-0.00585057404387773,0.00444189199505949,0.788507409099192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41650,0.000919675899757085,0.00346800586296774,-0.00587761559165969,0.00771696739117386,0.790868502569497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39831,-0.00231382177751396,0.00874447985410273,-0.0194530022915553,0.0148253587365274,0.791319891499365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39881,-0.00205597982360595,0.00779708695269985,-0.0173382702508977,0.0132263106036858,0.792027249509425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39665,0.00259400927929901,0.00986926405096613,-0.0167497482605946,0.0219377668191926,0.792681268073735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39784,0.00120012477754571,0.00457719578193131,-0.00777117895503966,0.0101714285101311,0.793175040686249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39768,0.00159921757504627,0.00610268737940116,-0.01036204968858,0.0135604848386726,0.793286944229099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39864,-0.00143464017689106,0.0054894918343005,-0.01219404417212,0.00932476381833792,0.793833065617098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,40080,0.00142229213599533,0.0054714418631224,-0.00930173391572458,0.0121463181877152,0.794908551951457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42215,-0.000770631412244191,0.00297787735473213,-0.00660727102751916,0.00506600820303078,0.795804854344176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42222,-0.000665487910812755,0.00260408676377818,-0.00576949796781799,0.00443852214619248,0.798298350293725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41829,-0.00118468384705903,0.00464735272203364,-0.010293495182245,0.0079241274881269,0.79879224663636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,42213,0.00152939240739509,0.00600265510643268,-0.010235811601213,0.0132945964160031,0.798892423061033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,42122,0.000824777959670949,0.00325039097860327,-0.00554598835839146,0.00719554427773336,0.799694818812941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,40080,-0.000782769367333338,0.00309193201089704,-0.00684295610869153,0.00527741737402485,0.800145392192602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39784,0.00126162266854812,0.00498800008313853,-0.00851485749440339,0.0110381028314996,0.800326006120184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41985,0.000981486470624739,0.0038909320276528,-0.00664474030357475,0.00860771324482422,0.800852110978906
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39764,0.000989027914848213,0.00393234399341921,-0.00671836631225344,0.00869642214194987,0.801423919694039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,42256,0.00159068686076667,0.00634376373975177,-0.0108430900691468,0.0140244637906801,0.802012794875428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41861,-0.00165795930030335,0.00665821404399348,-0.0147080588265306,0.0113921402259239,0.803357382927673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42004,0.00196914899383456,0.00798719453231937,-0.0136857522895114,0.0176240502771805,0.805269546082618
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39768,-0.00198154385976375,0.00804304807893519,-0.0177459180944767,0.0137828303749492,0.805402716507322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,42186,-0.0015620917143747,0.00635195400153335,-0.0140119215573801,0.0108877381286307,0.805745707950605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40020,0.00105502234933772,0.00430343926057727,-0.00737971860139373,0.00948976330006917,0.80633878036034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39706,-0.000993236007675923,0.00406410014636272,-0.00895887229454685,0.00697240027919501,0.806931541027231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,40020,-0.00205105851223527,0.00839447477800897,-0.0185042290771329,0.0144021120526623,0.806976514773042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39863,0.00142255436975978,0.0058881873551384,-0.0101182928463115,0.012963401585831,0.809098936467154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,42184,-0.0010453653763053,0.00435570267867205,-0.00958254262650251,0.00749181187389191,0.810334624948515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39804,-0.00147022540594769,0.00614566548305802,-0.0135157297527414,0.010575278940846,0.8109321330373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39768,-0.000773483177348204,0.00326343676926452,-0.00716981924510666,0.00562285289041026,0.812649813483648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39881,0.00131734197973797,0.00559603555434451,-0.00965088770677726,0.0122855716662532,0.813897913502012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39768,0.000892089453458473,0.0037921316548724,-0.00654048859009142,0.00832466749700837,0.814021203885925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40054,0.00078204342392723,0.00332529707922839,-0.00573553885136041,0.00729962569921487,0.814073449322637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42186,-0.00193469362924358,0.00825385815143878,-0.0181122556060636,0.0142428683475764,0.814679160611094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,40097,-0.00104722564598947,0.00448768442551982,-0.00984308712000832,0.00774863582802938,0.81548978001303
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42004,-0.00222440149915527,0.0095381464792869,-0.0209191685985576,0.016470365600247,0.815601223960244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39719,-0.00180293257873751,0.00774842615175051,-0.0169898478361685,0.0133839826786935,0.81601154047717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39768,-0.00189950620736301,0.00823633311797466,-0.0180427191185933,0.0142437067038673,0.817610428067477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40020,-0.00155687571060023,0.00676448132335728,-0.0148152591043805,0.01170150768318,0.817976077215671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42094,-0.00196948000335692,0.00857988847971255,-0.0187860614235935,0.0148471014168797,0.818448127809267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42296,-0.000895567200599478,0.00391790519681886,-0.00857466138636445,0.00678352698516549,0.819196471920555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39768,0.00251595077348192,0.0110586693982625,-0.0191590412471126,0.0241909427940765,0.820032092072154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40080,-0.000935550727248564,0.00411997602406156,-0.00901070373440921,0.00713960227991208,0.820368333903289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40097,-0.00058656643790344,0.00259310822053373,-0.00566905855014954,0.00449592567434266,0.821048503702827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39665,-0.00072302597915301,0.00321222413168348,-0.00701898527725263,0.00557293331894661,0.821916934231067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41829,-0.00105162419922867,0.00468312921758484,-0.010230557465695,0.00812730906723761,0.822328422605546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39706,-0.00118707388082669,0.00533101027047663,-0.0116358540109609,0.00926170624930749,0.823794075561507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40054,0.00135977103697238,0.00616047256693251,-0.0107147551942153,0.0134342972681601,0.825310621423564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39768,-0.000910874744886535,0.00414503845090702,-0.0090351501086643,0.00721340061889123,0.826069625580761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42095,0.000419570809089155,0.00194736188819873,-0.00339725849178036,0.00423640010995866,0.829415216848187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39784,-0.00191031934065603,0.00890904251759271,-0.0193720426751377,0.0155514039938257,0.830219960235104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,40097,-0.00214845582025094,0.0100372835722234,-0.0218215316218087,0.0175246199813068,0.830513990102755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41876,0.00157306377874213,0.00735663706186291,-0.0128459448625092,0.0159920724199934,0.830683694866827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40020,0.00114986219681732,0.0053818655312766,-0.00939859424448483,0.0116983186381195,0.830820170207278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,40007,-0.00130779693140993,0.00612849592483471,-0.013319648944086,0.0107040550812661,0.83102207052743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,42145,0.00227709648033197,0.0107073728241972,-0.0187093542550946,0.0232635472157585,0.831590665368884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,40097,0.000934769673804854,0.0044211508721467,-0.00773068603560268,0.00960022538321239,0.832554687043626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,42256,-0.000768588202372801,0.00365210886569693,-0.00792672157913878,0.00638954517439317,0.833319350356004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39665,-0.00101633212711918,0.00485268432434669,-0.0105275934028387,0.00849492914860034,0.83411110844502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41861,-0.00225140559243439,0.0108491472921476,-0.0235157342850438,0.019012923100175,0.835607791275681
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39665,0.00133992953874514,0.00646756232476006,-0.0113364926177846,0.0140163516952749,0.835875732604389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39881,0.00111584656051725,0.00539524800102783,-0.0094588395214973,0.0116905326425318,0.836154178093028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39768,-0.00105654201628988,0.0051313914118909,-0.011114069183596,0.00900098515101628,0.836874736160541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42256,0.0011939545762575,0.0058222188568837,-0.0102175943832345,0.0126055035357495,0.837521682912616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39719,0.000681601335611746,0.00333111898657349,-0.0058473918780723,0.00721059454929579,0.837875853831664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,42144,0.00251547424179067,0.012340914195092,-0.0216727175805896,0.026703666064171,0.838487923663159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42197,-0.000663175270287221,0.00325518887401647,-0.0070433454633595,0.00571699492278506,0.838568731831417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40020,-0.000777830458216862,0.00383844034924009,-0.00830117354272744,0.00674551262629371,0.839418417477249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39804,-0.000687748580958333,0.00341279625784425,-0.00737682924633307,0.0060013320844164,0.840295425193225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39804,-0.00186325791687483,0.00930245370751938,-0.0200960671836128,0.0163695513498632,0.841251782146456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39881,0.00144942389344277,0.00725781999357632,-0.0127759032939668,0.0156747510808523,0.841715000112427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39706,-0.00224906371187626,0.0113254129484722,-0.0244468730908817,0.0199487456671292,0.842590773919221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39784,-0.000603762960529078,0.0030833667164987,-0.00664716172486653,0.00543963580380838,0.844760374307306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39719,0.000956784850105384,0.00492934057761487,-0.00870472268201977,0.0106182923822305,0.846101352327371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41829,-0.00121699324395148,0.00631707784915808,-0.0135984658283013,0.0111644793403984,0.847235164069516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39881,0.00206178756928004,0.0107299282569574,-0.0189688718143566,0.0230924469529166,0.847626035667212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39665,-0.000832623071000582,0.00435481117287867,-0.00936805296984277,0.00770280682784161,0.84837563746956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41887,0.00157654537361994,0.00828566355605371,-0.0146633551962453,0.0178164459434852,0.84909756135178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39862,0.00106136785163699,0.00558380887005189,-0.00988289753366472,0.0120056332369387,0.849250414836354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39439,0.00100843200766467,0.0053063647414301,-0.00939204288553832,0.0114089069008677,0.849280007779011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39768,0.00106552892744747,0.0056313304093008,-0.0099718786747821,0.012102936529677,0.849928396409149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41887,0.00095068933743394,0.00502624043686141,-0.00890074191881442,0.0108021205936823,0.84998202727273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40080,0.000617649037146026,0.00326613186666292,-0.00578396942151329,0.00701926749580534,0.850012327522191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41949,0.00092793370758307,0.00492652056220761,-0.00872804659434385,0.01058391400951,0.850601540232054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42213,-0.00091293898502884,0.00485800658492312,-0.0104346318914782,0.00860875392142048,0.850938680474749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39838,-0.000951166580903003,0.00511803556753645,-0.0109825162932744,0.00908018313146844,0.852569049555341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39665,-0.00121655531219411,0.00658107906901206,-0.0141154702874577,0.0116823596630695,0.853345162682417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39774,-0.000660616277765447,0.00361162579396864,-0.00773940283394397,0.00641817027841308,0.854869142243238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41876,0.00176226520828941,0.00967523879307072,-0.0172012028261292,0.020725733242708,0.85547437316641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39768,-0.00126334303947759,0.00694526092043141,-0.0148760544435232,0.012349368364568,0.85566468242546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39719,0.000817759350949219,0.00451734091676374,-0.0080362288459077,0.00967174754780614,0.856350098749574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41887,-0.00122276426183389,0.00679114002620286,-0.0145333987131915,0.0120878701895237,0.857113935284723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39804,0.00123377174134563,0.00690130966211235,-0.0122927951963946,0.0147603386790858,0.858118915203054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40020,-0.000940622442428411,0.00529051879372331,-0.0113100392781261,0.00942879439326928,0.85888809430312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,40080,0.00116323649447357,0.00654868582846818,-0.0116721877293241,0.0139986607182712,0.859017655383034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41829,0.00111654559705798,0.00629459418120338,-0.0112208589981006,0.0134539501922166,0.859211451426248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39784,-0.000847065331914006,0.00478011437463966,-0.0102160895062077,0.00852195884237973,0.859349908788945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39768,-0.00145854465171979,0.00823237284703316,-0.0175939954319048,0.0146769061284652,0.859376806911266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39784,0.00113911450785689,0.00643727291307976,-0.0114779404017794,0.0137561694174932,0.85954628106079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39665,0.000691466635073872,0.00390837826440559,-0.00696895476316108,0.00835188803330882,0.85957538351912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39665,-0.0021278665702799,0.0120887460114778,-0.0258218087527764,0.0215660756122166,0.860281276646076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40021,0.00113188255589179,0.00653161599513082,-0.0116700847945646,0.0139338499063482,0.86242445836471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39881,-0.00119013996704539,0.0069167183438291,-0.0147469079209504,0.0123666279868596,0.863388001307789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39768,-0.000812076185811552,0.00472101410889604,-0.0100652638392478,0.00844111146762468,0.863430536366105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41861,0.000664285704486272,0.00389727103172054,-0.00697436551768599,0.00830293692665854,0.864659811251104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,40097,-0.00170344775669103,0.0100439219724997,-0.0213895348227904,0.0179826393094083,0.865327979421793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39768,-0.00106640791057452,0.00629947240397267,-0.013413373822361,0.0112805580012119,0.865575496823443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42022,0.000582727947617892,0.00346844413168865,-0.00621542255049186,0.00738087844572764,0.866579274279087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39665,0.00114638656920398,0.00685752835045914,-0.0122943689976959,0.0145871421361039,0.867237961651981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42120,-0.000891655709797882,0.00539434856918442,-0.0114645789053993,0.00968126748580357,0.868714836703814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39665,0.00071904235379873,0.00435704478059363,-0.00782076541616479,0.00925885012376225,0.868923689731528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41887,0.000716954590246744,0.00434988314868595,-0.00780881638117773,0.00924272556167121,0.869087046770389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41813,0.00101904063399685,0.00621929045023936,-0.0111707686484723,0.013208849916466,0.869850600950338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39784,0.00175788752610377,0.0107427223281841,-0.0192978482371371,0.0228136232893446,0.870021454516299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39665,0.00068267254250808,0.00417486670407919,-0.00750006619748713,0.00886541128250329,0.870112496380898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41829,-0.00119497849708414,0.00747240446413568,-0.0158408912467901,0.0134509342526218,0.872947538021559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42103,-0.00156317004333971,0.00978230341224083,-0.0207364847313317,0.0176101446446523,0.873044509769455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39881,0.000931669516585761,0.00583333794039446,-0.0105016728465874,0.0123650118797589,0.873108879802371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39768,0.00114473702340145,0.00723867713796755,-0.0130430701670149,0.0153325442138178,0.874348127681581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39784,0.000333151964070439,0.0021140375004727,-0.00381036153685605,0.00447666546499693,0.874782592317787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39804,-0.000289865306524185,0.00185843700578784,-0.00393240183786836,0.00335267122481999,0.876057562975896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,42213,0.000368064897831292,0.00237365273944128,-0.00428429447147361,0.0050204242671362,0.876774326178095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41887,-0.00148249038320243,0.00965035616149742,-0.0203971884597374,0.0174322076933325,0.877911590384469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40021,0.000889302766968207,0.00585025402179297,-0.010577195115746,0.0123558006496824,0.879181118651019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,42094,0.00119255353319271,0.00788726996573353,-0.014266495599645,0.0166516026660304,0.879820483106785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,42067,0.00129795196022671,0.00858448465158515,-0.0155276379568802,0.0181235418773336,0.879822351938418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39665,-0.000485961368536919,0.00321947555387541,-0.00679613345413273,0.00582421071705889,0.880022590354707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39999,-0.000825989472046912,0.00548168948428768,-0.0115701008612508,0.00991812191715693,0.880229740188485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41861,-0.00213547477958608,0.0143319538909881,-0.0302261044059227,0.0259551548467505,0.881555253399089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39665,-0.00101416678813107,0.00683610773879742,-0.014412937956174,0.0123846043799119,0.882065927415888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39719,-0.00112500936329027,0.00759021982862252,-0.0160018402273904,0.0137518215008099,0.882173341481973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41887,0.000690816418163212,0.00472954246927249,-0.00857908682161086,0.00996071965793729,0.883873096934915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39768,-0.00128417724017092,0.00887411975463935,-0.018677451959264,0.0161090974789222,0.884942301490075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39784,-0.000952451817985593,0.00661029030266726,-0.0139086208112134,0.0120037171752422,0.885435118722918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39706,0.000533996656164791,0.00373071566178546,-0.0067782060409347,0.00784619935326428,0.88618616514351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40054,-0.000649389094867707,0.00466425095697083,-0.00979132097053053,0.00849254278079511,0.889273452109116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41887,-0.000758050149802279,0.00545772877525597,-0.011455198549304,0.00993909824969942,0.889535483155961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39665,-0.000923501417171466,0.00678412476211894,-0.0142203859509246,0.0123733831165817,0.891723632323547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40021,-0.000637491428468453,0.00479059551898182,-0.0100270586456728,0.00875207578873592,0.894139357439947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40043,0.000929842188724527,0.007054771625029,-0.0128975101963323,0.0147571945737814,0.895142319530511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39768,-0.000690059057114302,0.00524340310858014,-0.0109671291499314,0.00958701103570278,0.895299084831779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39881,-0.00060209279885465,0.00457601289488805,-0.00957107807283523,0.00836689247512593,0.895322262952214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39768,-0.000872795806805982,0.00663422619263137,-0.0138758791443635,0.0121302875307515,0.895335185402768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40054,0.000767982744647825,0.00585217722393211,-0.0107022846142591,0.0122382501035548,0.89559558895176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42016,-0.000394075703936189,0.00300942137237044,-0.00629254159378226,0.00550439018590988,0.895819024712994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41829,-0.000390059078297095,0.0030093144692415,-0.00628831543801044,0.00550819728141626,0.896871314839955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41829,-0.000955061739248954,0.00738138458930201,-0.0154225755342809,0.013512452055783,0.897052793126032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40021,0.000565834942362805,0.00443804457581964,-0.00813273242624369,0.0092644023109693,0.898549848007975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42184,-0.00035950806171646,0.00284559714232587,-0.00593687846067516,0.00521786233724224,0.899466051948793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39706,-0.001201900725088,0.00952161635733282,-0.0198642687854603,0.0174604673352843,0.899553351861485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42184,0.000367408884466161,0.00291234557592577,-0.00534078844434834,0.00607560621328067,0.899610659806355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40054,0.000439772089199872,0.00350493658324347,-0.00642990361395732,0.00730944779235706,0.900152058120646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42186,-0.000709698433131139,0.00567430463087096,-0.0118313355096382,0.0104119386433759,0.900468233339859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,42094,-0.00104423859646123,0.00841781250044681,-0.017543151097337,0.0154546739044145,0.90127677687665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41861,0.000728722311035899,0.00589933800864996,-0.010833980185918,0.0122914248079898,0.90169245495206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41887,0.000928592911658092,0.00766727930193487,-0.0140992745201343,0.0159564603434504,0.903604925353332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42094,-0.000416853973136601,0.00348305934950407,-0.00724365029816457,0.00640994235189137,0.904738182570793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39784,0.000611529471095655,0.00511550179847495,-0.00941485405391524,0.0106379129961065,0.904846352615246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39719,0.000665667797077825,0.00559602469955357,-0.0103025406140472,0.0116338762082028,0.905314314017831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39665,0.000373052390029694,0.00314664519344323,-0.00579437218911904,0.00654047696917843,0.905629722139337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,40054,-0.000903526336307789,0.00762656066891593,-0.015851585247383,0.0140445325747674,0.905696656008562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,42120,0.000560105040475635,0.00477236187173344,-0.00879372422812191,0.00991393430907318,0.906573174861762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39784,0.000597472124048009,0.0051042788736452,-0.00940691446829659,0.0106018587163926,0.90682012345074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41829,-0.000441303165806321,0.00378301746247348,-0.00785601739225434,0.0069734110606417,0.907136297698788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40080,-0.000363508016704152,0.00311826923150825,-0.00647531571046033,0.00574829967705203,0.907200072339524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39881,0.000951010797744722,0.00819744307136275,-0.0151159776221263,0.0170179992176157,0.907644337922193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42186,0.000520359994206013,0.00450427873062117,-0.00830802631781148,0.0093487463062235,0.908030229416469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41829,0.000791571226507687,0.00685790427959241,-0.0126499211614934,0.0142330636145088,0.908110372967499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39784,0.00115311758233528,0.0100622549679457,-0.0185689021548382,0.0208751373195088,0.908765678618159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42296,-0.000825501595712687,0.00721843549818913,-0.0149736351721634,0.013322631980738,0.908954029529244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39863,0.000695382858364881,0.00613426434460003,-0.0113277752570512,0.0127185409737809,0.909746940731466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39768,-0.000602687336496488,0.00533849853048111,-0.0110661444562395,0.00986076978324649,0.910116308109798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42120,0.000494651694424115,0.00451917932344237,-0.00836293977952294,0.00935224316837117,0.912842447425734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40054,-0.00044650126426731,0.00409638958220132,-0.00847542484538189,0.00758242231684727,0.913205511016191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39706,-0.00111196351917804,0.0102427725165109,-0.0211877976515393,0.0189638706131832,0.9135529306106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42094,0.00027199810557692,0.00257927548548071,-0.00478338184596528,0.00532737805711912,0.916016227812827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39784,0.000459806142636932,0.00438242409449508,-0.00812974508257342,0.00904935736784728,0.916440876332848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39706,0.000576197983974592,0.00552596128398882,-0.0102546861326435,0.0114070821005927,0.916956212131171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42280,0.000254134308423479,0.0024550879015218,-0.00455783797855925,0.0050661065954062,0.917557161826663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42146,0.000560089163383836,0.00542901053062369,-0.0100807714766386,0.0112009498034063,0.917832841200003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40020,-0.000581900296848236,0.00566595422338848,-0.0116871705746897,0.0105233699809932,0.918202023534026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,40054,-0.000273084524146885,0.00266750701057118,-0.00550139826486639,0.00495522921657262,0.918461364750688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42094,0.000246111087911278,0.00240703360186509,-0.00447167477174431,0.00496389694756686,0.918562500936462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39881,-0.000539887278967439,0.00537809720668543,-0.0110809578040709,0.010001183246136,0.920039528977029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41829,-0.0005390003053182,0.00547335961489861,-0.0112667851505195,0.0101887845398831,0.921555057416223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,42120,0.000909101481213391,0.0092647216572485,-0.0172497529669937,0.0190679559294204,0.921834500352396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42004,-0.000786633225023523,0.00806259995084941,-0.0165893291286884,0.0150160626786413,0.922278686691636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39665,0.000603218346985868,0.00635606437707035,-0.011854667832072,0.0130611045260438,0.924392593714133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39804,0.000987071783195651,0.0104157575558963,-0.019427813026361,0.0214019565927523,0.924501559987781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,42208,0.000203702376953602,0.00214995941375913,-0.00401021807401429,0.00441762282792149,0.924517180269333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40020,-0.000395749384195594,0.00420408452595189,-0.0086357550550613,0.00784425628667011,0.925004059078737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39881,-0.000390109114935321,0.00420290455070454,-0.00862780203431621,0.00784758380444557,0.926049149610321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41876,0.000461448372750743,0.00498344052370228,-0.00930609505370573,0.0102289917992072,0.926225710989223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41876,-0.00048138464389311,0.00523995815276191,-0.0107517026233065,0.00978893333552023,0.926804341702161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40054,-0.00038686152022778,0.00428243251819827,-0.00878042925589639,0.00800670621544083,0.928021193329991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,40080,0.000427458829458803,0.004795695752941,-0.00897210484630555,0.00982702250522316,0.928977175134351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42144,0.000364860001057444,0.00409813819938565,-0.00766749086973844,0.00839721087185332,0.929058910292339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39665,0.000354299253733336,0.003990906920623,-0.00746787831068775,0.00817647681815442,0.929261131341021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39719,-0.000288348536325429,0.00325572981221331,-0.00666957896826352,0.00609288189561266,0.929428131780756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42200,-0.000592044015615802,0.00672467363293034,-0.0137724043361593,0.0125883163049277,0.929845796513282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,42132,-0.00049141004491503,0.00564460876382252,-0.0115548432220072,0.0105720231321771,0.930626518279048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42197,-0.000385302878310549,0.0044399645208547,-0.00908763333918577,0.00831702758256467,0.930847227930044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40054,0.000426207750747068,0.00500136907421332,-0.00937647563471104,0.0102288911362052,0.932089479757469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41876,0.000911161045782537,0.0108989089629293,-0.0204507005215588,0.0222730226131239,0.933374892291984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39863,0.000788143454440962,0.0095003242772747,-0.0178324921290175,0.0194087790378994,0.933885190191326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40020,0.000460721707626593,0.00565245990110737,-0.0106180996985438,0.011539543113797,0.935039328185805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39719,-0.000308008483806301,0.00381896655190388,-0.0077931829255379,0.0071771659579253,0.935719995769735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39719,0.000775538135716725,0.00978556479526405,-0.0184041688630008,0.0199552451344343,0.936832670849109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41887,-0.000238015190629889,0.00306027514041748,-0.00623615446584815,0.00576012408458837,0.938007663559941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39719,-0.000262406824859848,0.00341167813155287,-0.00694929596270347,0.00642448231298377,0.938693185894644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39784,0.000221506687359916,0.00289473308568486,-0.00545217016058241,0.00589518353530224,0.939006378028031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,42094,-0.000699060276370339,0.00920786076238363,-0.0187464673706423,0.0173483468179016,0.939483966678281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39784,-0.000705834851473248,0.00930125330716358,-0.0189362913335139,0.0175246216305674,0.939511233451447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39865,0.000787358237316106,0.0104768339410987,-0.0197472362872373,0.0213219527618695,0.940094939489308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39784,0.0001282201250319,0.00177626680992697,-0.00335326282242496,0.00360970307248876,0.942455908667426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41876,0.000321987573359571,0.00451302432676877,-0.00852354010710721,0.00916751525382635,0.943123274533831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,40102,-0.00018293968175861,0.00257301009205367,-0.0052260394621838,0.00486016009866658,0.943319884783594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41876,-0.000241415893635929,0.00341748853933849,-0.00693969343073936,0.0064568616434675,0.943684339611743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,40054,0.00015921493414575,0.0022869975173468,-0.00432330019985398,0.00464173006814548,0.94449942972542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,40054,0.000259097575389488,0.00374906184227184,-0.00708906363546331,0.00760725878624229,0.944903352393383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39881,-0.00028483263440637,0.00418176528048984,-0.00848109258416646,0.00791142731535372,0.945696945497296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42103,0.000694552416391627,0.0102833714841822,-0.0194608556926054,0.0208499605253887,0.9461518197621
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40020,0.000663125756509796,0.00990847197180887,-0.0187574793082356,0.0200837308212552,0.946642544354709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40102,-0.00019325998193011,0.00292459674961904,-0.00592546961118343,0.00553894964732321,0.947314629149393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39863,0.000568076865579245,0.00865980731015221,-0.0164051454623191,0.0175412991934776,0.947698115241754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39719,0.000330354386536195,0.00549419689558587,-0.0104382715288121,0.0110989803018845,0.952054930330375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39768,-0.000141257478493787,0.00238880342021509,-0.00482331218211536,0.00454079722512778,0.95284716987641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39768,0.000312967914261207,0.00544403548426405,-0.0103573416348963,0.0109832774634187,0.954157375237483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40054,0.000263657661440566,0.00458802398806599,-0.00872886935516877,0.00925618467804991,0.954174651672159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39706,-0.000326475783393794,0.00588586462708983,-0.0118627704524899,0.0112098188857023,0.955766860623883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39784,0.000444572237252432,0.00816286900410636,-0.015554651010796,0.0164437954853009,0.956567518593959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40054,-0.00016370099369998,0.00302931433067062,-0.0061011570818144,0.00577375509441444,0.956905118568586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40054,0.000574281663323319,0.010960279396522,-0.0209078659538598,0.0220564292805064,0.958213625977964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,42094,8.16693961594721e-05,0.00156501807646156,-0.00298576603370518,0.00314910482602412,0.958382638791984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41861,-0.000438040066173389,0.00864342961162233,-0.0173791621049532,0.0165030819726064,0.959582137731422
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41887,-0.000247582755358446,0.00496506499280384,-0.00997911014125397,0.00948394463053708,0.960230786924358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40021,0.000391639805506036,0.00809834463106058,-0.0154811156713727,0.0162643952823848,0.961429849582471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39665,-0.000232092183658827,0.00487155810480719,-0.00978034606908093,0.00931616170176327,0.962002236380931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39784,-0.000309889323317582,0.00655328484125417,-0.0131543276121757,0.0125345489655406,0.962284876810046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,40005,0.000416684709965871,0.00898568889834121,-0.0171952655307829,0.0180286349507146,0.963014579222307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42256,-0.000197000221304003,0.00427995254259946,-0.00858570720479895,0.00819170676219094,0.96328815862996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42162,-0.000338996534966142,0.00774565542209577,-0.0155204811622739,0.0148424880923416,0.965091584509327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39606,0.0001701515887852,0.00401420420376273,-0.00769768865058974,0.00803799182816014,0.966190703402767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39706,-0.000172558601366134,0.00418222123550578,-0.00836971222295746,0.00802459502022519,0.967089375661459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39706,0.000280243711641192,0.00686382920733374,-0.0131728615347329,0.0137333489580153,0.967432945542789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39804,-0.000389316143431566,0.00983837431089587,-0.0196725297927875,0.0188938975059243,0.968435743908363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,40054,-0.000527389518192806,0.013825739211521,-0.0276258383727739,0.0265710593363883,0.969572387582192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39881,0.000148194997763566,0.00392278765201273,-0.00754046880018138,0.00783685879570851,0.969865405991512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39706,0.00014721944153517,0.00404336907437612,-0.00777778394424202,0.00807222282731236,0.970956058310209
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41829,0.00014235192409691,0.00395068131178012,-0.00760098344699213,0.00788568729518595,0.971257215616283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39881,0.000247007372312848,0.00722427614708175,-0.0139125738759674,0.0144065886205931,0.972725244907401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39881,0.000276003651014149,0.00829712056379548,-0.015986352654025,0.0165383599560533,0.97346389168259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39719,-0.00016894532093023,0.00523086724760128,-0.0104214451262287,0.0100835544843683,0.974235203998473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39784,-0.000249556117304331,0.0077948729212363,-0.0155275070429275,0.0150283948083188,0.974460358499043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,42004,-0.00029665363548502,0.00977731638558477,-0.0194601937512312,0.0188668864802611,0.975795564562617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42120,8.13293012237261e-05,0.00273598522777859,-0.0052812017452223,0.00544386034766975,0.97628620863194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39706,0.000153446773760265,0.0052812398700706,-0.0101977833715781,0.0105046769190986,0.976821224236068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41861,-0.000238180042818423,0.00826700581834974,-0.0164415114467839,0.0159651513611471,0.977015845517566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,42103,-0.000202653368292248,0.00705176272669063,-0.0140241083126059,0.0136188015760214,0.977074014867406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40021,-8.9009932048922e-05,0.0031043684662694,-0.00617357212593695,0.00599555226183911,0.977126336329592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39665,0.000170270510566075,0.00642555601163147,-0.0124238192722316,0.0127643602933638,0.97885987319107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39719,-0.000253672461902249,0.00964387450292471,-0.0191556664876347,0.0186483215638302,0.979015364238111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39706,0.00012259219730073,0.00498263405943614,-0.0096433705591941,0.00988855495379556,0.980371380757125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40054,0.00022418995920441,0.00915673965526545,-0.0177230197651159,0.0181713996835247,0.980467314218391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,40031,0.000229433981681544,0.00940397469405632,-0.0182023564186688,0.0186612243820319,0.980535948465661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40061,5.40561903587404e-05,0.00230751126960502,-0.00446866589806711,0.00457677827878459,0.981310746697573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39665,-0.00010593599452305,0.00464942763628443,-0.00921881416164052,0.00900694217259442,0.981822415647906
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41887,-0.000150065587050281,0.00676702986537972,-0.0134134441231945,0.013113312949094,0.982307918613603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39784,-0.000196975177569914,0.00932024569493423,-0.018464656739641,0.0180707063845012,0.983139066450892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41861,-0.000159895668119237,0.00757376908032667,-0.0150044830655595,0.014684691729321,0.983156828698538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40020,-7.87550602852129e-05,0.00386569689798207,-0.00765552098033006,0.00749801085975964,0.983746359203946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39863,-0.000136179955148343,0.00726324853609458,-0.0143721470858937,0.014099787175597,0.985041545664087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39784,-5.09083375712387e-05,0.00275358446723414,-0.00544793389335015,0.00534611721820767,0.985249879152489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40054,5.24789924460869e-05,0.0028938772562579,-0.0056195204298194,0.00572447841471158,0.985531895385797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39706,6.42627466704456e-05,0.00381974235031693,-0.00742243225995073,0.00755095775329162,0.986577467684539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41887,9.78599939765299e-05,0.00678426758184982,-0.0131993044664491,0.0133950244544022,0.988491501588008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39665,5.11548319558652e-05,0.00355953612603302,-0.00692553597506884,0.00702784563898057,0.988534103969947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42096,-9.93738349762035e-05,0.00691487400577091,-0.0136525268862872,0.0134537792163348,0.98853419701127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39784,8.0956900380604e-05,0.00576446706734362,-0.0112173985516129,0.0113793123523741,0.988795041798229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41683,-5.34134968430317e-05,0.00384937099269986,-0.00759818064253476,0.0074913536488487,0.98892920848644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,42213,-8.18922566961263e-05,0.00614233744550536,-0.0121208736498866,0.0119570891364944,0.989362782925844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39719,-6.62158492040891e-05,0.00556125709950052,-0.0109662797642251,0.0108338480658169,0.990500331218565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39863,-4.4360112837673e-05,0.00376013805309418,-0.00741423069690226,0.00732551047122691,0.990587420404115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42103,9.88050643610563e-05,0.0106173972290411,-0.0207112935045595,0.0209089036332816,0.992575169880503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40080,-8.151009112577e-05,0.00911122876945943,-0.0179395184792662,0.0177764982970147,0.992862292912233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,42282,3.1348771931115e-05,0.00366097968793961,-0.00714417141643053,0.00720686896029276,0.99316797147348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39706,3.05583848509139e-05,0.00413989252565466,-0.00808363096543223,0.00814474773513406,0.994110653346082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39784,-5.34118550225231e-05,0.0096227148381792,-0.0189139329378538,0.0188071092278087,0.995571388083781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42184,-4.77348218647947e-05,0.0126714631310605,-0.0248838025587434,0.0247883329150138,0.996994344386259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39784,1.01588869941262e-05,0.00302061660636057,-0.00591024966147259,0.00593056743546085,0.99731663646407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41865,-7.48096673057816e-06,0.00442479837848009,-0.00868008578855155,0.0086651238550904,0.998651051023546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40021,-6.63381246331028e-06,0.00471019401147223,-0.00923861407494888,0.00922534645002225,0.998876289901371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40021,3.15303162561872e-06,0.00598021982362392,-0.0117180778226773,0.0117243838859285,0.999579330338641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39768,1.80751673936938e-06,0.00354401686981624,-0.00694446554810047,0.00694808058157921,0.999593073172888
